Feb. 10, 2011 (Business Wire) — IPG Photonics Corporation (NASDAQ: IPGP) today announced preliminary financial results for the fourth quarter ended December 31, 2010. The Company expects sales for the fourth quarter of 2010 to be approximately $100 million compared with the previously guided range of $80 to $86 million, and earnings per diluted share to be in a range of $0.53 to $0.56 compared with previous guidance of between $0.30 and $0.35. For the fourth quarter of 2009, IPG reported sales of $54.3 million and earnings per share of $0.07. As IPG Photonics’ year-end audit is not complete, these preliminary results are subject to adjustments from the audit.
“We expect to report more than 80% year-over-year growth in revenues and a seven-fold increase in earnings per share for the fourth quarter of 2010,” said Dr. Valentin Gapontsev, IPG Photonics’ Chief Executive Officer. “Our exceptional sales performance this quarter was driven by broad-based demand strength. Geographically, China and Europe were the stand-out performers for the quarter, although we experienced significant year-over-year sales increases across nearly all regions. Materials processing, communications and advanced applications were the strongest end markets and high-power and pulsed lasers both reported triple-digit year-over-year growth. Our expected bottom-line increase was due to the excellent leverage in our business model, resulting in further improvements in gross and operating margins.”
“We continue to see strong order flow into Q1 and expect the first quarter to show robust quarterly year-over-year revenue and earnings growth, even after taking into account historical seasonal patterns which typically result in lower sequential quarterly revenue in Q1. We enter 2011 with great momentum and expect to continue to capitalize on the demand for our fiber lasers and benefit from the leverage in our business model,” concluded Gapontsev.
IPG Photonics expects to provide revenue and earnings per share guidance for the first quarter of 2011 when it announces its financial results for the fourth quarter and full year 2010 on Friday, February 25, 2011.
Chief Financial Officer, Tim Mammen, will be presenting at Stifel Nicolaus’ 9th Annual Technology, Communications & Internet Conference on Friday, February 11, 2011 at 8:00 a.m. PT/11:00 a.m. ET. A live audio webcast of the presentation will be available through the “Investors” section of IPG’s website at www.ipgphotonics.com. For those unable to listen to the live webcast, an archive of the presentation will be available on the Company’s website for approximately 90 days.
About IPG Photonics Corporation
IPG Photonics Corporation is the world leader in high-power fiber lasers and amplifiers. Founded in 1990, IPG pioneered the development and commercialization of optical fiber-based lasers for use in a wide range of applications such as materials processing, advanced, telecommunications and medical. Fiber lasers have revolutionized the industry by delivering superior performance, reliability and usability at a lower total cost of ownership compared with conventional lasers, allowing end users to increase productivity and decrease operating costs. IPG has its headquarters in Oxford, Massachusetts, and has additional plants and offices throughout the world. For more information, please visit www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by the Company and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including, but not limited to, the Company’s expectations for revenue and earnings per share for the fourth quarter of 2010 and its expectations for robust year-over-year revenue and earnings growth in the first quarter of 2011. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of the business conditions in industries and geographic markets that the Company serves, particularly the effect of economic downturns; reduction in customer capital expenditures; potential order cancellations and push-outs and financial and credit market issues; the Company’s ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG’s products; effective management of growth; level of fixed costs from its vertical integration; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; inventory write-downs; foreign currency fluctuations; competitive factors, including declining average selling prices; building and expanding field service and support operations; uncertainties pertaining to customer orders; demand for products and services; development of markets for the Company’s products and services; and other risks identified in the Company’s SEC filings. Readers are encouraged to refer to the risk factors described in the Company’s Annual Report on Form 10-K (filed with the SEC on March 12, 2009) and its periodic reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
IPG Photonics Corporation
Tim Mammen, 508-373-1100
Chief Financial Officer
or
Sharon Merrill Associates, Inc.
David Calusdian, 617-542-5300
Executive Vice President
Thursday, February 10th, 2011UncategorizedComments Off on IPG (IPGP) Photonics Expects to Exceed Fourth-Quarter Guidance
VANCOUVER, BRITISH COLUMBIA–(Marketwire – 02/08/11) – Exeter Resource Corporation (TSX:XRC)(AMEX:XRA)(Frankfurt:EXB) (“Exeter” or the “Company”) is pleased to announce that it has optioned water rights to a total volume of 300 litres per second from a private Chilean company. The rights relate to surface water flows and are consumptive in nature. The option agreement provides for staged payments deductible from a purchase price of US$15 million. The Company can withdraw from the option at any time without penalty.
The Company has also applied for water exploration concessions over three separate water basins in its own right. Importantly with respect to obtaining permission to develop these basins, the aquifers are contained, and do not appear to contribute water to downstream catchments or basins.
Both the optioned water rights and the nearest basin are located some 100 kilometres north of the project, adjacent to water rights proposed for the Cerro Casale project, 10 kilometres south of Caspiche. Additional basins are 50-100km further north again.
AKER Solutions has begun work on two concurrent pre-feasibility studies (see Press Release dated 22 November, 2010). The first is designed to provide detailed economics for the development of the shallow, heap leachable gold-only oxide deposit. The second will focus on the development of the complete Caspiche resource. At this stage preliminary studies indicate that a gold-only heap leach project would require a water supply of less than 100 litres per second.
Yale Simpson, Exeter’s Executive Chairman said, “We are very pleased to have achieved another milestone for the project. Water is a fundamental component for any potential mining operation at Caspiche. The optioned water rights are more than sufficient to meet the needs of a gold-only oxide project at Caspiche. The oxide gold resource is a +100 metre thick blanket of gold bearing oxide material that overlies the large sulphide resource.
“Metallurgical studies to date have shown favourable heap leaching characteristics. Based on the measured and indicated resource for the oxide deposit, the gold-only oxide project could produce +150,000 ounces of gold per year for five years, providing early cash flow for the project.”
Jerry Perkins, Exeter’s VP Development and Operations and a “qualified person” within the definition of that term in National Instrument 43-101, Standards of Disclosure for Mineral Projects, has supervised the preparation of the technical information contained in this news release.
About Exeter
Exeter Resource Corporation is a Canadian mineral exploration company focused on the exploration and development of the Caspiche project in Chile. The project is situated in the Maricunga gold district, between the Refugio mine (Kinross Gold Corp.) and the giant Cerro Casale gold deposit (Barrick Gold Corp. and Kinross Gold Corp.). The discovery represents one of the largest mineral discoveries made in Chile in recent years. Exeter has initiated pre-feasibility studies with the aim of demonstrating the commercial viability of this world class discovery. The Company has cash reserves of $87 million and no debt.
Safe Harbour Statement – This news release contains “forward-looking information” and “forward-looking statements” (together, the “forward-looking statements”) within the meaning of applicable securities laws and the United States Private Securities Litigation Reform Act of 1995, including in relation to the Company’s belief as to the extent and timing of its drilling programs, adequacy of water resources, various studies including pre-feasibility studies, engineering, environmental, infrastructure and other studies, and exploration results, budgets for its exploration programs, the potential tonnage, grades and content of deposits, timing, establishment and extent of resources estimates, potential for financing its activities, potential production from and viability of its properties, permitting submission and timing and expected cash reserves. These forward-looking statements are made as of the date of this news release. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the future circumstances, outcomes or results anticipated in or implied by such forward-looking statements will occur or that plans, intentions or expectations upon which the forward-looking statements are based will occur.
While the Company has based these forward-looking statements on its expectations about future events as at the date that such statements were prepared, the statements are not a guarantee that such future events will occur and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, the effects of general economic conditions, the price of gold and copper, changing foreign exchange rates and actions by government authorities, uncertainties associated with legal proceedings and negotiations and misjudgements in the course of preparing forward-looking information. In addition, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Known risk factors include risks associated with project development; including risks associated with the failure to satisfy the requirements of the Company’s agreement with Anglo American on its Caspiche project which could result in loss of title; the need for additional financing; operational risks associated with mining and mineral processing; fluctuations in metal prices; title matters; uncertainties and risks related to carrying on business in foreign countries; environmental liability claims and insurance; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters of the Company with certain other projects; the absence of dividends; currency fluctuations; competition; dilution; the volatility of the Company’s common share price and volume; tax consequences to U.S. investors; and other risks and uncertainties, including those described in the Company’s Annual Information Form for the financial year ended December 31, 2009 dated March 25, 2010 filed with the Canadian Securities Administrators and available at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company is under no obligation to update or alter any forward-looking statements except as required under applicable securities laws.
Cautionary Note to United States Investors – The information contained herein and incorporated by reference herein has been prepared in accordance with the requirements of Canadian securities laws, which differ from the requirements of United States securities laws. In particular, the term “resource” does not equate to the term “reserve”. The Securities Exchange Commission’s (the “SEC”) disclosure standards normally do not permit the inclusion of information concerning “measured mineral resources”, “indicated mineral resources” or “inferred mineral resources” or other descriptions of the amount of mineralization in mineral deposits that do not constitute “reserves” by U.S., unless such information is required to be disclosed by the law of the Company’s jurisdiction of incorporation or of a jurisdiction in which its securities are traded. U.S. investors should also understand that “inferred mineral resources” have a great amount of uncertainty as to their existence and great uncertainty as to their economic and legal feasibility. Disclosure of “contained ounces” is permitted disclosure under Canadian regulations; however, the SEC normally only permits issuers to report mineralization that does not constitute “reserves” by SEC standards as in place tonnage and grade without reference to unit measures.
NEITHER THE TSX NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE
Contact:
Contacts:
Exeter Resource Corporation
B. Roxburgh
President
604.688.9592 or Toll-free: 1.888.688.9592
604.688.9532 (FAX)
Exeter Resource Corporation
Rob Grey
VP Corporate Communications
604.688.9592 or Toll-free: 1.888.688.9592
604.688.9532 (FAX)
exeter@exeterresource.comwww.exeterresource.com
Tuesday, February 8th, 2011UncategorizedComments Off on Exeter (XRA) Secures Option to Purchase Water Rights for the Caspiche Gold-Copper Project in Chile
TORONTO, CANADA–(Marketwire – 02/08/11) – An independent mineral resource model for Seabridge Gold’s (TSX:SEA)(AMEX:SA) Iron Cap Zone at its 100% owned KSM project estimates a new indicated resource containing 5.1 million ounces of gold and 1.7 billion pounds of copper immediately adjacent to the Mitchell deposit. The indicated resource is flanked by a halo of inferred resources containing an additional 3.4 million ounces of gold and 1.3 billion pounds of copper. The Iron Cap resource estimate was prepared by Resource Modeling Inc. (“RMI”) of Stites, Idaho and will be incorporated into an updated Preliminary Feasibility Study (“PFS”) scheduled for completion in April 2011.
The NI 43-101 compliant global resource estimate is as follows:
Iron Cap Mineral Resources at 0.50 g/t Gold Equivalent Cutoff-Grade
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Gold Copper
Tonnes Gold (000 of Cu (millions
Resource Category (000) (g/t) ounces) (%) of lbs)
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Indicated 361,700 0.44 5,117 0.21 1,674
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Inferred 297,300 0.36 3,441 0.20 1,310
----------------------------------------------------------------------------
----------------------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
Silver Moly
Silver (000 of Moly (millions
Resource Category (g/t) ounces) (ppm) of lbs)
-----------------------------------------------------------------
-----------------------------------------------------------------
Indicated 5.4 62,796 47 37.5
-----------------------------------------------------------------
-----------------------------------------------------------------
Inferred 3.9 37,278 60 39.3
-----------------------------------------------------------------
-----------------------------------------------------------------
A new global resource estimate for the KSM project, including the Mitchell, Sulphurets and Kerr zones, will be released shortly.
Seabridge Gold President and CEO Rudi Fronk said “the Iron Cap resource has exceeded our expectations. Our objective was to book a five million ounce gold resource in all categories. In fact, we have achieved more than five million ounces of indicated resources with a superior copper grade which should help us optimize mine plans to maintain a favorable copper head grade. We expect that most of the indicated resource should qualify as reserves in our new PFS and improve the economics for the KSM project.”
RMI estimated gold and copper grades using inverse distance weighting methods within geologically constrained gold and copper grade domains that were constructed for the Iron Cap zone. The grade models were validated visually and by comparisons with nearest neighbor models. The estimated block grades were classified into indicated and inferred mineral resource categories based on mineralized continuity that was determined both visually and statistically (i.e. variogram ranges) together with the proximity to drill hole data. To facilitate comparisons with previous resource estimates, recoverable gold equivalent grades were calculated using the same $650 gold price with a 70% recovery rate and a $2.00 copper price with an 85% recovery rate. The cutoff grade for resource tabulation was set at 0.50 grams per tonne (g/t) gold equivalent, also consistent with the cutoff grade used for previous KSM resource estimates.
The resource model for Iron Cap incorporates data from a total of 51 core holes (41 drilled by Seabridge in 2010 plus 10 holes drilled by previous operators) totaling about 17,700 meters. Grades from the 10 holes drilled by previous operators were compared with nearby holes drilled by Seabridge. The grades of the older holes were found to be comparable with the newer holes. For example, the average gold grade of the old and new holes within 50 meters of one another was 0.43 and 0.45 g/t, respectively. RMI reviewed the quality assurance/quality control protocols and results from Seabridge’s 2010 drilling program and has deemed that the number and type of gold and copper standard reference materials (standards, blanks, and duplicates) were reasonable. Based on the performance of those standard reference materials, RMI believes that the Seabridge drill samples are reproducible and suitable for estimating mineral resources. RMI constructed a preliminary block model in August 2010 using ten historic and eight 2010 Seabridge drill holes that had been completed as of that date. After the 2010 drilling campaign was completed, RMI compared the grades from 33 Seabridge core holes that were completed after the preliminary block model had been constructed. This comparison showed that the newly obtained drill hole intervals were slightly higher in grade (gold, copper, silver, and molybdenum) than the estimated preliminary model blocks. The infill drilling program also validated and expanded the volume of mineralization that was established by the initial ten drill holes.
Gold resource estimates included herein were prepared by Resource Modeling Inc. under the direction of Michael Lechner, who is independent of Seabridge and a Qualified Person as defined by National Instrument 43-101. Mr. Lechner is a highly regarded expert in his field and frequently undertakes independent resource estimates for major mining companies. Mr. Lechner has reviewed and approved this news release. The independent technical report detailing the Iron Cap resource model, plus updated resource estimates for the Mitchell, Sulphurets and Kerr zones will be filed on SEDAR at www.sedar.com.
Exploration activities by Seabridge Gold at KSM have been conducted under the supervision of William E. Threlkeld, Registered Professional Geologist, Senior Vice President of the Company and a Qualified Person as defined by National Instrument 43-101. An ongoing and rigorous quality control/quality assurance protocol was employed during the 2010 program including blank and reference standards in every batch of assays. Cross-check analyses are being conducted at a second external laboratory on 10% of the samples. Samples were assayed at Eco Tech Laboratory Ltd., Kamloops, B.C., using fire assay atomic adsorption methods for gold and total digestion ICP methods for other elements.
Seabridge holds a 100% interest in several North American gold projects. The Company’s principal assets are the KSM property located near Stewart, British Columbia, Canada and the Courageous Lake gold project located in Canada’s Northwest Territories. For a breakdown of Seabridge’s mineral reserves and mineral resources by category please visit the Company’s website at http://www.seabridgegold.net/resources.php.
All reserve and resource estimates reported by the Corporation were calculated in accordance with the Canadian National Instrument 43-101 and the Canadian Institute of Mining and Metallurgy Classification system. These standards differ significantly from the requirements of the U.S. Securities and Exchange Commission. Mineral resources which are not mineral reserves do not have demonstrated economic viability.
This document contains “forward-looking information” within the meaning of Canadian securities legislation and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995. This information and these statements, referred to herein as “forward-looking statements” are made as of the date of this document. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events and include, but are not limited to, statements with respect to: (i) the amount of mineral reserves and mineral resources; (ii) any potential for the increase of mineral reserves and mineral resources, whether in existing zones or new zones; (iii) the amount of future production; (iv) further optimization of the PFS including metallurgical performance; (v) completion of and submission of the Environmental Assessment Application; and (vi) potential for engineering improvements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects”, “anticipates”, “plans”, “projects”, “estimates”, “envisages”, “assumes”, “intends”, “strategy”, “goals”, “objectives” or variations thereof or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements.
All forward-looking statements are based on Seabridge’s or its consultants’ current beliefs as well as various assumptions made by them and information currently available to them. These assumptions include: (i) the presence of and continuity of metals at the Project at modeled grades; (ii) the capacities of various machinery and equipment; (iii) the availability of personnel, machinery and equipment at estimated prices; (iv) exchange rates; (v) metals sales prices; (vi) appropriate discount rates; (vii) tax rates and royalty rates applicable to the proposed mining operation; (viii) financing structure and costs; (ix) anticipated mining losses and dilution; (x) metallurgical performance; (xi) reasonable contingency requirements; (xii) success in realizing further optimizations and potential in exploration programs and proposed operations; (xiii) receipt of regulatory approvals on acceptable terms, including the necessary right of way for the proposed tunnels; and (xiv) the negotiation of satisfactory terms with impacted First Nations groups. Although management considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect. Many forward-looking statements are made assuming the correctness of other forward looking statements, such as statements of net present value and internal rates of return, which are based on most of the other forward-looking statements and assumptions herein. The cost information is also prepared using current values, but the time for incurring the costs will be in the future and it is assumed costs will remain stable over the relevant period.
By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, projections and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. We caution readers not to place undue reliance on these forward-looking statements as a number of important factors could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates assumptions and intentions expressed in such forward-looking statements. These risk factors may be generally stated as the risk that the assumptions and estimates expressed above do not occur, but specifically include, without limitation: risks relating to variations in the mineral content within the material identified as mineral reserves or mineral resources from that predicted; variations in rates of recovery and extraction; developments in world metals markets; risks relating to fluctuations in the Canadian dollar relative to the US dollar; increases in the estimated capital and operating costs or unanticipated costs; difficulties attracting the necessary work force; increases in financing costs or adverse changes to the terms of available financing, if any; tax rates or royalties being greater than assumed; changes in development or mining plans due to changes in logistical, technical or other factors; changes in project parameters as plans continue to be refined; risks relating to receipt of regulatory approvals or settlement of an agreement with impacted First Nations groups; the effects of competition in the markets in which Seabridge operates; operational and infrastructure risks and the additional risks described in Seabridge’s Annual Information Form filed with SEDAR in Canada (available at www.sedar.com) for the year ended December 31, 2009 and in the Corporation’s Annual Report Form 40-F filed with the U.S. Securities and Exchange Commission on EDGAR (available at www.sec.gov/edgar.shtml). Seabridge cautions that the foregoing list of factors that may affect future results is not exhaustive.
When relying on our forward-looking statements to make decisions with respect to Seabridge, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Seabridge does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by Seabridge or on our behalf, except as required by law.
Tuesday, February 8th, 2011UncategorizedComments Off on Seabridge (SA) Reports Major New Gold/Copper Resource at KSM’s Iron Cap Zone
WESTLAKE, Texas, Feb. 8, 2011 (GLOBE NEWSWIRE) — Animal Health International, Inc. (Nasdaq:AHII), a leading distributor of animal health products in the United States and Canada, today reported its financial results for the Company’s second fiscal quarter, which ended December 31, 2010.
Results include the following highlights.
Three Months Ended December 31, 2010
Net sales increased 16.3%, to $198.2 million, compared to $170.5 million for the same period a year ago. The increase in net sales was primarily attributable to improving economics in the beef market as well as continued growth in our veterinary business.
Gross margin increased $3.1 million for the quarter, with $4.5 million due to higher sales volume partially offset by a shift in mix to lower margin products of $0.9 million and a special one-time promotional rebate received last year of $0.5 million. Margin for the quarter was 16.4% of net sales, compared to 17.3% last year.
Selling, General and Administrative (SG&A) expenses declined to 12.5% of sales this year compared to 13.8% in the same period last year. SG&A expenses increased $1.3 million from the same period last year largely due to increased sales.
Adjusted earnings before interest, tax, depreciation and amortization (Adjusted EBITDA) increased by 29.8% or $1.9 million to $8.1 million for the quarter, compared to $6.2 million last year.
Net income increased 52.5% to $1.9 million, or $0.07 per fully diluted share, compared to $1.2 million or $0.05 per fully diluted share in last year’s second quarter. The net income for the quarter included a one-time adjustment for the completion of the FY2010 Canadian tax provision of $0.4 million. Net income excluding this adjustment would have been $2.3 million and an 87.1% increase over last year. Earnings per share would have been $0.09 without the one-time tax provision.
Fiscal Year to Date December 31, 2010
Net sales for the year to date were $374.7 million, an increase of 12.9% compared to $331.8 for the same period a year ago. Sales to beef producers and veterinarians led the increase.
Gross margin increased $4.5 million, compared to the same period last year, with $7.2 million due to the increase in volume, offset $2.0 million by a shift in mix to lower margin product and a special one-time promotional rebate received last year of $0.5 million. Margins for the first half were 16.0% of net sales, compared to 16.7% last year.
SG&A expenses declined to 13.2% of sales compared to 14.0% last year. SG&A increased $3.3 million from the same period last year primarily due to increased sales volume.
Adjusted EBITDA for the first half of the fiscal year increased 16.7% or $1.6 million to $11.2 million, compared to $9.6 million in the same period last year.
Net income was $1.3 million or $0.05 per fully diluted share, compared to last year’s net income of $0.5 million or $0.02 per fully diluted share. The net income for the year to date included a one-time adjustment for the completion of the FY2010 Canadian tax provision of $0.4 million. Net income excluding this adjustment would have been $1.8 million. Earnings per share would have been $0.07 without the one-time tax provision.
Jim Robison, Chairman and Chief Executive Officer, stated, “We are executing well and pleased with our second quarter results. With the refinancing of our debt completed during the quarter and good results, we are optimistic about the year.”
At December 31, 2010, the Company’s availability under its revolving credit facility totaled $30.1 million, and the Company is in compliance with all of its financial covenants.
Fiscal Year 2011 Guidance
The following statements are based on current information and the Company assumes no obligation to update them. These statements are forward-looking and inherently uncertain.
Management forecasts that our Adjusted EBITDA for the fiscal year ending June 2011 will be in the range of $25 – $27 million. This guidance excludes any projections of future acquisitions.
Conference Call
The Company plans to host its investor conference call today at 10:00 a.m. Eastern Time to discuss these results and its business outlook. You can access the conference call by dialing 877-407-9210. Participants will be required to register their name and company affiliation for the conference call. Audio replay will be made available by accessing the Company’s web site at www.ahii.com under the Investor Relations tab.
Use of Non-GAAP measures
Adjusted EBITDA represents net income (loss) before interest expense, income tax expense, depreciation and amortization, goodwill impairment, stock-based compensation expense, and acquisition costs. We present Adjusted EBITDA as a supplemental performance measure because we believe it facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expense), tax positions (such as the impact on periods or companies of changes in effective tax rates or net operating losses), the age and book depreciation of fixed assets (affecting relative depreciation expense), the non-cash impact of stock-based compensation expenses and the impact of purchase accounting. Because Adjusted EBITDA facilitates internal comparisons of our historical financial position and operating performance on a more consistent basis, we also use Adjusted EBITDA in measuring our performance relative to that of our competitors and in evaluating acquisition opportunities. Adjusted EBITDA is not a measurement of our financial performance under generally accepted accounting principles in the United States, or GAAP, and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as a measure of our profitability or liquidity. We understand that although Adjusted EBITDA is frequently used by securities analysts, lenders and others in their evaluation of companies, Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
Adjusted EBITDA does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments. Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and Adjusted EBITDA does not reflect any cash requirements for such replacements;
Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
Adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
Other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.
About Animal Health International, Inc.
Animal Health International, Inc., through its wholly owned subsidiaries, is engaged in the distribution of animal health products in the United States and Canada. The Company’s subsidiaries distribute more than 40,000 products sourced from over 1,500 manufacturers to over 71,000 customers, including veterinarians, production animal operators, and animal health product retailers. Products the Company’s subsidiaries distribute include pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, sanitizers, pet foods, devices and supplies. The Company was founded in 1954, and has its corporate headquarters located in Westlake, Texas.
The Animal Health International logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3240
Safe Harbor for Forward-Looking Statements
Certain items in this press release may constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Animal Health International can give no assurance that expectations will be attained. Factors that could cause actual results to differ materially from our expectations include, but are not limited to, the current general economic conditions, our inability to maintain relationships with manufacturers, an adverse change in manufacturer rebates or our inability to meet applicable rebate targets, the outbreak of infectious disease within an animal population, the loss of products or delays in product availability from one or more manufacturers, the loss of key personnel, the consolidation among animal health product vendors, consolidation among our customers, currency exchange rates and other risks detailed in our filings with the Securities and Exchange Commission, including our 2010 Annual Report on Form 10-K, which was filed on September 10, 2010. Such forward-looking statements speak only as of the date of this press release. Animal Health International expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Animal Health International’s expectations with regard thereto or change in events, conditions, or circumstances on which any such statement is based.
ANIMAL HEALTH INTERNATIONAL, INC.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
Three months ended December 31,
Six months ended December 31,
2010
2009
2010
2009
Net sales
$198,220
$170,487
$374,695
$331,816
Direct cost of products sold
165,745
141,071
314,830
276,454
Gross Profit
32,475
29,416
59,865
55,362
Selling, general, and administrative expenses (including salary, wages, commission, and related benefits)
24,793
23,540
49,595
46,328
Depreciation and amortization
2,006
2,022
3,943
4,000
Operating income
5,676
3,854
6,327
5,034
Other income (expense):
Other income
167
166
308
300
Interest expense
(2,176)
(2,068)
(3,757)
(4,579)
Income before income taxes
3,667
1,952
2,878
755
Income tax expense
(1,809)
(734)
(1,535)
(284)
Net income
$1,858
$1,218
$1,343
$471
Income per share:
Basic
$0.07
$0.05
$0.05
$0.02
Diluted
$0.07
$0.05
$0.05
$0.02
Weighted average shares outstanding:
Basic
24,794
24,691
24,794
24,691
Diluted
25,396
24,691
25,284
24,691
ANIMAL HEALTH INTERNATIONAL, INC.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
Assets
December 31, 2010
June 30, 2010
Current assets:
Cash and cash equivalents
$1,736
$2,243
Accounts receivable, net
92,924
77,954
Merchandise inventories, net
109,908
99,545
Other current assets
4,409
5,097
Total current assets
208,977
184,839
Noncurrent assets:
Property, plant, and equipment, net
14,411
14,657
Goodwill and other intangible assets, net
122,373
122,391
Other noncurrent assets, net
4,570
3,044
Total assets
$350,331
$324,931
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
$99,437
$94,705
Accrued liabilities
13,809
9,891
Current portion of long-term debt
433
129,339
Total current liabilities
113,679
233,935
Noncurrent liabilities:
Long-term debt, net of current portion
144,600
—
Other noncurrent liabilities
23,524
24,532
Total liabilities
281,803
258,467
Stockholders’ equity
68,528
66,464
Total liabilities and stockholders’ equity
$350,331
$324,931
ANIMAL HEALTH INTERNATIONAL, INC.
Adjusted EBITDA Reconciliation
(In thousands)
(Unaudited)
Three months ended December 31,
Six months ended December 31,
2010
2009
2010
2009
Net income
$1,858
$1,218
$1,343
$471
Interest expense
2,176
2,068
3,757
4,579
Income tax expense
1,809
734
1,535
284
Depreciation and amortization
2,006
2,022
3,943
4,000
Stock-based compensation
222
140
436
245
Acquisition costs
22
55
230
55
Adjusted EBITDA
$8,093
$6,237
$11,244
$9,634
CONTACT: Animal Health International, Inc.
William F. Lacey
817-859-3000
Tuesday, February 8th, 2011UncategorizedComments Off on Animal Health International, Inc. (AHII) Reports Its Second Quarter of Fiscal 2011 Earnings
Feb. 8, 2011 (Business Wire) — Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a commercial healthcare company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, announced today it had received a new FDA 510(k) clearance for its uniquely formulated Microcyn-based Epicyn™ HydroGel. Under the supervision of a healthcare professional, it is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis and radiation dermatitis. Epicyn HydroGel may also be used to relieve the pain of first- and second-degree burns and can help to relieve dry waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process. The hydrogel is a shelf-stable hypochlorous acid formulation based on the company’s proprietary Microcyn Technology platform.
“Our newly approved dermatology indication opens two interesting new markets to Oculus — atopic dermatitis, which afflicts 15 million U.S. patients, and radiation dermatitis, with over one million U.S. patients. The use of the proprietary Microcyn Technology for these challenging skin afflictions is truly a unique approach and adds both depth and breadth to Oculus’ dermatology product portfolio,” said Hoji Alimi, founder and CEO of Oculus. “And in line with our business strategy, we plan to partner this new indication at the earliest for faster commercialization.”
About Atopic Dermatitis
More than 15 million patients have symptoms of atopic dermatitis, characterized by itchy skin, which can lead to rash, redness, swelling, crusting and scaling. The disease affects up to 20 percent of infants and young children, who continue to have symptoms as adults with significant impact on their quality of life. The exact cause is unknown, but genetics are considered a key factor.
In a 2009 GlobalData study, it was estimated the global atopic dermatitis therapeutics market delivered revenues of $643 million in 2009. It is expected to grow to $810 million at a Compound Annual Growth Rate (CAGR) of 3.4% by 2016. This growth is primarily attributed to an increase in competition among existing products and the presence of a strong pipeline with more emerging therapies. Globally, the United States remains the largest market for atopic dermatitis therapeutics, and generated revenue of $402 million in 2009. It is forecast to grow at a CAGR of 3.8% over the next seven years to reach $582 million by 2016.
About Radiation Dermatitis
Radiation dermatitis is an unintended and often unavoidable skin reaction commonly experienced by patients receiving radiation therapy as part of their cancer treatment. This side effect, caused by radiation passing through skin cells, is often unpleasant and painful and may contribute to poor quality of life in cancer patients. In some cases, radiation dermatitis may become so severe as to necessitate interruption or cessation of radiation therapy. A wide variety of products have been used to treat radiation dermatitis with little or no evidence to support their use. According to estimates from the International Agency for Research on Cancer (IARC), there were 12.7 million new cancer cases in 2008 worldwide, of which 5.6 million occurred in economically developed countries and 7.1 million in economically developing countries. Of the total cancer patients, approximately 60 percent receive radiation treatment, and up to 95% of those are afflicted with radiation dermatitis.
About Oculus Innovative Sciences
Oculus Innovative Sciences is a commercial healthcare company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, which significantly reduces the need for antibiotics while reducing infections and accelerating healing. The Microcyn Technology addresses the need for improved solutions in multiple markets, including dermatology, oral care, cosmeceutical, wound care and others. It features a biocompatible, shelf-stable solution that is currently commercialized in the United States, Europe, India, China and Mexico and select Middle East countries under various country-specific regulatory clearances and approvals. Several solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores; increase blood flow to the wound site; and reduce both inflammation and pain while assisting in faster wound closure. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. More information can be found at www.oculusis.com.
Forward-Looking Statements
Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the Company’s commercial and technology progress and future financial performance. These forward-looking statements are identified by the use of words such as “opens,” “adds” and “plan,” among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the Company’s business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the Company’s patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the Company’s products will not be as large as expected, the Company’s products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to fund further development and clinical studies, the Company may not meet its future capital needs, and its ability to obtain additional funding, as well as uncertainties relative to varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission, including the annual report on Form 10-K for the year ended March 31, 2010. Oculus Innovative Sciences disclaims any obligation to update these forward-looking statements except as required by law.
Oculus, Epicyn and Microcyn Technology are trademarks or registered trademarks of Oculus Innovative Sciences, Inc. All other trademarks and service marks are the property of their respective owners.
Tuesday, February 8th, 2011UncategorizedComments Off on Oculus Innovative Sciences (OCLS) Receives New FDA 510(k) Clearance for Microcyn-Based Dermatology HydroGel
TIRAT CARMEL, ISRAEL — (Marketwire) — 02/07/11 — D. Medical Industries Ltd. (NASDAQ: DMED)(TASE: DMDC) (“D. Medical” or the “Company”), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today that its subsidiary, Spring-Set Health Solutions Ltd. (formerly “Medx- Set Ltd.”), has achieved ISO 13485:2003 and ISO 9001:2008 certifications. Spring-Set designs and markets the Company’s Universal Detach Detect Infusion Sets.
ISO 13485:2003 is an internationally recognized standard developed to ensure that companies provide medical devices that consistently meet regulatory requirements. In order to obtain the certification, Spring-Set demonstrated the ability to consistently meet strict requirements for Quality Management Systems (QMS) applicable to medical device manufacturing and related services.
ISO 9001:2008 is an internationally recognized quality management standard. The standard focuses on defining customer quality requirements, use of data to analyze the processes, meeting applicable customer and regulatory requirements, enhancing customer satisfaction and continually improving business performance.
“The achievement of both ISO 13485:2003 and ISO 9001:2008 certifications demonstrates our continued commitment to the highest levels of quality management and design controls to ensure the delivery of safe and effective products to our international customer base. In addition, as we prepare to launch our Universal Detach Detect Infusion Sets in the United States, Canada, Europe, Mexico and the BRIC countries of Brazil, Russia, India and China – commencing in 2011 – we believe these certifications will help to simplify and, in some cases, potentially shorten this key product’s regulatory pathway in those markets,” said Efri Argaman, D. Medical’s Chief Executive Officer.
About D. Medical
D. Medical is a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery. D. Medical has developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient’s body, using its proprietary spring-based delivery technology. D. Medical believes that its spring-based delivery mechanism is cost-effective compared to the motor and gear train mechanisms that drive competitive insulin pumps and also allows it to incorporate certain advantageous functions and design features in its insulin pumps. D. Medical has also developed an infusion set for insulin pumps and is focusing its research and development efforts on the development of next generation insulin pumps and a device that will combine a continuous glucose monitoring system and an insulin pump on the same patch. For more information, please visit http:www.dmedicalindustries.com (corporate) and http://www.springnow.com (healthcare professionals, patients and care givers).
Forward-Looking Statements
This press release contains forward-looking statements (as defined by the Israeli Securities Law, 1968, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) that involve risks and uncertainties. These statements include, forecasts, goals, uncertainties and assumptions and relate, inter alia, to D. Medical’s future expectations in connection with its level of sales and cost of sales, manufacturing volumes, the cost-effectiveness of its spring-based design, target markets, regulatory approvals and timing of markets penetration. The forward-looking statements are based on D. Medical’s current expectations and beliefs which are based on, among other things, its analysis of publicly available information and market research reports. All forward-looking statements are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the impact of general economic conditions, competitive products, product demand, product performance, the performance of D. Medical’s contract manufacturer and distributors, regulatory trends and approvals and healthcare reform legislation. If one or more of these risks and/or uncertainties materialize, or if the underlying assumptions prove to be incorrect, D. Medical’s actual results, performance or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements or results which are based upon such assumptions. No assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or of any of them will transpire or occur, what impact it will have on D. Medical’s results of operations or financial condition. D. Medicals does not undertake to update any forward-looking statements.
Contacts:
D. Medical Industries Ltd.
Amir Loberman
Chief Financial Officer
+972-73-2507135
info@springnow.com
D. Medical Industries Ltd.
Stephen Kilmer
North American Investor Contact
T: 212.618.6347
M: 905-906-6908
stephen@dmedicalindustries.com
NEW YORK, Feb. 7, 2011 (GLOBE NEWSWIRE) — Vringo, Inc. (NYSE Amex:VRNG), a provider of video ringtones and personalization solutions for mobile devices, today announced that it will exhibit at the upcoming GSMA Mobile World Congress 2011 (MWC) to be held February 14-17 in Barcelona, Spain. MWC is the leading mobile industry event of the year with 50,000 attendees from over 200 countries.
Conference participants are encouraged to join us at our booth (No. 7D46, Hall P7 – App Planet) where they can demo the latest iteration of Vringo’s award-winning video ringtone platform which has been successfully deployed for leading carrier partners such as Orange UK, Maxis, Etisalat and more. Vringo will also be demonstrating its new video remix platform for Android which it recently released with T-Pain’s Nappy Boy Entertainment.
Andrew Perlman, President of Vringo, said, “Mobile carriers around the world should be looking at Vringo’s popular service and apps that bring video ringtones, user-generated video content, and social networking to both smart phones and feature phones. We look forward to meeting with prospective new carrier and content partners at the upcoming MWC conference in Barcelona.”
Vringo’s fully-hosted carrier platform has now been deployed for international partners in six markets with new launches anticipated in the next quarter. Vringo’s scalable, cloud-based, distributed application architecture enables a carrier’s subscribers to browse and download mobile videos, set them as video ringtones and instantly share them with friends. In addition to carrier partners, Vringo has content partnerships with major content providers including EMI, T-Pain, Marvel, Discovery Mobile, Ingrooves and Agence France-Presse.
About Vringo
Founded in 2006, Vringo (NYSE Amex:VRNG) is bringing about the evolution of ringtones. With its award-winning video ringtone application and mobile software platform, Vringo transforms the basic act of making and receiving mobile phone calls into a highly visual, social experience. By installing Vringo’s application, which is compatible with more than 200 handsets, users can create or take video, images and slideshows from virtually anywhere and make them into their personal call signature. Vringo’s patented VringForward™ technology allows users to share video clips with friends with a simple call. Vringo has launched its service with various international mobile operators and dozens of content partners, and maintains a library of more than 5,000 video ringtones and growing. For more information, visit http://ir.vringo.com.
For more information about how video ringtones work, visit www.vringo.com/p_video_ringtones.html.
The Vringo, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8289
Forward-Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Vringo expressly disclaims any obligation to publicly update any forward-looking statements contained herein, whether as a results of new information, future events or otherwise, except as required by law.
CONTACT: Vringo, Inc.
Jonathan Medved
CEO
Email: jon@vringo.com
Phone: +1 646-525-4319 x 2501
Investor Relations Firm:
Crescendo Communications, LLC
John J. Quirk / David K. Waldman
Email: vrng@crescendo-ir.com
Phone: +1 212-671-1020
Monday, February 7th, 2011UncategorizedComments Off on Vringo (VRNG) to Exhibit at GSMA Mobile World Congress 2011
SUN VALLEY, Calif., Feb. 7, 2011 (GLOBE NEWSWIRE) — Emergent Group Inc. (NYSE Amex Equities:LZR), a leading provider of mobile medical lasers and surgical equipment through its wholly owned subsidiary, PRI Medical Technologies, Inc., today announced that it has signed a definitive agreement with Universal Hospital Services, Inc. (UHS), whereby UHS will make a cash tender offer of $8.46 per share for all outstanding shares of Emergent Group after a customary “go-shop” period of 21 days. UHS has estimated that the total enterprise value of the transaction including debt assumption is approximately $70 million.
Assuming that UHS acquires at least 65% of the outstanding shares on a fully diluted basis, UHS intends to promptly take appropriate action to merge Emergent Group into a wholly-owned UHS subsidiary and pay all-non-tendering holders of Emergent Group the same consideration per share as paid in the tender offer. The directors and executive officers of Emergent Group, holding in the aggregate approximately 47% of the outstanding shares, have agreed to tender their shares in the tender offer unless it is terminated as a result of a superior proposal.
The tender offer is expected to commence in early March 2011. The transaction is not subject to a financing condition. The companies expect to close the transaction within 45 to 90 days.
“This transaction represents a new opportunity for PRI Medical and its employees to bring its cost-effective solutions nationwide through Universal Hospital Services’ extensive distribution network covering all 50 states,” said Bruce J. Haber, Chairman and CEO of both Emergent Group and PRI Medical. “We also believe that the transaction will be highly beneficial to shareholders. Emergent Group’s leadership has always acted with our shareholders in mind, as evidenced by our past efforts to enhance shareholder value and our Board’s declarations of sizeable annual dividends.”
PRI Medical currently operates in 16 states and provides surgical equipment and laser technology to hospitals, outpatient surgery centers and physicians’ offices. The equipment is supplied with specialized technicians, who support its proper operation and maintenance. PRI Medical also sells its customers the consumable items required for the equipment’s operation. The company’s equipment rentals allow hospitals and other providers to conserve capital and upgrade to new, cost-effective, physician-preferred medical technologies used primarily to treat the rapidly growing older population. PRI Medical also has partnered with medical technology manufacturers, recommending rentals as one alternative to their long selling cycles and, thus, opening up additional revenue streams for them.
“PRI Medical will allow us to expand our offerings into state-of-the-art surgical equipment and services for our hospital and surgery center customers,” said Gary Blackford, Chairman and CEO of UHS. “It will enhance and expand our ability to meet our commitment to our customers to bring comprehensive solutions that reduce costs, increase efficiencies and drive better health care outcomes.”
IMPORTANT INFORMATION AND WHERE TO FIND IT
This press release is not an offer to purchase or a solicitation of an offer to sell any securities of Emergent Group Inc. The planned tender offer by UHS for all of the outstanding shares of common stock of Emergent Group has not yet been commenced. Upon commencement of the tender offer, UHS will mail to Emergent Group stockholders an offer to purchase and related materials and Emergent will mail to its stockholders a solicitation/recommendation statement with respect to such tender offer. UHS will file its offer to purchase with the Securities and Exchange Commission (the “SEC”) on Schedule TO and Emergent Group will file its solicitation/recommendation statement with the SEC on Schedule 14D-9. Emergent Group stockholders are urged to read these materials carefully when they become available since they will contain important information, including the terms and conditions of the offer. Emergent Group stockholders may obtain a free copy of these materials (when they become available) and other documents filed by UHS or Emergent Group with the SEC at the website maintained by the SEC at www.sec.gov. The offer to purchase and related materials, the solicitation/recommendation statement, the Schedule TO, and the Schedule 14D-9 also may be obtained (when they become available) for free by contacting the information agent for the tender offer (when one is selected).
About Emergent Group Inc.
Emergent Group Inc., through its wholly owned subsidiary, PRI Medical Technologies, Inc., provides mobile medical laser and surgical equipment in 16 states on a per-procedure basis to hospitals, outpatient surgery centers and physicians’ offices. Surgical equipment is provided to customers along with technical support personnel to ensure that such equipment is operating correctly. PRI Medical currently offers its services in five states in the western United States and 11 states along the eastern seaboard. Emergent Group, Inc. is a member of the Russell Microcap® Index. For investor and product information, please visit Emergent Group’s website, www.emergentgroupinc.com.
Forward-Looking Statements
Statements in this news release contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934. These statements are based upon management’s current expectations and are subject to uncertainty and changes in circumstances, including the risks that the proposed transactions may not be consummated, regulatory approval that may be required is not obtained on a timely basis or is obtained with unanticipated conditions, and that, as a result of continuing diligence by UHS and unanticipated future events (some of which are discussed in the Company’s most recent Annual Report on Form 10-K and subsequently filed SEC reports), the proposed per share price may be reduced. There is no assurance that any forward-looking statements will prove accurate, as actual results and future events could differ materially from those presently anticipated.
CONTACT: Bruce J. Haber
Emergent Group/PRI Medical
(914) 235-5550, x. 12
bhaber@primedical.net
Thomas C. Blum
G.C. Andersen Partners, LLC
(212) 842-1608
tblum@andersenllc.com
Monday, February 7th, 2011UncategorizedComments Off on Emergent Group/PRI Medical (LZR) to be Acquired by Universal Hospital Services
MORRISVILLE, NC — (Marketwire) — 02/07/11 — Charles & Colvard, Ltd. (NASDAQ: CTHR), the sole manufacturer of moissanite lab-created gemstones, The Most Brilliant Jewel in the World®, today announced the appointment of Steven M. Larkin to its Board of Directors.
Since January 2010, Mr. Larkin, age 52, has served as Senior Vice President, Direct, of Golfsmith International Holdings, Inc. (“Golfsmith”), a specialty retailer of golf and tennis equipment, apparel, and accessories. From November 2009 to January 2010, he was a consultant to Golfsmith. From August 2008 to June 2009, Mr. Larkin served as Executive Vice President, Chief Marketing and E-Commerce Officer at Zale Corporation, a specialty retailer of diamonds and other jewelry products. He was Zale Corporation’s Senior Vice President, Brand Marketing and E-Commerce, from February 2008 to August 2008 and its Senior Vice President, Direct to Consumer, from January 2006 to February 2008. Before joining Zale Corporation, Mr. Larkin served in a variety of e-commerce and marketing-related executive positions with various companies in the retail industry for over 20 years, including ShopNBC, The Fingerhut Corporation, and Federated Department Stores/Macy’s, Inc.
“We are very pleased to welcome Steve Larkin as an independent member of our Board of Directors,” stated Randy N. McCullough, Chief Executive Officer of Charles & Colvard, Ltd. “An important element in our growth strategy involves e-commerce marketing initiatives. Steve’s extensive experience in this area and his understanding of the jewelry industry should prove invaluable to our management team and is consistent with our Board’s strategic direction as we seek to realize the potential of moissanite in the $120 billion global jewelry industry.”
About Charles & Colvard, Ltd.
Charles & Colvard, Ltd., based in the Research Triangle Park area of North Carolina, is the global sole source of moissanite, a unique, near-colorless lab-created gemstone that is distinct from other gemstones and jewels based on its exceptional fire, brilliance, luster, durability, and rarity. Charles & Colvard Created Moissanite® is currently incorporated into fine jewelry sold through domestic and international retailers and other sales channels. Charles & Colvard, Ltd. is headquartered in Morrisville, North Carolina, and the Company’s common stock is listed on the NASDAQ Global Select Market under the symbol “CTHR”. For more information, please access www.moissanite.com or www.charlesandcolvard.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as “may,” “will,” “should,” “could,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “continue,” and similar words, although some forward-looking statements are expressed differently.
All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management’s current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, our dependence on consumer acceptance and growth of sales of our products; general economic and market conditions, including the current economic environment; dependence on Cree, Inc. as the current supplier of the raw material; dependence on third parties for the sales and marketing of our products to end consumers; intense competition in the worldwide jewelry industry; financial difficulties or insolvency of one or more of our major customers; our ability to protect our intellectual property; possible adverse effects of governmental regulation and oversight; risks of conducting business in foreign countries; and the pricing of precious metals, which is beyond our control, in addition to the other risks and uncertainties described in more detail in our filings with the Securities and Exchange Commission, or the SEC, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the SEC that discuss other factors relevant to our business.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Company Contact: Timothy Krist
Chief Financial Officer
919.468.0399, ext. 295
Email Contact
Investor Relations: R. Jerry Falkner
RJ Falkner & Company, Inc.
Investor Relations Counsel
800.377.9893
Email Contact
Monday, February 7th, 2011UncategorizedComments Off on Charles & Colvard (CTHR) Appoints Steven M. Larkin to Board of Directors
WOODBURY, NY — (Marketwire) — 02/07/11 — Research Frontiers Inc. (NASDAQ: REFR) has scheduled a conference call at 4:15 pm EST on Wednesday, February 9, 2011 to discuss their announcement today that its patented SPD-Smart light-control technology was selected by Daimler AG for the MAGIC SKY CONTROL panoramic glass roof offered on the new Mercedes-Benz SLK that debuted on January 29, 2011.
Shareholders and other interested parties may participate in the conference call by dialing 877-317-6789 (domestic) or 412-317-6789 (international) and request to be connected to the “Research Frontiers Conference Call.”
To cover as many topics of interest as possible, we encourage participants to email their questions to questions@SmartGlass.com by 1:00 pm EST February 9, 2011.
A replay of the conference call will be available one hour after the call concludes through Wednesday, February 16, 2011 at 9:00 am EST by dialing 877-344-7529 (domestic) or 412-317-0088 (international) and entering the conference ID Number 447641.
About Research Frontiers Inc.
Research Frontiers Inc. is the developer of SPD-Smart light-control technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic, either manually or automatically. Having spent over $80 million to date to develop its technology, Research Frontiers currently holds approximately 500 patents and patent applications and has built an infrastructure of 39 licensed companies that collectively are capable of serving the growing global demand for smart glass products in automobiles, homes, buildings, aircraft and boats. Further information about SPD-Smart technology, Research Frontiers and its licensees can be found at www.SmartGlass.com.
Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release may contain forward-looking statements. Actual results could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc. “MAGIC SKY CONTROL” and “Mercedes-Benz” are trademarks of Daimler AG.
For further information, please contact:
Seth L. Van Voorhees
Vice President-Business Development and Chief Financial Officer
(516) 364-1902
info@SmartGlass.com
Monday, February 7th, 2011UncategorizedComments Off on Research Frontiers (REFR) to Host Investor Conference Call
China Electric Motor Inc. is a China-based company that engages in the design, production, marketing and sale of micro motor products through its subsidiaries, Shenzhen YuePengCheng Motor Co., Ltd. and Ningbo Heng Bang Long Electrical Equipment Co., Ltd. The Company’s products are incorporated into consumer electronics, automobiles, power tools, toys and household appliances.
Despite 48.90% year-over-year growth in revenues and continued profitability, CELM is now trading at a P/E of less than 6 (the average for the industry is approximately 28). The company is also undervalued by P/S, PEG, Price/Book and Price/Cash Flow. Currently two analysts cover the stock, one with a “Strong Buy” rating and one with a “Buy” rating. The average of their price targets is $9.50.
As of last report, the company had a very strong balance sheet with $75.9 million in total assets and $9.5 million in total liabilities. The management team has also shown great strength in efficiency, returning 28.1% on equity, 24.1% on assets and 28.1% on capital.
In most recent news, the company announced that through an indirect wholly owned subsidiary it will acquire Shenzhen Guofa Optoelectronics Co., Ltd. Through this acquisition, CELM will gain new production lines and expertise focused on high-end DC micro motors as well as a blue chip customer base. The acquisition is expected to be accretive immediately upon the closing.
Key statistics (2/4/11):
Market cap: $91.72 Million
P/E Ratio: 6.1 versus industry average of 28.0
P/S Ratio: 0.90 versus industry average of 2.33
Debt/Equity Ratio: 0.00 versus industry average of 0.67
Current Ratio:6.5 versus industry average of 1.9
Quick Ratio: 5.6 versus industry average of 1.5
Return on Equity: 28.1% versus industry average of 1.7%
Return on Assets: 24.1% versus industry average of 3.3%
Return on Capital: 28.1% versus industry average of 2.4%
Saturday, February 5th, 2011UncategorizedComments Off on China Electric Motor Inc. (CELM)
VANCOUVER, BRITISH COLUMBIA — (Marketwire) — 02/01/11 — Endeavour Silver Corp. (TSX: EDR)(NYSE Amex: EXK)(DBFrankfurt: EJD) released today its review of exploration results in 2010 and its exploration plans for 2011. The Company’s exploration drilling programs in Mexico met with continued success in 2010, highlighted by the discovery of new, high grade silver-gold mineralized zones near Endeavour’s two silver mining operations, Guanacevi Mines in Durango State, and Guanajuato Mines in Guanajuato State.
Barry Devlin, Vice President of Exploration, commented, “Last year, our talented exploration team once again delivered some exciting new silver-gold vein discoveries which will be included in our next NI 43-101 reserve/resource estimate expected in a few weeks time. Endeavour drilled approximately 41,400 meters (136,000 feet) in 148 drill holes testing multiple exploration targets in five separate mining districts in order to make new discoveries and expand silver resources.”
“At Guanacevi, our focus last year moved north into the San Pedro area, where we received encouraging sample and drill results from a number of recently discovered mineralized zones on historic mine properties. Two exciting new finds, Epsilon and La Blanca, are in the vicinity of historic high grade silver mines along the western side of San Pedro, and two more, San Joachin and Santa Isabel, lie along strike to the north of historic high grade silver mines that occupy the east-bounding faults of the Guanacevi horst block (Endeavour’s Santa Cruz, Porvenir Norte, Porvenir Dos and Porvenir Cuatro mines are all located along the west-bounding fault of the Guanacevi horst block).”
“At Guanajuato, we enjoyed significant exploration success in 2010 extending high grade silver-gold mineralization within the Lucero vein for more than 800 meters along strike and more importantly, Endeavour discovered three new mineralized veins parallel to and in the footwall of Lucero, the Karina, Fernanda and Daniela veins. Two drill rigs are working full time to extend these mineralized zones and several compelling new vein targets will also be drilled this year. As a result, Endeavour has commenced a major expansion of the Guanajuato plant to 1000 tonnes per day in the 3rd Quarter, 2011.”
Guanacevi District
Endeavour currently holds 100% interests in 1,072 hectares (2,649 acres) within the historic silver district of Guanacevi which produced over 450 million ounces (oz) of silver according to SGM, the Mexican Geological Service. Since acquiring Guanacevi in 2004, Endeavour has found five high-grade silver ore-bodies along a five kilometer (3 mile) length of the prolific Santa Cruz silver vein (see Guanacevi maps on website, http://www.edrsilver.com/s/Guanacevi.asp).
In 2010, Endeavour drilled 7,000 meters in 23 holes in the San Pedro area resulting in two exciting new finds, Epsilon and La Blanca. Recent drill results not previously announced include 3,319 grams per tonne (gpt) silver and 7.1 gpt gold over a 2.0 meter (m) true width in the Epsilon area (hole EPS1-2), and 3,000 gpt silver and 7.7 gpt gold over a 2.1 m true width in the La Blanca area (hole BC-03).
Endeavour continued to expand its land position at Guanacevi in 2010 with the addition of the 3 properties totaling 25 hectares. Many of the old silver mining properties in Guanacevi had histories of small high grade mine production but very few of them were ever systematically explored and drilled.
Previously unreleased highlights of the 2010 drilling programs at Guanacevi were as follows:
Endeavour currently holds 100% interests in 2,314 hectares (5,719 acres) within the historic silver district of Guanajuato which produced over 1.2 billion oz silver according to the SGM. Since acquiring Guanajuato in 2007, Endeavour has discovered three high-grade silver-gold ore-bodies, one along the Veta Madre ore-bearing structure northwest of the Cebada mine and two along the La Luz mineralized veins southeast of the Lucero/Bolanitos mine (see Guanajuato maps on website, http://www.edrsilver.com/s/BolanitosMine.asp).
In 2010, Endeavour drilled 18,000 meters in 61 holes in the Lucero area resulting in three exciting new finds, Karina, Fernanda and Daniela. Recent drill results not previously announced include 158 gpt silver and 6.7 gpt gold over an 8.1 m true width in the Daniela vein (hole KA-27), and 367 gpt silver and 1.9 gpt gold over a 1.8 m true width in the Karina vein (hole KA-29).
Like Guanacevi, Endeavour continued to expand its land position at Guanajuato in 2010 with the addition of the 4 properties totaling 243 hectares. Many of the old silver mining properties in Guanajuato also had histories of small high grade mine production but few of them were systematically explored and drilled.
Previously unreleased highlights of the 2010 drilling programs at Guanajuato were as follows:
In 2010, Endeavour drilled 10,000 meters in 34 holes at the San Juanico property in order to extend the known silver-gold-lead-zinc mineralization on Endeavour’s adjacent El Cometa property. Both properties are located within the historic silver district of Parral, Chihuahua, which produced more than 250 million oz silver according to the SGM.
As of March 2009, Endeavour reported an NI 43-101 indicated resource at Cometa of 1.5 million oz silver and inferred resources totaling 1.0 million oz plus significant gold, lead and zinc resources (see Parral maps on website, http://www.edrsilver.com/s/ParralMine.asp). An updated combined resource estimate is anticipated for El Cometa and San Juanico shortly.
Recent drill results not previously announced include 52 gpt silver, 0.7 gpt gold, 4.2% lead and 1.9% zinc over an 4.8 m true width in the Cometa vein (hole SJ0-2), and 267 gpt silver, 1.2 gpt gold, 0.4% lead and 0.4% zinc over a 2.0 m true width also in the Cometa vein (hole SJ1-1). Once the resource estimate is completed, management will review the economic mining potential of the Parral project.
An additional 1200 meters of drilling in 12 holes was carried out at Endeavour’s 1,215 hectare (3,002 acre) Arroyo Seco project in Michoacan to try and extend the previously discovered manto-style silver-lead-zinc mineralization along strike and down dip.
Recent drill results not previously announced include 864 gpt silver and 0.82% lead over an 1.1 m true width in hole AS-14, and 311 gpt silver and 0.94% copper over a 2.0 m true width in hole AS-13. Management has decided to seek a partner or buyer for the Arroyo Seco properties as they do not have sufficient silver potential to be of interest to Endeavour.
2011 Exploration Plans
In 2011, Endeavour plans an aggressive $9.2 million, 47,000 meter, 175-hole exploration drill program to test multiple exploration targets within three of the mining districts where Endeavour is currently active in Mexico plus any new targets within new districts the Company may acquire during the year.
The first priorities will be to follow up the new discoveries made near Endeavour’s two mining operations at Guanacevi and Guanajuato as highlighted above and to test several new prospective targets within those two districts. Management is confident that the potential to discover and develop new silver-gold resources at both Guanacevi and Guanajuato remains high.
Endeavour will also commence surface exploration drilling on the San Sebastian properties acquired last year in Jalisco state, Mexico. Surface sampling has identified numerous high-grade silver and gold mineralized zones at San Sebastian that will be tested in 2011.
Significant sample results are as follows:
SIGNIFICANT SAN SEBASTIAN SAMPLE RESULTS
----------------------------------------------------------------------
Width Ag Au Pb Zn
Sample ID Zone (m) (gpt) (gpt) (ppm) (ppm)
----------------------------------------------------------------------
ESA 10014 Los Pollos Grab 1,185 0.74 1,370 355
----------------------------------------------------------------------
ESA 10027 La Obra 1.15 1,120 1.06 547 124
----------------------------------------------------------------------
ESA 10037 Ocote Alto 0.80 821 0.69 371 98
----------------------------------------------------------------------
ESA 10045 San Martin 0.30 364 1.23 1,130 734
----------------------------------------------------------------------
ESA 10058 La Obra 0.40 370 0.13 71 86
----------------------------------------------------------------------
ESA 10060 Guadalupe 0.35 647 2.51 34 105
----------------------------------------------------------------------
ESA 10066 La Obra 1.00 548 0.38 631 281
----------------------------------------------------------------------
ESA 10069 La Obra 0.20 429 0.07 724 535
----------------------------------------------------------------------
ESA 10075 El Tajo Grab 1,295 2.82 11,150 500
----------------------------------------------------------------------
ESA 10076 El Porvenir Grab 5,040 18.80 4,920 4,610
----------------------------------------------------------------------
ESA 10089 El Culebro Grab 534 1.94 1,160 63
----------------------------------------------------------------------
ESA 10096 El Tajo 0.55 673 0.64 18,800 227
----------------------------------------------------------------------
ESA 10098 El Tajo 0.50 581 1.16 13,200 5,240
----------------------------------------------------------------------
ESA 10099 El Tajo 0.56 1,295 2.02 25,100 3,630
----------------------------------------------------------------------
ESA 10903 El Tajo 1.50 414 0.37 897 293
----------------------------------------------------------------------
ESA 10904 El Tajo 1.50 474 0.78 449 366
----------------------------------------------------------------------
ESA 10907 San Agustin 0.50 603 0.23 2,050 1,755
----------------------------------------------------------------------
ESA 10912 El Rosario 0.30 634 0.68 740 164
----------------------------------------------------------------------
ESA 10926La Carbonera Grab 4,010 14.75 11,800 743
----------------------------------------------------------------------
Barry Devlin, M.Sc., P.Geo. Vice President, Exploration is the Qualified Person who reviewed this news release and supervised the surface drilling and sampling programs at the Parral, Guanacevi and Guanajuato Projects. Godfrey Walton, M.Sc. P.Geo. President and Chief Operating Officer is the Qualified Person who reviewed this news release and supervised the mine surface and underground drilling programs at the Guanacevi and Guanajuato Mines. A Quality Control sampling program of reference standards, blanks and duplicates has been instituted to monitor the integrity of all assay results. All core samples are split at the Parral, Guanajuato, or Guanacevi field offices and shipped to ALS-Chemex Labs, where they are dried, crushed, split and 50 gram pulp samples are prepared for analysis. Gold and silver are determined by fire assay with an atomic absorption (AA) finish and lead, zinc and copper are determined by AA.
Endeavour Silver Corp. is a mid-cap silver mining company focused on the growth of its silver production, reserves and resources in Mexico. Since start-up in 2004, Endeavour has posted six consecutive years of growing silver production, reserves and resources. The organic expansion programs now underway at Endeavour’s two operating silver mines in Mexico combined with its strategic acquisition and exploration programs should help Endeavour achieve its goal to become the next premier mid-tier silver mining company.
This news release contains “forward-looking statements” within the meaning of the United States private securities litigation reform act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking statements and information herein include, but are not limited to, statements regarding Endeavour’s anticipated future performance, including silver and gold production, timing and expenditures to develop new silver mines and mineralized zones, silver and gold grades and recoveries, cash costs per ounce, capital expenditures and sustaining capital and the use of proceeds from the Company’s recent financing. The Company does not intend to, and does not assume any obligation to update such forward-looking statements or information, other than as required by applicable law. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Endeavour and its operations to be materially different from those expressed or implied by such statements.
Such factors include, among others: fluctuations in the prices of silver and gold, fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and U.S. dollar); changes in national and local governments, legislation, taxation, controls, regulations and political or economic developments in Canada and Mexico; operating or technical difficulties in mineral exploration, development and mining activities; risks and hazards of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected geological conditions, pressures, cave-ins and flooding); inadequate insurance, or inability to obtain insurance; availability of and costs associated with mining inputs and labour; the speculative nature of mineral exploration and development, diminishing quantities or grades of mineral reserves as properties are mined; the ability to successfully integrate acquisitions; risks in obtaining necessary licenses and permits, and challenges to the company’s title to properties; as well as those factors described in the section “risk factors” contained in the Company’s most recent form 40F/Annual Information Form filed with the S.E.C. and Canadian securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or information, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed or intended. There can be no assurance that any forward-looking statements or information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information.
The TSX Exchange has neither approved nor disapproved the contents of this news release.
TravelCenters of America LLC Announces Amendments to Lease Agreements with Hospitality Properties Trust and Settlement of Litigation
TravelCenters of America LLC Announces Amendments to Lease Agreements with Hospitality Properties Trust and Settlement of Litigation
Feb. 1, 2011 (Business Wire) — TravelCenters of America LLC (NYSE Amex: TA) today announced that it has entered amendments to its lease agreements with Hospitality Properties Trust (NYSE: HPT) as follows:
Historical Agreements:
TA has two historical leases with HPT:
One lease for 145 travel centers located in 39 states operated under the “TA” or “Travel Centers” brands extends to 2022 and requires annual rent of $165.1 million/year, increasing to $170.1 million/ year on February 1, 2011, increasing to $175.1 million/year on February 1, 2012, plus increases based upon percentages of increases in gross revenues starting in 2012 (the “TravelCenters Lease”).
One lease for 40 travel centers located in 25 states operated under the “Petro” brand extends to 2024 and requires annual rent of $66.2 million/year plus increases starting in 2013 based upon percentages of increases in gross revenues (the “Petro Lease”).
The total contractual rent payable by TA to HPT under these two leases currently is approximately $231.3 million/year (i.e., $165.1 million plus $66.2 million). Effective July 1, 2008, in consideration of the impact of market conditions upon TA’s business, TA and HPT entered into a rent deferral arrangement whereby TA was permitted to defer up to $5.0 million /month of its combined rents due to HPT through December 31, 2010, and that required the amount of any such deferred rent, plus any unpaid interest, would be due from TA to HPT on or before July 1, 2011. Pursuant to that agreement TA has deferred a total of $150.0 million of rent, and all interest due with respect to such deferrals has been paid through December 31, 2010.
New Agreements:
The amended terms which have been agreed between TA and HPT are as follows:
The TravelCenters Lease is modified effective January 1, 2011 so that the current rent is reduced from $165.1 million/year to $135.1 million/year. The rent will increase to $140.1 million/year effective February 1, 2012, plus increases thereafter based upon percentages of increases in gross revenues.
The Petro Lease is modified effective January 1, 2011 so that the current rent is reduced from $66.2 million/year to $54.2 million/ year plus increases starting in 2013 based upon percentages of increases in gross revenues which exceed a threshold amount; and the first $2.5 million of percentage rent which becomes due under the Petro Lease shall be waived provided the settlement of certain litigation pending against TA, HPT and others is approved (see below).
The $150.0 million of previously deferred rent due from TA to HPT is further deferred, without interest, so that $107.1 million will be due in 2022 and $42.9 million shall be due in 2024. These deferred amounts will become due and interest may begin to accrue in certain circumstances set forth in the amended leases, including a change of control of TA.
Litigation Settlement:
In February 2008, a shareholder derivative litigation was begun against TA and its directors which, among other matters, disputes the rent payable by TA under one of its leases with HPT. Counsel for the plaintiff in that case participated in aspects of the negotiations between TA and HPT that resulted in certain of the lease modifications announced today. Specifically, in exchange for settling the litigation, HPT agreed to waive payment of the first $2.5 million of percentage rent that becomes due under the Petro Lease. This settlement is subject to approval by the Delaware Court of Chancery where this case is pending. Further details of this proposed settlement will be provided to TA shareholders in accordance with the Court of Chancery rules.
TA’s travel centers are operated under the “TravelCenters of America”, “TA”, and “Petro Stopping Centers” brand names and offer diesel and gasoline fueling services, restaurants, heavy truck repair facilities, stores and other services. TA’s nationwide business includes travel centers located in 41 U.S. states and in Canada.
WARNING REGARDING FORWARD LOOKING STATEMENTS
THIS PRESS RELEASE CONTAINS FORWARD LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND OTHER SECURITIES LAWS. THESE FORWARD LOOKING STATEMENTS ARE BASED UPON TA’S CURRENT BELIEFS AND EXPECTATIONS, BUT THEY ARE NOT GUARANTEED TO OCCUR AND MAY NOT OCCUR FOR VARIOUS REASONS, INCLUDING SOME REASONS BEYOND TA’S CONTROL. FOR EXAMPLE:
THIS PRESS RELEASE DESCRIBES TA RENT REDUCTIONS AND DEFERRALS WHICH HAVE BEEN AGREED WITH HPT. AN IMPLICATION OF THIS DESCRIPTION MAY BE THAT TA WILL BE ABLE TO OPERATE PROFITABLY IN THE FUTURE. IN FACT, THERE ARE MANY FACTORS WHICH WILL IMPACT THE PROFITABILITY OF TA’ S FUTURE OPERATIONS IN ADDITION TO RENTS, INCLUDING SOME FACTORS WHICH ARE BEYOND TA’S CONTROL SUCH AS THE CONDITION OF THE U.S. ECONOMY GENERALLY AND THE FUTURE DEMAND FOR TA’S GOODS AND SERVICES, AND COMPETITION IN TA’S BUSINESS. TA HAS REPORTED OPERATING PROFITS IN ONLY A FEW QUARTERLY REPORTING PERIODS SINCE IT BECAME A SEPARATE PUBLICLY OWNED COMPANY IN 2007 AND TA HAS ACCUMULATED SIGNIFICANT LOSSES SINCE THAT TIME. THERE IS NO ASSURANCE THAT TA WILL BE ABLE TO PRODUCE FUTURE OPERATING PROFITS.
THIS PRESS RELEASE STATES THAT THE PARTIES INVOLVED IN A DERIVATIVE LITIGATION HAVE AGREED TO SETTLE THAT LITIGATION. AS NOTED ABOVE, THIS SETTLEMENT IS SUBJECT TO APPROVAL BY THE DELAWARE COURT OF CHANCERY. LITIGATION AND A COURT APPROVAL PROCESS SOMETIMES PRODUCE UNEXPECTED RESULTS. TA CAN PROVIDE NO ASSURANCE THAT THE REQUIRED COURT APPROVAL WILL BE OBTAINED OR THAT THIS SETTLEMENT WILL BE CONCLUDED.
FOR MORE INFORMATION ABOUT THE FORMER AND CURRENT RELATIONSHIPS WHICH EXIST BETWEEN TA AND HPT AND ABOUT THE RISKS WHICH MAY ARISE FROM THESE RELATIONSHIPS OR OTHER RISKS WHICH MAY AFFECT TA’S ABILITY TO OPERATE PROFITABLY, PLEASE SEE THE FORM 8-K DATED FEBRUARY 1, 2011 FILED WITH THE SEC IN CONNECTION WITH THE EVENTS DESCRIBED IN THIS PRESS RELEASE, TA’S ANNUAL REPORT ON FORM 10 K FOR THE YEAR ENDED DECEMBER 31, 2009, ESPECIALLY THE SECTIONS ENTITLED “BUSINESS”, “RISK FACTORS” (AS UPDATED IN TA’S QUARTERLY REPORT ON FORM 10 Q FOR THE PERIOD ENDED JUNE 30, 2010) AND “MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — RELATED PERSONS TRANSACTIONS” (AS UPDATED IN OUR QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED SEPTEMBER 30, 2010), IN TA’S PROXY STATEMENT DATED FEBRUARY 24, 2010 RELATED TO ITS 2010 ANNUAL MEETING OF SHAREHOLDERS, ESPECIALLY THE INFORMATION REGARDING TA’S DIRECTORS AND OFFICERS AND THE SECTION ENTITLED “RELATED PERSON TRANSACTIONS AND COMPANY REVIEW OF SUCH TRANSACTIONS”, AND OUR CURRENT REPORT ON FORM 8 K FILED WITH THE SEC ON JANUARY 28, 2010, ITEM 1.01; ALL OF WHICH DOCUMENTS ARE AVAILABLE AT THE SEC WEBSITE: WWW.SEC.GOV.
FOR THE FOREGOING REASONS, AMONG OTHERS, INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE UPON FORWARD LOOKING STATEMENTS IN THIS PRESS RELEASE OR THEIR IMPLICATIONS.
TravelCenters of America LLC
Timothy A. Bonang, 617-796-8251
Vice President, Investor Relations
or
Carlynn Finn, 617-796-8251
Manager, Investor Relations
www.tatravelcenters.com
Tuesday, February 1st, 2011UncategorizedComments Off on TravelCenters of America LLC (TA) Announces Amendments to Lease Agreements
GONGYI, China, Feb. 1, 2011 /PRNewswire-Asia/ — China GengSheng Minerals, Inc. (“GengSheng”) (AMEX: CHGS), a leading China-based high-tech industrial materials manufacturer producing heat resistant, energy efficient materials for a variety of industrial applications, today announced that GengSheng has signed a full-service refractories supply contract with Fushun New Steel Corporation. Shipments under the contract began in January 2011, and are expected to continue through December 2012. Revenue contribution from this new client is expected to begin in the first quarter of 2011.
Under the agreement, GengSheng will provide refractory materials, as well as installation and on site support services. Revenue will be recognized based on Fushun New Steel’s production volume. Based on Fushun’s current manufacturing capacity, GengSheng expects revenue of approximately $10 million over the two-year term of the contract.
GengSheng launched full-service programs for refractory customers in late 2003. These programs include refractory product installation, testing, maintenance, repair and replacement, in addition to traditional products sales. These full service programs, which are generally carried out under one- to- two-year contracts, generate stable and recurring revenue streams and have higher margins than product sales alone. GengSheng currently has nine full service clients. The full service programs contributed approximately 52% of GengSheng’s refractories total sales in the first nine months of 2010.
“Our full service programs are an ideal solution for steel manufacturers who face an increasingly challenging market environment, as they are able to adjust purchasing and implementation based on output,” said Shunqing Zhang, CEO of China GengSheng Minerals. “This offering has been well received by customers since its introduction, allowing GengSheng to build additional brand equity and grow our share of the refractories market. In addition, full service programs enable us to develop deeper relationships with customers, allowing us to better understand their needs and increase the value we bring to the industry.”
About China GengSheng Minerals, Inc.
China GengSheng Minerals, Inc. (“GengSheng”) develops, manufactures and markets a broad range of high-tech industrial material products, including monolithic refractories, industrial ceramics and fracture proppants. A market leader offering customized solutions, GengSheng sells its products primarily to the iron-and-steel industry as heat-resistant components for steel-making furnaces, industrial kilns and other high-temperature vessels to guarantee and improve the productivity of those expensive pieces of equipment while reducing their consumption of energy. Founded in 1986 and based in China‘s Henan province, GengSheng currently has over 200 customers in the iron, steel, oil, glass, cement, aluminum and chemical businesses located in China and other countries. GengSheng conducts business through GengSheng International Corporation, a British Virgin Islands company, and its Chinese subsidiaries, which are Henan GengSheng Refractories Co., Ltd., Zhengzhou Duesail Fracture Proppant Co., Ltd., Henan GengSheng Micronized Powder Materials Co., Ltd, Guizhou SouthEast Prefecture Co., Ltd., GengSheng New Materials Co., Ltd, and Henan GengSheng High Temperature Materials Co., Ltd.
For more information about GengSheng, please visit http://www.gengsheng.com .
To be added to GengSheng’s email distribution for future press releases, please send your request to gengsheng@tpg-ir.com.
Note Regarding Forward-Looking Statements
This press release contains statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words “estimate,” “project,” “intend,” “forecast,” “anticipate,” “plan,” “planning,” “expect,” “believe,” “will,” “will likely,” “should,” “could,” “would,” “may” or words or expressions of similar meaning. Such forward-looking statements are only predictions and are not guarantees of future performance. Investors are cautioned that any such forward-looking statements are and will be, as the case may be, subject to many risks, uncertainties, certain assumptions and factors relating to the operations and business environments of China GengSheng Minerals, Inc. and its subsidiaries that may cause the actual results of the companies to be materially different from any future results expressed or implied in such forward-looking statements. Although China GengSheng Minerals, Inc. believes that the expectations and assumptions reflected in the forward-looking statements are reasonable based on information currently available to its management, China GengSheng Minerals, Inc. cannot guarantee future results or events. China GengSheng Minerals, Inc. expressly disclaims a duty to update any of the forward-looking statement.
For more information, please contact:
The Piacente Group, Inc.
Investor Relations
Brandi Floberg or Lee Roth
Tel: 1+212-481-2050
Email: gengsheng@tpg-ir.com
China GengSheng Minerals, Inc.
Investor Relations
Mr. Shuai Zhang
Email: gszs@gengsheng.com
Tel: +86-135-2551-0415
Tuesday, February 1st, 2011UncategorizedComments Off on China GengSheng Minerals (CHGS) Signs 2-Year $10 Million Refractories Contract
SANTA BARBARA, Calif., Feb. 1, 2011 (GLOBE NEWSWIRE) — Superconductor Technologies Inc. (Nasdaq:SCON) (“STI”), a world leader in the development and production of high temperature superconducting (HTS) materials and associated technologies, has successfully produced second generation (2G) HTS wire samples that meet requirements specified by customers for HTS AC power cable, superconducting fault current limiter (SFCL) and HTS wind turbine applications. Delivery of the samples for customer testing is expected to begin shortly. STI’s strategic 2G HTS wire program utilizes its specialized HTS material deposition processes and volume manufacturing expertise to produce energy efficient, cost-effective and high performance HTS wire for next generation power applications and other attractive new markets.
Jeff Quiram, STI’s president and chief executive officer, said, “Achieving our goal of completing all three wire samples is an enormous accomplishment for STI’s 2G HTS wire initiative. Each application has demanding technical requirements and our team worked very hard over the recent months to meet these wire performance objectives. We look forward to building on this success as we move closer to establishing future commercial relationships with our valued customers.”
STI’s 2G HTS wire product development is focused on large markets where the advantages of HTS wire are recognized by the industry. STI’s initial product roadmap targets three important applications:
Superconducting High Power Transmission Cables: HTS advanced power transmission cable transmits five to twenty times the electrical power of traditional copper or aluminum cables with much improved efficiency.
Superconducting Fault Current Limiters (SFCL): SFCLs act like powerful surge protectors, preventing harmful faults from taking down costly substation equipment. SFCLs enable the energy efficient connections of distributed power sources to the grid, fast reliable grid protection, and utilize smart grid design criteria.
Superconducting Wind Turbine Generators: Superconducting wind turbines allow utilities to add more “power per tower” by significantly reducing turbine size and weight and improving power generation efficiency.
About Superconductor Technologies Inc. (STI)
Superconductor Technologies Inc., headquartered in Santa Barbara, CA, has been a world leader in HTS materials since 1987, developing more than 100 patents as well as proprietary trade secrets and manufacturing expertise. For more than a decade, STI has been providing innovative interference elimination and network enhancement solutions to the commercial wireless industry. The company is currently leveraging its key enabling technologies, including RF filtering, HTS materials and cryogenics to develop energy efficient, cost-effective and high performance second generation (2G) HTS wire for existing and emerging power applications, to develop applications for advanced RF wireless solutions and innovative adaptive filtering, and for government R&D. Superconductor Technologies Inc.’s common stock is listed on the NASDAQ Capital Market under the ticker symbol “SCON.” For more information about STI, please visit http://www.suptech.com.
The Superconductor Technologies Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3963
Safe HarborStatement
“Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are “forward-looking statements” that involve risks and uncertainties, including without limitation, the risk that this offering will not close. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. These factors and uncertainties include, but are not limited to: our limited cash and a history of losses; the limited number of potential customers; the limited number of suppliers for some of our components; there being no significant backlog from quarter to quarter; our market being characterized by rapidly advancing technology; fluctuations in product demand from quarter to quarter; the impact of competitive filter products, technologies and pricing; manufacturing capacity constraints and difficulties; and local, regional, and national and international economic conditions and events and the impact they may have on us and our customers, such as the current worldwide recession.
Forward-looking statements can be affected by many other factors, including, those described in the “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of STI’s Annual Report on Form 10-K for the year ended December 31, 2009 and in STI’s other public filings. These documents are available online at STI’s website, www.suptech.com, or through the SEC’s website, www.sec.gov. Forward-looking statements are based on information presently available to senior management, and STI has not assumed any duty to update any forward-looking statements.
Contact
For further information please contact Investor Relations, invest@suptech.com, Cathy Mattison or Mary Magnani of Lippert / Heilshorn & Associates, +1-415-433-3777, for Superconductor Technologies Inc.
Tuesday, February 1st, 2011UncategorizedComments Off on Superconductor Technologies Inc. (SCON) Produces 2G HTS Wire Samples
TORONTO, ONTARIO — (Marketwire) — 01/31/11 — Denison Mines Corp. (TSX: DML) (NYSE Amex: DNN) (“Denison” or the “Company”) announces that its 2011 operating plan forecasts production of 1.2 million pounds U3O8 and 2.2 million pounds V2O5 from its operations in the United States. “The 2011 plan and budget is focused on the growth of the Company with the largest exploration program ever undertaken on our Wheeler River project, the recommencement of drilling on our Zambian project and the development of our second mine on the Arizona Strip” said Ron Hochstein, President and CEO of Denison. Unless otherwise stated all figures are in U.S. dollars.
2011 Operating Plans
Production
Denison’s uranium production is expected to total 1.2 million pounds of U3O8 from ore in stockpile and from the Beaver, Pandora and Arizona 1 mines and production from the alternate feed circuit at the White Mesa Mill in the United States. Vanadium production is projected to total approximately 2.2 million pounds of V2O5. The White Mesa mill is anticipated to continue processing conventional ore during most of 2011, except for scheduled maintenance shutdowns. Production of alternate feed material will continue throughout 2011. The cash cost of production is expected to average approximately $43.50 per pound of U3O8 net of vanadium credits, excluding sales royalties. The cash cost per pound reflects the impact of an increase of over 200% of the cost of sulphuric acid as compared to 2010. Capital expenditures on the mines and mill facilities are estimated at $9.7 million.
Sales
Uranium sales are forecast to be approximately 1.3 million pounds of U3O8 of which just over 500,000 pounds will be sold into long term contracts and the remainder will be sold on the spot market. Vanadium sales are projected to be 2.8 million pounds V2O5 in 2011.
Business Development
Denison’s business development activities include advancement of its existing development stage projects and exploration projects and the search for new potential acquisitions. These activities, as part of its Five Year Business Development Plan, are aimed at increasing Denison’s sustainable uranium production to at least 10 million pounds per year by 2020.
In 2011, Denison will participate in exploration programs in Canada and the United States. The total budget for these programs will be $15.0 million of which Denison’s share will be $8.8 million. The Wheeler River program at a total cost of $10.0 million (Denison’s share $6.0 million) represents the most significant of these programs. A 35,000 metre drilling program has begun to test additional areas with known uranium mineralization along the same mineralized trend hosting the Phoenix deposit.
Exploration work in Canada will also be carried out on the Moore Lake, Hatchet Lake, Murphy Lake, Bell Lake, McClean Lake and Wolly projects at a total cost of $3.8 million (Denison’s share $1.6 million). In the United States, drilling is planned on the Beaver mine trend and at the Sunday Complex to outline potential resources which could extend the life of existing operations on these properties. In Arizona, an exploration program on the Company’s DB1 breccia pipe is planned. The total cost of the U.S. exploration program is $1.3 million.
The Company is pleased to announce that exploration and development activities will be restarted at its Mutanga project in Zambia. A 17,000 metre exploration drill program will follow up on positive drilling results obtained in 2009 and metallurgical test work will be undertaken to further define process design criteria and operating costs. The Zambian program will total an estimated $6.2 million.
In Mongolia, a $7.4 million exploration and development program is projected. A $3.0 million, 38,000 metre exploration program is anticipated to be undertaken on license areas that currently do not have defined resources in order to confirm resources and support future work on these license areas. Development activities on license areas which are more advanced will include drilling of initial test patterns and pilot plant design. The implementation of the Mongolian program is contingent upon resolution of outstanding issues with the Mongolian Government regarding the Nuclear Energy Law and the structure of the Gurvan Saihan Joint Venture. The Company remains hopeful that these issues will be resolved early in 2011 such that the planned programs can be completed.
In Canada and the U.S., a total of $6.4 million will be spent by Denison on development stage projects in 2011. In the United States, development of the Pinenut mine is moving forward with initial production anticipated in early 2012, and permitting will be advanced for the EZ1/EZ2 and Canyon deposits. The cost of these programs is estimated at $5.6 million. In Canada, the McClean North underground development feasibility study will be advanced along with continued evaluation of the Midwest development project under the operatorship of majority owner AREVA Resources Canada Inc.
2010 PRODUCTION AND SALES
Denison’s uranium production in 2010 was 1.4 million pounds U3O8 from its U.S. operations and its 22.5% share of production from the McClean Lake operation in the Athabasca basin in Canada. Vanadium production totalled 2.3 million pounds V2O5 from its White Mesa mill in Utah.
Uranium sales in 2010 totalled 1.8 million pounds U3O8 at an average realized price of $47.67 per pound U3O8. Vanadium sales in 2010 sales were 2.4 million pounds V2O5 equivalent, at an average realized price of $6.33 per pound V2O5.
About Denison
Denison Mines Corp. is a mid-sized uranium producer in North America, with mining assets in the Athabasca Basin region of Saskatchewan, Canada and the southwest United States including Colorado, Utah, and Arizona. The Company has ownership interests in two conventional uranium mills in North America. Denison also has a strong exploration and development portfolio including the Phoenix discovery in the Athabasca Basin as well as large land positions in the United States, Canada, Mongolia and Zambia.
Cautionary Statements Regarding Forward Looking Information
Certain information contained in this press release constitutes “forward-looking information”, within the meaning of the United States Private Securities Litigation Reform Act of 1995 and similar Canadian legislation concerning the business, operations and financial performance and condition of Denison.
Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” and “has the potential to”.
Forward looking statements are based on the assumptions noted in this press release and on the opinions and estimates of management as of the date such statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Denison to be materially different from those expressed or implied by such forward-looking statements. Denison believes that the expectations reflected in this forward-looking information is reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information included in this press release should not be unduly relied upon. This information speaks only as of the date of this press release. In particular, this press release may contain forward-looking information pertaining to the following: the estimates of Denison’s mineral reserves and mineral resources; uranium and vanadium production and sales volumes; capital expenditure programs, estimated production costs, exploration and development expenditures and reclamation costs; expectations of market prices and costs; supply and demand for uranium and vanadium; possible impacts of litigation on Denison; exploration, development, production and expansion plans and objectives; Denison’s expectations regarding raising capital and adding to its mineral reserves through acquisitions and development; and receipt of regulatory approvals and permits and treatment under governmental regulatory regimes.
There can be no assurance that such statements will prove to be accurate, as Denison’s actual results and future events could differ materially from those anticipated in this forward-looking information as a result of those factors discussed in or referred to under the heading “Risk Factors” in Denison’s Annual Information Form dated March 19, 2010, available at http://www.sedar.com and its Form 40-F for the financial year ended December 31, 2009, available at http://www.sec.gov, as well as the following: global financial conditions; volatility in market prices for uranium and vanadium; changes in foreign currency exchange rates and interest rates; the market price of Denison’s securities; the ability to access capital; the ability of Denison to meet its obligations to its creditors; liabilities inherent in mining operations; uncertainties associated with estimating mineral reserves and resources; failure to obtain industry partner and other third party consents and approvals, when required; delays in obtaining permits and licenses for development properties; competition for, among other things, capital, acquisitions of mineral reserves, undeveloped lands and skilled personnel; incorrect assessments of the value of acquisitions; geological, technical and processing problems; and, the potential influence of, or reliance upon, a business partner.
Accordingly, readers should not place undue reliance on forward-looking statements. These factors are not, and should not be construed as being, exhaustive. Statements relating to “mineral reserves” or “mineral resources” are deemed to be forward-looking information, as they involve the implied assessment, based on certain estimates and assumptions that the mineral reserves and mineral resources described can be profitably produced in the future. The forward-looking information contained in this press release is expressly qualified by this cautionary statement. Denison does not undertake any obligation to publicly update or revise any forward-looking information after the date of this press release to conform such information to actual results or to changes in Denison’s expectations, except as otherwise required by applicable legislation.
Contacts:
Denison Mines Corp.
Ron Hochstein
President and Chief Executive Officer
(416) 979-1991 Extension 232
Denison Mines Corp.
Jim Anderson
Executive Vice President and CFO
(416) 979-1991 Extension 372
Monday, January 31st, 2011UncategorizedComments Off on Denison (DNN) Outlines 2011 Operating Plans and Releases Final 2010 Production and Sales Volumes
JUNAN COUNTY, China, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ — American Lorain Corporation (NYSE Amex: ALN) (“American Lorain” or the “Company”), an international processed snack foods, convenience foods, and frozen foods company based in the Shandong Province, China, today announced that on January 28th, 2011, DEG has disbursed the second tranche of its loan to American Lorain in the amount of $10 million.
American Lorain signed the loan agreement with DEG on May 31, 2010. The total amount of the loan with DEG is $15 million, the first tranche of $5 million has been disbursed on December 13, 2010. The loan has a term of 5 years and commencing from the full disbursement, the interest rate will be fixed at 5.51% per annum.
Mr. Si Chen, Chairman and CEO of American Lorain commented: “We are very pleased to see the loan with DEG finally approved and disbursed. DEG is a German financial institution dedicated to providing debt and equity financing for quality enterprises in developing counties. The final approval of the loan reflected the trust and support this rigorous German institution has in American Lorain. The loan also comes in very attractive rate, which we believe will well serve to support American Lorain’s business and thus maximize shareholder value.”
About DEG
DEG (Deutsche Investitions- und Entwicklungsgesellschaft) translates into German Investment Corporation. Founded in 1962, DEG is headquartered in Cologne, Germany and is a member of KfW Bank Group (KfW Bankengruppe), a German government-owned development bank based in Frankfurt. It finances investments of private companies in developing and emerging economies. As one of Europe’s largest development finance institutions, it promotes private business structures to contribute to sustainable economic growth and improved living conditions in these countries. For more information, please visit http://www.deginvest.de/EN_Home/index.jsp or www.kfw.de.
About American Lorain Corporation
American Lorain Corporation products include chestnut products, convenience food products and frozen food products. The Company currently sells over 234 products to 26 provinces and administrative regions in China as well as to 42 foreign countries. The Company operates through its five direct and indirect subsidiaries and one leased factory located in China. For further information about American Lorain Corporation, please visit the Company’s website at http://www.americanlorain.com.
For more information, please contact:
At the company:
American Lorain Corporation
Mr. David She, CFO
Tel: +86-10 8411 3393
Email: david.she@americanlorain.com
Web: http://www.americanlorain.com
SOURCE American Lorain Corporation
Monday, January 31st, 2011UncategorizedComments Off on DEG Disburses American Lorain (ALN) the Second Tranche of $15 Million Loan
HANGZHOU, China, Jan. 31, 2011 (GLOBE NEWSWIRE) — Sky-mobi Limited (Nasdaq:MOBI) (“Sky-mobi” or the “Company”), the leading mobile application store in China, today announced that the Company and Tencent, one of China’s most popular Internet portals, have formed a strategic partnership. This strategic partnership is to promote Tencent’s QQ Mobile Browser on Sky-mobi’s Maopao application store and make Sky-mobi a preferred partner for a series of Tencent’s mobile software, including mobile security software and Tencent miniblog.
Under the terms of the collaboration agreement between the two companies, Tencent will pay Sky-mobi a commission for each of its users that become an active Tencent QQ Mobile Browser user. Sky-mobi estimates that this partnership will make a meaningful contribution to its top- and bottom-line results in the quarters ahead, driven by Sky-mobi’s large user base and access to the Maopao application store.
“The collaboration we have announced today represents another step in establishing Maopao as the leading application store in China,” commented Michael Song, Chairman and CEO of Sky-Mobi. “Our large user base will have access to Tencent’s QQ browser, which adds to the range of fun and useful Tencent services available on Maopao. In return, Tencent will have the opportunity to introduce its services to mobile phone users across China. We look forward to a successful collaboration for both parties.”
Sky-mobi’s Maopao store is accessed by hundreds of millions of Chinese mobile phone users and includes a variety of utilities, games and entertainment options. Sky-mobi collaborates with mobile service providers and handset vendors who pre-install the Sky-mobi’s Maopao platform on their mobile phones. The Maopao store offers a large number of applications and content titles that extends the usability of low-to-mid range mobile phones, or feature phones, by giving them many of the capabilities of more expensive smart phones, with such features as leading-edge user interfaces and Internet access. The partnership with Tencent is another important step in extending the range of applications available to Maopao users to make their phones smarter.
About Tencent:
Tencent Holdings Limited (SEHK 700) was founded in November, 1998, and has since grown into one of China’s largest and most widely used Internet portal. Presently, Tencent is providing value-added Internet, mobile and telecom services as well as online advertising with the goal of providing users with “one-stop online lifestyle services”. Tencent’s leading Internet platforms in China — QQ (QQ Instant Messenger), QQ.com, QQ Games, Qzone, 3g.QQ.com, SoSo, PaiPai and Tenpay — have brought together China’s largest Internet community, to meet the various needs of Internet users including communication, information, entertainment, e-commerce and others. As of September 30, 2010, active QQ user accounts for QQ IM totaled 636.6 million while peak concurrent users reached 118.7 million.
About Sky-mobi Limited:
Sky-mobi Limited (Nasdaq:MOBI) operates the leading mobile application store in China. Sky-mobi works with handset companies to pre-install its Maopao mobile application store on handsets and with content developers to provide users with high quality applications and content titles. Users of the Maopao store can browse, download and purchase a wide range of applications and content such as single-player games, mobile music and books. In addition, Sky-mobi has established a leading mobile social network community in China, the Maopao Community, where it offers popular localized mobile social games as well as applications and content with social network functions to its registered members. The Maopao store enables mobile applications and content to be downloaded and run on a variety of mobile handsets with different hardware and operating system configurations.
The Sky-mobi Limited logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8458
Safe Harbor Statement
This press release contains forward-looking statements that reflect the Company’s current expectations and views of future events that involve known and unknown risks, uncertainties and other factors that may cause its actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. You should understand that the Company’s actual future results may be materially different from and worse than what the Company expects. Information regarding these risks, uncertainties and other factors is included in the Company’s registration statement on Form F-1 and other filings with the SEC.
CONTACT: Sky-mobi Limited
Mr. Carl Yeung, CFO
Phone: +(86) 571-87770978 (Hangzhou)
Email: ir@sky-mobi.com
CCG Investor Relations
Mr. Ed Job, Account Manager
Phone: +(86) 21-3133-5075 (Shanghai)
Email: ed.job@ccgir.com
Ms. Kristin Knies, Sr. MI Executive (New York)
Phone: + (1) 646-833-3401
Monday, January 31st, 2011UncategorizedComments Off on Sky-mobi (MOBI) and Leading Chinese Portal Tencent Form Strategic Partnership
Jan. 31, 2011 (Business Wire) — NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced that its Phase 3 pivotal study of GATTEX® (teduglutide) met the primary efficacy endpoint of reducing parenteral nutrition (PN) dependence in patients with adult short bowel syndrome (SBS). The 24-week randomized, double-blind study, known as STEPS, was designed to compare the efficacy, safety and tolerability of GATTEX to placebo.
The study reached statistical significance for the primary efficacy endpoint, defined as the percentage of patients who achieved a 20 percent or greater reduction in weekly PN volume at Weeks 20 and 24, compared to baseline. In an intent-to-treat analysis, 63 percent (27/43) of GATTEX-treated patients responded versus 30 percent (13/43) of placebo-treated patients (p=0.002). Patients treated with GATTEX for 24 weeks also achieved significantly greater reductions in weekly PN volume versus placebo. On average, patients who received GATTEX experienced a 4.4 liter reduction in weekly PN volume from a pre-treatment baseline of 12.9 liters; patients who received placebo experienced a 2.3 liter reduction from a pre-treatment baseline of 13.2 liters (p less than or equal to 0.001).
“SBS patients who receive their nutrients and fluids intravenously due to malabsorption and diarrhea are prone to a number of serious complications including life-threatening infections, blood clots and liver and kidney damage. The STEPS results suggest teduglutide helps restore normal intestinal function in patients with short bowel syndrome, thereby reducing dependence on parenteral nutrition and potentially improving their quality of life,” said Palle Bekker Jeppesen, M.D., associate professor, department of medical gastroenterology, Rigshospitalet, University Hospital of Copenhagen, Denmark. “These findings bring us closer to an important new therapeutic option for patients with this debilitating condition.”
The STEPS study showed that GATTEX was well tolerated. Four of the 86 randomized patients discontinued the study due to adverse events, of which one was GATTEX-treated and three were placebo-treated. Adverse events appear to be consistent with the pharmacological effects of the drug.
“We are very pleased with these findings as they confirm our belief that GATTEX provides meaningful clinical benefits to adult patients with short bowel syndrome,” said Francois Nader, MD, president and chief executive officer of NPS Pharmaceuticals. “Based on these results, we expect to file for FDA approval of GATTEX in the second half of this year as a first-in-class treatment for SBS. We thank the patients, clinical investigators, and study coordinators who participated in this landmark study, as well as our ex-North American partner Nycomed who co-managed and co-funded the study. We look forward to reporting additional results from the STEPS study at upcoming medical meetings.”
More than 97 percent of eligible patients who participated in STEPS elected to roll into STEPS 2, an open-label continuation study in which all participants receive up to an additional 24 months of GATTEX therapy.
STEPS study design
STEPS was an international, double-blind, placebo-controlled Phase 3 pivotal study designed to provide additional evidence of safety and efficacy of GATTEX in reducing PN dependence in adult SBS patients.
Twenty-nine centers in North America and Europe enrolled patients in the STEPS study. Eighty-six patients were randomized and analyzed for efficacy and safety. The trial included an initial PN optimization and stabilization period, after which patients were randomized 1:1 to compare daily subcutaneous dosing of 0.05 mg/kg of GATTEX to placebo over a 24-week treatment period. A total of 78 patients completed the study.
The primary efficacy endpoint was the percentage of patients who achieved a 20 percent or greater reduction in weekly PN volume at Week 20 and maintained that response at Week 24, compared to baseline. The study’s secondary endpoints included reductions in PN volume and the direct effects of improved intestinal absorption of fluid.
NPS conducted STEPS with the support of its partner, Nycomed, a global pharmaceutical company, headquartered in Switzerland, which holds the rights to develop and commercialize teduglutide outside of North America. Nycomed expects to submit a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teduglutide in the first half of 2011. The two companies share certain external costs for the teduglutide development program.
Conference Call Information
NPS will host a conference call today at 9:00 a.m. Eastern Time to discuss these findings. To participate in the conference call, dial (888) 396-2356 and use pass code 22757353. International callers may dial (617) 847-8709, using the same pass code. In addition, a live audio of the conference call will be available over the Internet. Interested parties can access the event through the NPS website, http://www.npsp.com.
For those unable to participate in the live call, a replay will be available at (888) 286-8010, with pass code 24296023, until midnight Eastern Time, February 14, 2011. International callers may access the replay by dialing (617) 801-6888, using the same pass code. The webcast will also be available through the NPS website for the same period.
About Short Bowel Syndrome
Short bowel syndrome, or SBS, is a highly disabling condition that can impair a patient’s quality-of-life and lead to serious life-threatening complications. SBS typically arises after extensive resection of the bowel due to Crohn’s disease, ischemia or other conditions. SBS patients often suffer from malnutrition, severe diarrhea, dehydration, fatigue, osteopenia, and weight loss due to the reduced intestinal capacity to absorb nutrients, water, and electrolytes. The usual treatment for short bowel syndrome is nutritional support, including parenteral nutrition (PN) or intravenous feeding to supplement and stabilize nutritional needs.
Although PN can provide nutritional support for short bowel syndrome patients, it does not improve the body’s own ability to absorb nutrients. PN is also associated with serious complications, such as infections, blood clots or liver damage, and the risks increase the longer patients are on PN. Patients on PN often experience a poor quality-of-life with difficulty sleeping, frequent urination and loss of independence.
There are an estimated 10,000 to 15,000 SBS patients in the U.S. who are dependent on PN, the direct cost of which can exceed $100,000 annually per patient.
About GATTEX® (teduglutide)
GATTEX (teduglutide) is a novel, recombinant analog of human glucagon-like peptide 2, a protein involved in the rehabilitation of the intestinal lining. GATTEX is in Phase 3 development to reduce dependence on parenteral nutrition (PN) in adult patients with short bowel syndrome (SBS). NPS has reported findings from completed studies in which GATTEX demonstrated a favorable safety profile and reductions in mean PN volume from pretreatment baseline were observed. NPS is also advancing preclinical studies to evaluate teduglutide in additional intestinal failure related conditions.
Teduglutide has received orphan drug designation for the treatment of SBS from the U.S. Food and Drug Administration and the European Medicines Agency.
In 2007, NPS granted Nycomed the rights to develop and commercialize teduglutide outside the United States, Canada and Mexico. NPS retains all rights to teduglutide in North America.
About NPS Pharmaceuticals
NPS Pharmaceuticals is developing new treatment options for patients with rare gastrointestinal and endocrine disorders. The company is currently advancing two Phase 3 registration programs. Teduglutide, a proprietary analog of GLP-2, is in Phase 3 development for parenteral nutrition dependent adult short bowel syndrome and is in preclinical development for additional intestinal failure related conditions. NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is in Phase 3 development as a hormone replacement therapy for hypoparathyroidism. NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil Pharmaceutical.
“NPS”, “NPS Pharmaceuticals”, and “GATTEX” are the company’s registered trademarks. All other trademarks, trade names or service marks appearing in this press release are the property of their respective owners.
Statements made in this press release, which are not historical in nature, constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These statements are based on the company’s current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Risks associated to the company’s business include, but are not limited to, the risks associated with any failure by the company to successfully complete its preclinical and clinical studies within the projected time frames or not at all, the risk of not gaining marketing approvals for GATTEX and NPSP558, the risks associated with the company’s strategy, as well as other risk factors described in the company’s periodic filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and Form 10-Qs. All information in this press release is as of the date of this release and NPS undertakes no duty to update this information.
ELK GROVE VILLAGE, Ill., Jan. 28, 2011 /PRNewswire/ — Material Sciences Corporation (Nasdaq: MASC), a leading provider of material-based solutions for acoustical and coated applications, today announced that the company’s board of directors has authorized the repurchase of up to one million shares of common stock. These one million shares are in addition to the 114,081 shares remaining available for repurchase under the Board’s January 7, 2008 authorization. The share repurchases will be made from time to time at MSC’s discretion, subject to market conditions and other factors, and will be funded with internally generated cash. As of January 27, 2011, MSC had 12,909,133 shares outstanding.
About Material Sciences
Material Sciences Corporation is a leading provider of material-based solutions for acoustical and coated applications. MSC uses its expertise in materials, which it leverages through relationships and a network of partners, to solve customer-specific problems. The company’s stock is traded on the NASDAQ Capital Market under the symbol MASC.
SOURCE Material Sciences Corporation
Friday, January 28th, 2011UncategorizedComments Off on Material Sciences Corp. (MASC) Announces Stock Repurchase Program
PHILADELPHIA, Jan. 27, 2011 /PRNewswire/ — Destination Maternity Corporation (Nasdaq: DEST), the world’s leading maternity apparel retailer, today announced operating results for the first quarter of fiscal 2011, which ended December 31, 2010, with its first quarter diluted earnings per share significantly exceeding both its prior earnings guidance and its prior year first quarter earnings results. The Company also increased its earnings guidance for the full year fiscal 2011. In addition, yesterday the Company announced that its Board of Directors has initiated a regular quarterly cash dividend and approved a two-for-one split of its common stock in the form of a stock dividend.
First Quarter Fiscal 2011 Financial Results
GAAP net income for the first quarter of fiscal 2011 was $5.2 million, or $0.81 per share (diluted), a significant improvement compared to GAAP net income of $1.3 million, or $0.20 per share (diluted) for the first quarter of fiscal 2010. This first quarter fiscal 2011 GAAP earnings performance was better than the Company’s guidance, provided in its November 18, 2010 press release, of GAAP diluted earnings per share of between $0.51 and $0.66.
Non-GAAP adjusted net income (before restructuring and other charges, stock compensation expense, and loss on extinguishment of debt) for the first quarter of fiscal 2011 was $5.7 million, or $0.88 per share (diluted), an increase of 49% over the comparably adjusted non-GAAP net income for the first quarter of fiscal 2010 of $3.8 million, or $0.62 per share (diluted). This first quarter fiscal 2011 non-GAAP adjusted earnings performance was better than the Company’s guidance, provided in its November 18, 2010 press release, of non-GAAP adjusted diluted earnings per share of between $0.56 and $0.71.
Adjusted EBITDA was $13.3 million for the first quarter of fiscal 2011, an increase of 69% over the $7.9 million of Adjusted EBITDA for the first quarter of fiscal 2010.
Adjusted EBITDA before restructuring and other charges was $13.3 million for the first quarter of fiscal 2011, an increase of 14% over the $11.6 million of Adjusted EBITDA before restructuring and other charges for the first quarter of fiscal 2010.
Net sales for the first quarter of fiscal 2011 increased 1.2% to $135.4 million from $133.8 million for the first quarter of fiscal 2010 and were at the top end of the Company’s guidance range of $132.5 to $135.5 million provided in November. The increase in sales for the first quarter of fiscal 2011 compared to fiscal 2010 resulted primarily from an increase in comparable store sales, increased sales due to the opening of an additional 217 Sears® and Kmart® leased department locations in September and October 2010, and increased Internet sales, partially offset by decreased sales related to the Company’s continued efforts to close underperforming stores and decreased sales from the Company’s licensed relationship.
Comparable retail sales (which consists of comparable store sales and Internet sales) for the first quarter of fiscal 2011 increased 2.1% versus a comparable retail sales decrease of 4.4% for the first quarter of fiscal 2010. During the first quarter of fiscal 2011, comparable store sales increased 1.2%, and Internet sales increased 17.9%. The comparable store sales increase of 1.2% during the first quarter of fiscal 2011 exceeded the top end of the Company’s guidance range of down 1.5% to up 0.5% provided in November.
Cash Dividend and Stock Split
Yesterday the Company announced that its Board of Directors has initiated a regular quarterly cash dividend and approved a two-for-one split of the Company’s common stock in the form of a stock dividend. The first quarterly cash dividend of $0.35 per share pre-split (equivalent to $0.175 per share post-split) is payable March 11, 2011 to stockholders of record at the close of business on February 16, 2011. As a result of the stock split, on March 1, 2011 stockholders of record at the close of business on February 16, 2011 will receive one additional common share for every share held. Upon completion of the split, the number of common shares outstanding will be approximately 12.7 million. All share and per share amounts included in this first quarter fiscal 2011 earnings release are presented on a pre-split basis unless otherwise specifically stated.
Restructuring and Other Charges
Beginning in late fiscal 2008, the Company implemented a significant restructuring and cost reduction program, with the objectives of simplifying its merchandise brand and store nameplate structure, improving and simplifying critical processes, and reducing its expense structure. The Company has substantially completed the planned activities of the initiative and incurred $3.9 million of pretax expense related to this initiative in fiscal 2010, of which $2.5 million was incurred in the first quarter of fiscal 2010. This initiative resulted in pretax savings of approximately $12 million in fiscal 2009, with incremental pretax savings of approximately $11 million in fiscal 2010. The Company projects total annualized pretax savings of approximately $27 to $30 million in fiscal 2011 as a result of this initiative, which includes the savings realized in fiscal 2009 and fiscal 2010.
In addition, the Company recorded pretax charges of $1.3 million in the first quarter of fiscal 2010 associated with the retirement of the Company’s President and Chief Creative Officer in September 2010 and the retirement of the Company’s non-executive Chairman of the Board in January 2010.
Retail Locations
The table below summarizes store opening and closing activity for the first quarter of fiscal 2011 and 2010, as well as the Company’s store, total retail location and total international franchised location count at the end of each fiscal period. The increase in leased department locations at December 31, 2010 versus December 31, 2009 predominantly reflects the opening of an additional 217 Sears and Kmart leased department locations in September and October 2010.
First Quarter Ended
12/31/10
12/31/09
Store Openings (1)
Total
1
2
Multi-Brand Store Openings
1
1
Store Closings (1)
Total
9
5
Closings Related to Multi-Brand Store Openings
1
2
Period End Retail Location Count (1)
Stores
690
721
Leased Department Locations
1,192
980
Total Retail Locations (1)
1,882
1,701
(1) Excludes international franchised locations.
First Quarter Ended
12/31/10
12/31/09
International Franchised Location Openings
Stores
—
1
Shop-in-Shop Locations
13
—
Total International Franchised Location Openings
13
1
Period End International Franchised Location Count
Stores
8
2
Shop-in-Shop Locations
36
7
Total International Franchised Locations
44
9
Commentary
Ed Krell, Chief Executive Officer and President of Destination Maternity Corporation, noted, “We are pleased with the continued increase in the profitability of our business, as well as the improvement of our sales performance for the first quarter of fiscal 2011. Our GAAP diluted earnings per share of $0.81 for the first quarter exceeded the top end of our prior earnings guidance range of $0.51 to $0.66 per share that we provided in our November 18, 2010 press release, and was significantly higher than last year’s first quarter GAAP diluted earnings of $0.20 per share. Our sales performance for the first quarter was at the high end of our sales guidance, with our comparable retail sales increasing 2.1% and our comparable store sales increasing 1.2% for the quarter.
“As we have indicated previously, we are keenly focused on initiatives to drive profitable sales growth, including increasing our comparable store sales, and we are pleased that our comparable store sales and comparable retail sales were positive for the first quarter. Among our other initiatives, the significant expansion of our maternity apparel leased department relationship with Macy’s® will occur in February 2011, through which we will expand from our current 115 Macy’s locations to over 615 Macy’s locations throughout the United States, offering a mix of Motherhood Maternity® and A Pea in the Pod® branded merchandise. This expansion with Macy’s will deepen our position as the leading maternity apparel retailer in the world. In addition, we are focused on continuing to enhance our merchandise assortments, merchandise presentation and customer experience.”
Cash Dividend and Stock Split
“Yesterday we announced that our Board of Directors has initiated a regular quarterly cash dividend and approved a two-for-one split of our common stock. Initiating a regular quarterly cash dividend demonstrates the Board’s confidence in our Company’s financial strength and our prospects for the future, and highlights our strong earnings and cash flow generation and our commitment to continue to drive shareholder value. In addition, we believe that the stock split, combined with the regular quarterly cash dividend, will make our stock even more attractive to a broader range of investors and may increase the trading liquidity of our stock.
“Over the past several years, we have used our free cash flow predominantly to pre-pay debt and, as a result, we have significantly reduced our financial leverage and our interest expense, as reflected by our total debt decreasing from $128.9 million at the end of fiscal 2005 to $45.2 million at the end of fiscal 2010, and our interest expense decreasing from $15.3 million in fiscal 2005 to $3.3 million in fiscal 2010. With this significant reduction in our financial leverage and interest expense, we believe it is now appropriate for us to use a portion of our earnings and cash flow to return cash to our stockholders through a regular quarterly cash dividend which can enhance the total return to our stockholders, while also potentially broadening our investor base.”
Guidance for Fiscal 2011
“Looking forward, we are confident that we can continue to drive significant growth in earnings, while also growing our sales and positioning our company for continued future growth, by continuing to improve our product and customer experience, and continuing to focus on our strategic plan as summarized in our five key goals and strategic objectives discussed later under “Company Strategy.” For fiscal 2011, we look forward to: the expansion into over 500 additional Macy’s locations in February 2011; the continued growth of our Internet and international sales; the continued rollout of our multi-brand Destination Maternity stores; and the continued enhancement of our merchandise assortments, merchandise presentation and customer experience. Given the continued uncertainty as to the timing and extent of a recovery in consumer spending, we continue to plan our sales and inventory conservatively.
“Our financial guidance for the full year fiscal 2011 is as follows:
Net sales in the $560 to $570 million range, representing a projected sales increase of between 5.4% and 7.3% versus fiscal 2010 net sales of $531.2 million. The planned increase in net sales for fiscal 2011 versus fiscal 2010 is driven primarily from the expansion into over 500 additional Macy’s locations in February 2011; the expansion of the Sears and K-Mart relationships, with 217 additional Sears and K-Mart maternity locations added in September and October 2010; and the continued planned growth of our Internet and international sales.
We are planning continued improvement in our comparable store sales performance, especially in the second half of fiscal 2011. However, it is important to note that our comparable store sales and comparable retail sales will be negatively impacted by our significant Macy’s leased department expansion in February 2011. The following table provides guidance for our projected full year fiscal 2011 comparable store sales and comparable retail sales, both before and after the projected impact of this leased department expansion. Included in the guidance range for comparable retail sales (which consists of comparable store sales and Internet sales) is a projected increase in Internet sales of between 15% and 20% for fiscal 2011.
Comparable Store Sales
Comparable Retail Sales
Including projected
cannibalization impact of
leased department expansion
Down 1.5% to Up 0.5%
Down 0.5% to Up 1.5%
Excluding projected
cannibalization impact of
leased department expansion
Up 0.5% to Up 2.5%
Up 1.5% to Up 3.5%
Gross margin for fiscal 2011 is expected to increase modestly versus fiscal 2010, primarily driven by leveraging product overhead expenses over a larger planned sales volume, with product cost reductions expected to be recognized for much of the year being partially offset by the expected impact of upward product cost pressures for Summer 2011 and Fall 2011 merchandise to be recognized later in fiscal 2011.
Total selling, general and administrative (SG&A) expenses are planned to be higher than fiscal 2010 in dollar terms and comparable to fiscal 2010 as a percentage of net sales. The projected SG&A expense increase for the full year primarily results from additional operating expenses resulting from the Macy’s leased department expansion in February 2011 and certain other projected expense increases, including increased marketing expenses, partially offset by expense savings from the Company’s restructuring and cost reduction initiatives.
Operating income in the $40.9 to $44.9 million range, a projected increase of between 30% and 43% compared to fiscal 2010 operating income of $31.4 million. Operating income before restructuring and other charges is projected in the $41.2 to $45.2 million range, a projected increase of between 11% and 22% compared to fiscal 2010 operating income, before restructuring and other charges, of $37.1 million.
GAAP diluted earnings per share of between $3.62 and $3.98 per share for fiscal 2011, a projected increase of between 37% and 50% compared to earnings of $2.65 per share (diluted) for fiscal 2010. This guidance range for fiscal 2011 GAAP diluted earnings per share of $3.62 to $3.98 is higher than the prior guidance range of $3.52 to $3.87 provided by the Company in its November 18, 2010 press release.
Non-GAAP adjusted diluted earnings per common share (before restructuring and other charges, stock compensation expense, and loss on extinguishment of debt) is projected to be between $3.89 and $4.24 per share for fiscal 2011, a projected increase of between 14% and 25% versus non-GAAP adjusted diluted earnings per share of $3.40 per share for fiscal 2010, and higher than the Company’s prior guidance range of $3.76 to $4.10.
Adjusted EBITDA in the $58.0 to $62.0 million range, a projected increase of between 20% and 28% compared to the fiscal 2010 Adjusted EBITDA of $48.3 million. Adjusted EBITDA before restructuring and other charges is projected in the $58.3 to $62.3 million range, a projected increase of between 8% and 15% versus the fiscal 2010 figure of $54.0 million.
Open approximately 12 to 19 new stores during the year, including approximately 6 to 12 new multi-brand Destination Maternity stores, and close approximately 45 to 62 stores, with approximately 12 to 24 of these planned store closings related to openings of new Destination Maternity stores.
Capital expenditures planned at between $15 and $18 million compared to fiscal 2010 capital expenditures of $10.4 million. After deducting projected tenant construction allowance payments to us from store landlords, the Company expects net cash outlay for capital projects to be between $10 million and $12 million, compared to $7.4 million in fiscal 2010.
Inventory at fiscal 2011 year end planned to be approximately 4-8% higher (approximately $3 to $6 million higher) than fiscal 2010 year end, primarily due to inventory increases related to the Macy’s expansion.
Given these assumptions, the Company plans to generate free cash flow (defined as net cash provided by operating activities minus capital expenditures) of approximately $13 to $19 million for the full year fiscal 2011.
“We expect our comparable store sales for the full month of January to decrease between 0.5% and 3.0% on a reported basis, and to be between a decrease of 2.0% and an increase of 0.5% after adjusting for the “days adjustment calendar shift,” reflecting one less Friday in January 2011 compared to January 2010. We expect our comparable retail sales for the full month of January to be between a decrease of 1.0% and an increase of 2.0% after adjusting for the “days adjustment calendar shift.”
“Our financial guidance for the second quarter of fiscal 2011 is as follows:
Net sales in the $134 to $137 million range.
Comparable store sales decrease of between 0.5% and 2.5% on a reported basis (including the projected cannibalization impact of the Macy’s leased department expansion) and an increase in Internet sales of between 15% and 20%. Excluding the projected cannibalization impact of the Macy’s leased department expansion, comparable store sales are projected to be between a decrease of 1.0% and an increase of 1.0%, with comparable retail sales projected to be between flat and an increase of 2.0%.
GAAP diluted earnings per common share of between $0.60 and $0.71 per share, a significant projected improvement versus GAAP diluted earnings per share of $0.42 for the second quarter of fiscal 2010.
Non-GAAP adjusted diluted earnings per common share (before restructuring and other charges, stock compensation expense, and loss on extinguishment of debt) of between $0.64 and $0.75 per share, versus comparably adjusted non-GAAP diluted earnings per share of $0.61 for the second quarter of fiscal 2010.
Company Strategy
Mr. Krell added, “As we plan and execute our business for both the coming year and beyond, we continue to be guided by our five key goals and strategic objectives:
Be a profitable global leader in the maternity apparel business, treating all our partners and stakeholders with respect and fairness.
Increase the profitability of our U.S. business, focusing on the following:
Increase comparable store sales, through continued improvement of merchandise assortments, merchandise presentation and customer experience, providing a more shoppable store environment for our customers, and through enhanced marketing and advertising.
Reduce our expenditures and continue to be more efficient in operating our business—streamline, simplify and focus.
Continue to expand our multi-brand Destination Maternity store chain where ROI hurdles are met, with the goal of operating fewer but larger stores over time.
Continue to close underperforming stores.
In addition to achieving increased comparable store sales, we aim to grow our sales where we can do so profitably, including the following areas of focus:
International expansion
Potential growth of our leased department and licensed relationships
Increased utilization of the Internet to drive sales, targeting both increased direct Internet sales and enhanced web marketing initiatives to drive store sales
Selective new store openings and relocations in the U.S. and Canada
Continued focus on enhancing our overall customer relationship, including our marketing partnership programs.
Focus on generating free cash flow to drive increased shareholder value.
Maintain and intensify our primary focus on delivering great maternity apparel product and service in each of our brands and store formats, to serve the maternity apparel customer like no one else can.”
Mr. Krell concluded, “We feel very good about our Company’s position and the actions we have taken to improve the profitability of our business and generate increased shareholder value, even in the face of a challenging sales environment, while also making investments and pursuing targeted initiatives for profitable future sales growth. We are proud of what we have accomplished in the past two years to significantly improve our operating results, our financial position, and our outlook. At the same time, we have not been satisfied with our sales performance, although we recognize that over the past two to three years we have faced the dual challenges of a deep recession and a 6.0% decrease in births in the United States. We are focused on turning around our sales performance through initiatives to continue to enhance our merchandise assortments, merchandise presentation and customer experience, and we are cautiously optimistic that we may be starting to see some initial signs of this turnaround, as evidenced by our positive comparable store sales for the first quarter. We are confident in our ability to continue to manage our business through this uncertain consumer environment and to continue to drive near term improvements while also making progress towards our longer term goals.”
Conference Call Information
As announced previously, the Company will hold a conference call today at 9:00 a.m. Eastern Time, regarding the Company’s first quarter fiscal 2011 earnings and future financial guidance. You can participate in this conference call by calling (800) 901-5231. Please call ten minutes prior to 9:00 a.m. Eastern Time. The conference call (listen only) will also be available on the investor section of our website at http://investor.destinationmaternity.com. The passcode for the conference call is “79373208.” In the event that you are unable to participate in the call, a replay will be available through Thursday, February 10, 2011 by calling (888) 286-8010. The passcode for the replay is “94896169.”
Destination Maternity Corporation is the world’s largest designer and retailer of maternity apparel. In the United States and Canada, as of December 31, 2010, Destination Maternity operates 1,882 retail locations, including 690 stores, predominantly under the tradenames Motherhood Maternity®, A Pea in the Pod®, and Destination Maternity®, and sells on the web through its DestinationMaternity.com and brand-specific websites. Destination Maternity also distributes its Oh Baby by Motherhood™ collection through a licensed arrangement at Kohl’s® stores throughout the United States and on Kohls.com. In addition, Destination Maternity is expanding internationally and has exclusive store franchise and product supply relationships in India and the Middle East.
The Company cautions that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this press release or made from time to time by management of the Company, including those regarding the continuation of the regular quarterly cash dividend, the trading liquidity of our common stock, earnings, net sales, comparable retail sales, comparable store sales, Internet sales, other results of operations, liquidity and financial condition, and various business initiatives, involve risks and uncertainties, and are subject to change based on various important factors. The following factors, among others, in some cases have affected and in the future could affect the Company’s financial performance and actual results and could cause actual results to differ materially from those expressed or implied in any such forward-looking statements: the continuation of the economic recovery of the retail industry in general and on apparel purchases in particular, our ability to successfully manage our various business initiatives, our ability to successfully implement our merchandise brand and retail nameplate restructuring, the success of our international expansion, our ability to successfully manage and retain our leased department and licensed relationships and marketing partnerships, future sales trends in our existing store base, unusual weather patterns, changes in consumer preferences,raw material price increases, overall economic conditions and other factors affecting consumer confidence, demographics and other macroeconomic factors that may impact the level of spending for maternity apparel, expense savings initiatives, our ability to anticipate and respond to fashion trends and consumer preferences, anticipated fluctuations in our operating results, the impact of competition and fluctuations in the price, availability and quality of raw materials and contracted products, availability of suitable store locations, continued availability of capital and financing, our ability to hire and develop senior management and sales associates, our ability to develop and source merchandise, our ability to receive production from foreign sources on a timely basis, potential stock repurchases, potential debt prepayments, changes in market interest rates, war or acts of terrorism and other factors set forth in the Company’s periodic filings with the Securities and Exchange Commission, or in materials incorporated therein by reference.
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
Consolidated Statements of Income
(in thousands, except per share data)
(unaudited)
First Quarter Ended
12/31/10
12/31/09
Net sales
$
135,435
$
133,771
Cost of goods sold
62,502
62,077
Gross profit
72,933
71,694
Gross margin
53.9
%
53.6
%
Selling, general and administrative expenses (SG&A)
63,504
63,933
SG&A expenses as a percentage of net sales
46.9
%
47.8
%
Store closing, asset impairment and asset disposal expenses
243
688
Restructuring and other charges
—
3,777
Operating income
9,186
3,296
Interest expense, net
644
955
Loss on extinguishment of debt
9
30
Income before income taxes
8,533
2,311
Income tax provision
3,285
1,055
Net income
$
5,248
$
1,256
Net income per share – basic (1)
$
0.84
$
0.21
Average shares outstanding – basic (1)
6,254
6,048
Net income per share – diluted (1)
$
0.81
$
0.20
Average shares outstanding – diluted (1)
6,497
6,223
Supplemental information:
Net income, as reported
$
5,248
$
1,256
Add: restructuring and other charges, net of tax
—
2,304
Add: stock compensation expense, net of tax
465
269
Add: loss on extinguishment of debt, net of tax
6
18
Adjusted net income, before restructuring and
other charges, stock compensation expense,
and loss on extinguishment of debt
$
5,719
$
3,847
Adjusted net income per share – diluted, before
restructuring and other charges, stock compensation
expense, and loss on extinguishment of debt (1)
$
0.88
$
0.62
(1) Does not reflect the effect of the two-for-one stock split payable March 1, 2011.
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
Selected Consolidated Balance Sheet Data
(in thousands)
(unaudited)
December 31,
2010
September 30,
2010
December 31,
2009
Cash and cash equivalents
$ 35,976
$ 24,633
$ 14,273
Inventories
72,287
80,735
74,161
Property, plant and equipment, net
58,255
58,702
62,642
Line of credit borrowings
—
—
—
Total debt
42,266
45,161
51,138
Net debt (1)
6,290
20,528
36,865
Stockholders’ equity
77,717
71,598
51,988
(1) Net debt represents total debt minus cash and cash equivalents and short-term investments.
DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES
Supplemental Financial Information
Reconciliation of Operating Income to Adjusted EBITDA(1) and Adjusted EBITDA Before Restructuring and Other Charges, and Operating Income Margin to Adjusted EBITDA Margin and Adjusted EBITDA Margin Before Restructuring and Other Charges
(in thousands, except percentages)
(unaudited)
First Quarter Ended
12/31/10
12/31/09
Operating income
$
9,186
$
3,296
Add: depreciation and amortization expense
3,144
3,441
Add: loss on impairment of long-lived assets
129
675
Add: loss on disposal of assets
70
3
Add: stock compensation expense
745
441
Adjusted EBITDA (1)
13,274
7,856
Add: restructuring and other charges
—
3,777
Adjusted EBITDA before restructuring and other charges
$
13,274
$
11,633
Net sales
$
135,435
$
133,771
Operating income margin (operating income as
a percentage of net sales)
6.8%
2.5%
Adjusted EBITDA margin (Adjusted EBITDA as a
percentage of net sales)
9.8%
5.9%
Adjusted EBITDA margin before restructuring and other
charges (Adjusted EBITDA before restructuring and other
charges as a percentage of net sales)
9.8%
8.7%
(1) Adjusted EBITDA represents operating income before deduction for the following non-cash charges: (i) depreciation and amortization expense; (ii) loss on impairment of tangible and intangible assets; (iii) loss on disposal of assets; and (iv) stock compensation expense.
Consolidated Statement of Income
For the Twelve Months Ended December 31, 2010
(in thousands, except percentages and per share data)
(unaudited)
Net sales
$
532,856
Cost of goods sold
240,591
Gross profit
292,265
Gross margin
54.8
%
Selling, general and administrative
expenses (SG&A)
251,224
SG&A expenses as a percentage of net sales
47.1
%
Store closing, asset impairment and asset
disposal expenses
1,837
Restructuring and other charges
1,881
Operating income
37,323
Interest expense, net
2,989
Loss on extinguishment of debt
30
Income before income taxes
34,304
Income tax provision
13,483
Net income
$
20,821
Net income per share – basic (1)
$
3.36
Average shares outstanding – basic (1)
6,204
Net income per share – diluted (1)
$
3.25
Average shares outstanding – diluted (1)
6,415
Supplemental information:
Net income, as reported
$
20,821
Add: restructuring and other charges, net of tax
1,168
Add: stock compensation expense, net of tax
1,400
Add: loss on extinguishment of debt, net of tax
19
Adjusted net income, before restructuring and other
charges, stock compensation expense, and loss on
extinguishment of debt
$
23,408
Adjusted net income per share – diluted, before
restructuring and other charges, stock compensation
expense, and loss on extinguishment of debt (1)
$
3.65
(1) Does not reflect the effect of the two-for-one stock split payable March 1, 2011.
Reconciliation of Operating Income to Adjusted EBITDA
and Adjusted EBITDA Before Restructuring and Other Charges,
and Operating Income Margin to Adjusted EBITDA Margin
and Adjusted EBITDA Margin Before Restructuring and Other Charges
For the Twelve Months Ended December 31, 2010
(in thousands, except percentages)
(unaudited)
Operating income
$
37,323
Add: depreciation and amortization expense
12,619
Add: loss on impairment of long-lived assets
1,319
Add: loss on disposal of assets
263
Add: stock compensation expense
2,240
Adjusted EBITDA
53,764
Add: restructuring and other charges
1,881
Adjusted EBITDA before restructuring and other charges
$
55,645
Net sales
$
532,856
Operating income margin
7.0
%
Adjusted EBITDA margin
10.1
%
Adjusted EBITDA margin before restructuring and other
charges
10.4
%
Reconciliation of Net Income Per Share – Diluted
to Adjusted Net Income Per Share – Diluted,
Before Restructuring and Other Charges, Stock Compensation
Expense, and Loss on Extinguishment of Debt
(unaudited)
Projected for the
Year Ending
Actual for the
Year Ended
9/30/11 (1) (2)
9/30/10 (2)
Net income per share – diluted (3)
$
3.62 to 3.98
$
2.65
Add: per share effect of restructuring and other charges
0.03
0.55
Add: per share effect of stock compensation expense
0.23
0.19
Add: per share effect of loss on extinguishment of debt
0.01
0.01
Adjusted net income per share – diluted, before restructuring
and other charges, stock compensation expense, and loss
on extinguishment of debt (3)
$
3.89 to 4.24
$
3.40
(1) Components do not add to total due to rounding.
(2) Does not reflect the effect of the two-for-one stock split payable March 1, 2011.
(3) Projected net income and projected adjusted net income per share – diluted for the year ending September 30, 2011 are based on approximately 6,535,000 to 6,571,000 projected average diluted shares outstanding.
Reconciliation of Net Income Per Share – Diluted
to Adjusted Net Income Per Share – Diluted,
Before Restructuring and Other Charges, Stock Compensation
Expense, and Loss on Extinguishment of Debt
(unaudited)
Projected for the
Second Quarter Ending
Actual for the
Second Quarter Ended
3/31/11 (1)
3/31/10 (1)
Net income per share – diluted (2)
$
0.60 to 0.71
$
0.42
Add: per share effect of restructuring and other charges
—
0.14
Add: per share effect of stock compensation expense
0.04
0.05
Adjusted net income per share – diluted, before restructuring
and other charges, stock compensation expense, and loss
on extinguishment of debt (2)
$
0.64 to 0.75
$
0.61
(1) Does not reflect the effect of the two-for-one stock split payable March 1, 2011.
(2) Projected net income and projected adjusted net income per share – diluted for the second quarter ending March 31, 2011 are based on approximately 6,497,000 to 6,546,000 projected average diluted shares outstanding.
Reconciliation of Operating Income to Adjusted EBITDA
and Adjusted EBITDA Before Restructuring and Other Charges
(in millions, unaudited)
Projected for the
Year Ending
Actual for the
Year Ended
9/30/11
9/30/10
Operating income
$
40.9 to 44.9
$
31.4
Add: depreciation and amortization expense
12.9
12.9
Add: loss on impairment of long-lived assets and loss on
disposal of assets
1.7
2.1
Add: stock compensation expense
2.5
1.9
Adjusted EBITDA
58.0 to 62.0
48.3
Add: restructuring and other charges
0.3
5.7
Adjusted EBITDA before restructuring and other charges
$
58.3 to 62.3
$
54.0
Thursday, January 27th, 2011UncategorizedComments Off on Destination Maternity (DEST) Reports Q1 Earnings Significantly Higher Than Prior Guidance and Last Year
Jan. 27, 2011 (Business Wire) — Cirrus Logic, Inc. (Nasdaq: CRUS),a leader in high-precision analog and digital signal processing components, today announced financial results for the third quarter of fiscal year 2011, which ended Dec. 25, 2010.
Revenue for the quarter was $95.6 million, up 47 percent compared to the same quarter a year ago, and down five percent sequentially from the previous quarter. Gross margin for the quarter was 55 percent, up slightly from 54 percent in the third quarter a year ago, and down slightly from 56 percent for the previous quarter.
Total GAAP operating expenses for the quarter were approximately $29.4 million, compared to $27.7 million in the previous quarter. Non-GAAP operating expenses for the quarter were approximately $28.0 million compared to $27.6 million in the previous quarter.
Income from operations on a GAAP basis was approximately $23.1 million, representing an operating margin of 24 percent. Income from operations on a non-GAAP basis was $24.5 million, representing a non-GAAP operating margin of 26 percent
GAAP net income for the quarter was approximately $24.6 million, or $0.34 per share, based on 71.7 million average diluted shares outstanding. Non-GAAP net income was $24.2 million, or $0.34 per diluted share.
A reconciliation of the non-GAAP charges is included in a table below.
“Revenue from portable audio products exceeded our expectations, helping to drive overall Q3 revenue growth of 47 percent year over year,” said Jason Rhode, president and chief executive officer, Cirrus Logic. “Looking at both the fourth quarter and the next fiscal year, we believe we will continue to grow revenue at a faster rate than the semiconductor industry as a whole. With the production ramps continuing this next year in portable audio, new design wins in other audio markets, and ongoing design activity with our strategic energy initiatives, we are very excited about the opportunities ahead.”
Outlook forFourth Quarter FY 2011 (ending Mar. 26, 2011):
Revenue is expected to range between $88 million and $94 million;
Gross margin is expected to be between 54 percent and 56 percent; and
Combined R&D and SG&A expenses are expected to range between $31 million and $33 million, which include approximately $2.5 million in share-based compensation and amortization of acquisition-related intangibles expenses.
Other Highlights and Company News
The company repurchased and retired approximately 1.76 million shares during the quarter, at an average price of $12.94, while cash and cash equivalents grew by approximately $8 million during the quarter.
Total employee headcount during the quarter increased to 549 employees, a net increase of 15 employees.
In January, the company began construction on its new headquarters facility at 800 W. Sixth Street in downtown Austin that is expected to be completed in the summer of 2012.
Thurman Case, chief financial officer, will be presenting at the Stifel Nicolaus Technology Conference in San Francisco on February 11, at 11:00 a.m. ET. A live webcast will be available in the investor relations section of cirrus website.
Conference Call
Cirrus Logic management will hold a conference call to discuss the company’s results for the third quarter fiscal year 2011, on January 27, at 10:30 a.m. ET. The conference call will be simulcast over the internet in the investor relations section of the company website at http://investor.cirrus.com. A replay of the conference call will be available on the website listed above beginning one hour following the completion of the call, or by calling (303) 590-3030, or toll-free at (800) 406-7325 (Access Code: 4398706).
Shareholders who would like to submit a question to be addressed during the call are requested to email investor.relations@cirrus.com.
Cirrus Logic, Inc.
Cirrus Logic develops high-precision, analog and mixed-signal integrated circuits for a broad range of innovative customers. Building on its diverse analog and signal-processing patent portfolio, Cirrus Logic delivers highly optimized products for a variety of audio and energy-related applications. The company operates from headquarters in Austin, Texas, with offices in Tucson, Ariz., Europe, Japan and Asia. More information about Cirrus Logic is available at www.cirrus.com.
Use of non-GAAP Financial Information
To supplement Cirrus Logic’s financial statements presented on a GAAP basis, Cirrus has provided non-GAAP financial information, including non-GAAP operating expenses, non-GAAP net income, non-GAAP income from operations, non-GAAP operating margin and non-GAAP diluted earnings per share. A reconciliation of the adjustments to GAAP results is included in the tables below. Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. As a note, the non-GAAP financial information used by Cirrus Logic may differ from that used by other companies.These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.
Safe Harbor Statement
Except for historical information contained herein, the matters set forth in this news release contain forward-looking statements, including our estimates of fourth quarter fiscal year 2011 revenue, our future growth rate, gross margin, combined research and development and selling, general and administrative expense levels, share-based compensation expense, and amortization of acquired intangible expenses. In some cases, forward-looking statements are identified by words such as “expect,” “anticipate,” “target,” “project,” “believe,” “goals,” “opportunity,” “estimates,” “intend,” and variations of these types of words and similar expressions.In addition, any statements that refer to our plans, expectations, strategies or other characterizations of future events or circumstances are forward-looking statements.These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, the following: the level of orders and shipments during the fourth quarter of fiscal year 2011, as well as customer cancellations of orders, or the failure to place orders consistent with forecasts; the loss of a key customer; and the risk factors listed in our Form 10-K for the year ended March 27, 2010, and in our other filings with the Securities and Exchange Commission, which are available at www.sec.gov.The foregoing information concerning our business outlook represents our outlook as of the date of this news release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new developments or otherwise.
Cirrus Logic and Cirrus are trademarks of Cirrus Logic Inc.
CRUS-F
Summary financial data follows:
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS
(unaudited)
(in thousands, except per share data)
Three Months Ended
Nine Months Ended
Dec. 25,
Sep. 25,
Dec. 26,
Dec. 25,
Dec. 26,
2010
2010
2009
2010
2009
Q3’11
Q2’11
Q3’10
Q3’11
Q3’10
Audio products
$
72,716
$
71,171
$
47,063
$
197,875
$
113,121
Energy products
22,909
29,427
18,099
80,263
45,229
Net revenue
95,625
100,598
65,162
278,138
158,350
Cost of sales
43,163
43,818
30,276
122,161
74,903
Gross Profit
52,462
56,780
34,886
155,977
83,447
Operating expenses:
Research and development
16,348
15,450
12,834
46,890
37,697
Selling, general and administrative
13,431
15,372
11,428
42,814
33,245
Restructuring and other costs, net
(395
)
401
86
6
(79
)
Charge (proceeds) from non-marketable securities
–
500
(500
)
500
(500
)
Provision for (proceeds from) litigation expenses and settlements
(30
)
–
135
105
(2,610
)
Patent purchase agreement, net
–
(4,000
)
–
(4,000
)
(1,400
)
Total operating expenses
29,354
27,723
23,983
86,315
66,353
Operating income
23,108
29,057
10,903
69,662
17,094
Interest income, net
212
233
269
673
1,108
Other expense, net
(31
)
(14
)
(7
)
(13
)
(46
)
Income before income taxes
23,289
29,276
11,165
70,322
18,156
Provision (benefit) for income taxes
(1,332
)
(1,598
)
110
(2,775
)
116
Net income
$
24,621
$
30,874
$
11,055
$
73,097
$
18,040
Basic income per share:
$
0.36
$
0.45
$
0.17
$
1.08
$
0.28
Diluted income per share:
$
0.34
$
0.42
$
0.17
$
1.02
$
0.28
Weighted average number of shares:
Basic
68,074
68,513
65,302
67,731
65,279
Diluted
71,695
72,878
65,632
71,868
65,452
Prepared in accordance with Generally Accepted Accounting Principles
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED BALANCE SHEET
(in thousands)
Dec. 25,
Mar. 27,
Dec. 26,
2010
2010
2009
(unaudited)
(unaudited)
ASSETS
Current assets
Cash and cash equivalents
$
28,491
$
16,109
$
24,831
Restricted investments
5,755
5,855
5,755
Marketable securities
156,052
85,384
77,636
Accounts receivable, net
37,266
23,963
25,131
Inventories
40,196
35,396
30,408
Other current assets
22,612
18,148
6,318
Total Current Assets
290,372
184,855
170,079
Long-term marketable securities
–
34,278
25,235
Property and equipment, net
32,919
18,674
18,499
Intangibles, net
20,688
21,896
22,654
Goodwill
6,027
6,027
6,027
Other assets
1,978
1,880
1,906
Total Assets
$
351,984
$
267,610
$
244,400
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable
$
25,371
$
20,340
$
25,172
Accrued salaries and benefits
9,509
9,962
7,609
Other accrued liabilities
5,034
5,100
5,047
Deferred income on shipments to distributors
7,108
6,488
4,033
Total Current Liabilities
47,022
41,890
41,861
Long-term restructuring accrual
179
596
492
Other long-term obligations
6,113
6,523
6,555
Stockholders’ equity:
Capital stock
982,610
952,803
950,023
Accumulated deficit
(683,220
)
(733,553
)
(753,911
)
Accumulated other comprehensive loss
(720
)
(649
)
(620
)
Total Stockholders’ Equity
298,670
218,601
195,492
Total Liabilities and Stockholders’ Equity
$
351,984
$
267,610
$
244,400
Prepared in accordance with Generally Accepted Accounting Principles
CIRRUS LOGIC, INC.
RECONCILIATION BETWEEN GAAP AND NON-GAAP FINANCIAL INFORMATION
(unaudited, in thousands, except per share data)
(not prepared in accordance with GAAP)
Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. As a note, the non-GAAP financial information used by Cirrus Logic may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.
Three Months Ended
Nine Months Ended
Dec. 25,
Sep. 25,
Dec. 26,
Dec. 25,
Dec. 26,
2010
2010
2009
2010
2009
Net Income Reconciliation
Q3’11
Q2’11
Q3’10
Q3’11
Q3’10
GAAP Net Income
$
24,621
$
30,874
$
11,055
$
73,097
$
18,040
Amortization of acquisition intangibles
353
353
404
1,076
1,212
Stock based compensation expense
1,467
3,025
1,397
5,848
4,133
Facility Related adjustments
–
(100
)
(375
)
(96
)
(397
)
International sales reorganization charges
–
–
–
790
–
Provision for (proceeds from) litigation expenses and settlements
(30
)
–
135
105
(2,610
)
Restructuring and other costs, net
(395
)
401
86
6
(79
)
Charge (proceeds) from non-marketable securities
–
500
(500
)
500
(500
)
Patent purchase agreement, net
–
(4,000
)
–
(4,000
)
(1,400
)
Provision (benefit) for income taxes
(1,847
)
(2,229
)
–
(4,076
)
–
Non-GAAP Net Income
$
24,169
$
28,824
$
12,202
$
73,250
$
18,399
Earnings Per Share Reconciliation
GAAP Diluted income per share
$
0.34
$
0.42
$
0.17
$
1.02
$
0.28
Effect of Amortization of acquisition intangibles
–
–
0.01
0.02
0.02
Effect of Stock based compensation expense
0.02
0.04
0.02
0.08
0.06
Effect of Facility Related adjustments
–
–
–
–
(0.01
)
Effect of International sales reorganization charges
–
–
–
0.01
–
Effect of Provision for (proceeds from) litigation expenses and settlements
–
–
–
–
(0.04
)
Effect of Restructuring and other costs, net
–
0.01
–
–
–
Effect of Charge (proceeds) from non-marketable securities
–
0.01
(0.01
)
0.01
(0.01
)
Effect of Patent purchase agreement, net
–
(0.05
)
–
(0.06
)
(0.02
)
Effect of Provision (benefit) for income taxes
(0.02
)
(0.03
)
–
(0.06
)
–
Non-GAAP Diluted income per share
$
0.34
$
0.40
$
0.19
$
1.02
$
0.28
Operating Income Reconciliation
GAAP Operating Income (Loss)
$
23,108
$
29,057
$
10,903
$
69,662
$
17,094
GAAP Operating Margin
24
%
29
%
17
%
25
%
11
%
Amortization of acquisition intangibles
353
353
404
1,076
1,212
Stock compensation expense – COGS
46
64
55
165
150
Stock compensation expense – R&D
579
617
438
1,717
1,380
Stock compensation expense – SG&A
842
2,344
904
3,966
2,603
Facility Related adjustments
–
(100
)
(375
)
(96
)
(397
)
International sales reorganization charges
–
–
–
790
–
Provision for (proceeds from) litigation expenses and settlements
(30
)
–
135
105
(2,610
)
Restructuring and other costs, net
(395
)
401
86
6
(79
)
Charge (proceeds) from non-marketable securities
–
500
(500
)
500
(500
)
Patent purchase agreement, net
–
(4,000
)
–
(4,000
)
(1,400
)
Non-GAAP Operating Income (Loss)
$
24,503
$
29,236
$
12,050
$
73,891
$
17,453
Non-GAAP Operating Margin
26
%
29
%
18
%
27
%
11
%
Operating Expense Reconciliation
GAAP Operating Expenses
$
29,354
$
27,723
$
23,983
$
86,315
$
66,353
Amortization of acquisition intangibles
(353
)
(353
)
(404
)
(1,076
)
(1,212
)
Stock compensation expense – R&D
(579
)
(617
)
(438
)
(1,717
)
(1,380
)
Stock compensation expense – SG&A
(842
)
(2,344
)
(904
)
(3,966
)
(2,603
)
Facility Related adjustments
–
100
375
96
397
International sales reorganization charges
–
–
–
(790
)
–
Provision for (proceeds from) litigation expenses and settlements
Jan. 27, 2011 (Business Wire) — Arctic Cat Inc. (NASDAQ:ACAT) today reported net earnings of $9.3 million, or $0.50 per diluted share, on net sales of $152.0 million for the fiscal 2011 third quarter ended December 31, 2010. Arctic Cat reported net earnings in the prior-year third quarter of $2.6 million, or $0.14 per diluted share, on net sales of $131.0 million.
For the nine months ended December 31, 2010, Arctic Cat’s net earnings were $22.6 million, or $1.22 per diluted share, on net sales of $391.2 million. In the first nine months of last fiscal year, the company reported net earnings of $11.4 million, or $0.63 per diluted share, on net sales of $366.7 million.
Commented Arctic Cat’s president and chief executive officer Claude Jordan: “We are very pleased with the company’s strong third-quarter and year-to-date performance. Our results were fueled by higher sales across all product lines, including double-digit gains in our snowmobile business. The combination of increased volume, product mix, product cost-reduction efforts, higher selling prices and a continued focus on efficiency led to another quarter of significantly improved gross margins and profitability.”
Among the highlights of Arctic Cat’s 2011 third quarter and year-to-date financial results versus the same periods last year:
Gross margins improved 430 basis points in the quarter and 370 basis points year to date;
Operating profit for the quarter rose to $12.2 million from $0.6 million, and year to date increased to $32.7 million from $13.9 million;
Factory inventory declined 27 percent to $77.2 million from $106.3 million;
Total cash and short-term investments rose to $107.1 million from $50.4 million; and
The company has no short- or long-term debt.
“We are excited by the traction and momentum we’ve achieved year to date,” said Jordan. “We continued to successfully execute against our objectives to reduce dealer and factory inventory, improve gross margins and keep operating expenses flat as a percent of sales.”
Business Line Results
Snowmobile sales grew 33 percent to $77.8 million in the third quarter compared to $58.7 million in the prior-year quarter, led by increases in both North American dealer sales and international sales to distributors. Year-to-date snowmobile sales increased 15 percent to $186.5 million versus $162.3 million in the same period last year, led by higher international sales to distributors.
All-terrain vehicle (ATV) sales rose 1 percent to $48.6 million in the third quarter versus $48.2 million in the prior-year quarter, chiefly driven by sales of the company’s new Prowler HDX heavy duty utility vehicle. During the quarter, Arctic Cat announced the launch of three all-new 2011 ATV models: the full-featured, value-priced 350 4X4 automatic; the valued-priced 425 EFI 4X4 automatic; and the XC450i 4X4, a crossover model for consumers seeking four-wheel-drive capabilities in a sport ATV. Arctic Cat’s year-to-date ATV sales were up 1 percent to $133.0 million compared to $132.1 million in the first nine months of fiscal 2010.
Sales of parts, garments and accessories (PG&A) in the third quarter grew 6 percent to $25.6 million versus $24.2 million in the prior-year quarter, primarily driven by stronger garments sales including the new Drift garment line. Year-to-date PG&A sales totaled $71.7 million, down 1 percent from $72.3 million in the year-ago period.
Outlook
“We remain confident that the company is on track to deliver improved operating results, increased profitability and enhanced shareholder value again this fiscal year,” Jordan said.
Arctic Cat is focused on improving its profitability in a continued low-demand recreational vehicle market, which remains well below pre-recession industry sales levels. The company’s fiscal 2011 outlook includes the following assumptions: ATV industry retail sales declining approximately 15 to 20 percent; snowmobile industry retail sales increasing 5 to 10 percent; Arctic Cat dealer inventories declining 20 to 30 percent; improving gross margins between 200 to 300 basis points; achieving flat to slightly down operating expense levels as a percent of sales; increasing cash flow from operations; and ending the year with more cash on the balance sheet.
Based on its year-to-date results and expectations of future performance, Arctic Cat is raising and narrowing its estimated full-year earnings for the current fiscal year ending March 31, 2011. The company now anticipates that fiscal 2011 earnings will be in the range of $0.57 to $0.65 per diluted share, driven by increased international revenue, as well as higher gross margins resulting from higher volume, product mix and cost reduction efforts. The company’s previous guidance anticipated fiscal 2011 earnings of $0.40 to $0.55 per diluted share. The company continues to estimate fiscal 2011 net sales of $453 million to $463 million.
Conference Call
A conference call is scheduled for 11:00 a.m. CT (12:00 p.m. ET) today. To listen to the live webcast or replay of this call via the Internet, go to the corporate portion of the company’s website at www.arcticcat.com. To listen to a telephone replay of the conference call, dial 800-406-7325 and enter conference call passcode 4403970. The telephone replay will be available through Thursday, February 3, 2011.
About Arctic Cat
Arctic Cat Inc. designs, engineers, manufactures and markets all-terrain vehicles (ATVs) and snowmobiles under the Arctic Cat® brand name, as well as related parts, garments and accessories. Its common stock is traded on the Nasdaq Global Select Market under the ticker symbol “ACAT.” More information about Arctic Cat and its products is available at www.arcticcat.com.
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for certain forward-looking statements. The Company’s Annual Report, as well as the Report on Form 10-K and future filings with the Securities and Exchange Commission, the Company’s press releases and oral statements made with the approval of an authorized executive officer, contain forward-looking statements that reflect the Company’s current views with respect to future events and financial performance. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or those anticipated. The words “aim,” “believe,” “expect,” “anticipate,” “intend,” “estimate” and other expressions that indicate future events and trends identify forward-looking statements. Actual future results and trends may differ materially from historical results or those anticipated depending on a variety of factors, including, but not limited to: product mix and volume; competitive pressure on sales and pricing; cost and availability of financing for the Company, our dealers and our suppliers; increase in material or production cost which cannot be recouped in product pricing; changes in the sourcing of snowmobile engines from Suzuki; warranty expenses; foreign currency exchange rate fluctuations; product liability claims and other legal proceedings in excess of insured amounts; environmental and product safety regulatory activity; effects of the weather; overall economic conditions; and consumer demand and confidence. The Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
ARCTIC CAT INC.
Financial Highlights
(000s omitted, except per share amounts)(Unaudited)
Three Months Ended
Nine Months Ended
December 31,
December 31,
2010
2009
2010
2009
Net Sales
Snowmobile & ATV Units
$
126,381
$
106,879
$
319,485
$
294,433
Parts Garments & Accessories
25,595
24,161
71,709
72,277
Total Net Sales
151,976
131,040
391,194
366,710
Cost of Goods Sold
Snowmobile & ATV Units
104,723
95,025
254,252
249,115
Parts Garments & Accessories
14,521
13,434
42,193
42,255
Cost of Goods Sold
119,244
108,459
296,445
291,370
Gross Profit
32,732
22,581
94,749
75,340
Operating Expenses
Selling & Marketing
8,502
8,941
24,973
24,982
Research & Development
3,418
2,979
9,828
9,177
General & Administrative
8,595
10,037
27,255
27,323
Total Operating Expenses
20,515
21,957
62,056
61,482
Operating Profit
12,217
624
32,693
13,858
Other Income (Expense)
Interest Income
28
—
72
4
Interest Expense
(1
)
(2
)
(11
)
(249
)
Total Other Income (Expense)
27
(2
)
61
(245
)
Earnings Before Income Taxes
12,244
622
32,754
13,613
Income Tax Expense (Benefit)
2,982
(1,980
)
10,161
2,178
Net Earnings
$
9,262
$
2,602
$
22,593
$
11,435
Net Earnings Per Share
Basic
$
0.51
$
0.14
$
1.24
$
0.63
Diluted
$
0.50
$
0.14
$
1.22
$
0.63
Weighted Average Shares
Outstanding:
Basic
18,236
18,228
18,214
18,217
Diluted
18,644
18,297
18,484
18,249
December 31,
Selected Balance Sheet Data:
2010
2009
Cash and Short-term Investments
$
107,070
$
50,356
Accounts Receivable, net
50,301
43,008
Inventories
77,150
106,264
Total Assets
296,505
267,077
Short-term Bank Borrowings
0
0
Total Current Liabilities
102,984
82,788
Long-term Debt
0
0
Shareholders’ Equity
190,953
179,710
Three Months Ended
Nine Months Ended
December 31
December 31
Product Line Data:
2010
2009
Change
2010
2009
Change
Snowmobiles
$
77,822
$
58,665
33%
$
186,452
$
162,321
15%
All-terrain Vehicles
48,559
48,214
1%
133,033
132,112
1%
Parts, Garments & Accessories
25,595
24,161
6%
71,709
72,277
-1%
Total Sales
$
151,976
$
131,040
16%
$
391,194
$
366,710
7%
Arctic Cat Inc.
Timothy C. Delmore, 763-354-1800
Chief Financial Officer
or
Padilla Speer Beardsley Inc.
Shawn Brumbaugh, 612-455-1754
Thursday, January 27th, 2011UncategorizedComments Off on Arctic Cat (ACAT) Reports Fiscal 2011 Third Quarter Results
LOS ANGELES, Jan. 27, 2011 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (Nasdaq:HAFC), the holding company for Hanmi Bank, today reported a fourth quarter profit of $5.3 million or $0.04 per diluted share, with substantial improvement in credit metrics. In the fourth quarter of 2009, Hanmi’s net loss totaled $35.9 million, or $0.70 per share. For the full year in 2010, the net loss improved to $88.0 million, or $0.93 per share, compared to $122.3 million, or $2.57 per share in 2009.
“We believe that our continuing efforts to shed problem assets through credit workouts and asset sales has improved credit quality metrics and allowed us to return to profitability,” said Jay S. Yoo, President and Chief Executive Officer. “Our successful capital raise earlier in July 2010 was an additional factor in strengthening our capital position. Hanmi Bank continued to be categorized as ‘well-capitalized’ for regulatory purposes at December 31, 2010.”
2010 Highlights
Hanmi’s fourth quarter results mark the first time in over two years that Hanmi Financial has earned a quarterly profit of $5.3 million.
Credit metrics, which began to improve at the beginning of 2010, continued improving as the year progressed. Non-performing assets (NPA), which is non-performing loans (NPLs) and other real estate owned (OREO) assets, decreased by 20% to $173.1 million, or 5.95% of total assets, from $215.3 million or 7.25% of total assets in the third quarter and $245.4 million, or 7.76% a year ago. The coverage ratio of the allowance to non-performing loans increased to 86.4% at December 31, 2010 compared to 66.2% a year ago while slightly decreased compared to 90.4% in the prior quarter.
During 2010, the successful deleveraging of the balance sheet reduced total assets by 8% or $256 million to $2.91 billion, with gross loans down 20%.
Net interest margin (NIM) was stable at 3.48% in the fourth quarter of 2010, down one basis point from 3.49% in the third quarter of 2010 and up 2 basis points from the fourth quarter a year ago. For the full year, NIM increased 71 basis points to 3.55% from 2.84% at December 31, 2009.
Capital Management
“The successful rights offering and best efforts stock offerings in July 2010 have provided the necessary capital to return our balance sheet to ‘well capitalized’ regulatory status and provided us with the capital resources to assist us in achieving profitability in this most recently completed quarter,” Mr. Yoo stated. “We understand that Woori Finance continues to work closely with regulators to achieve approval for the previously announced transaction. While this transaction is no longer exclusive, we believe it is still quite viable. In addition, we are also considering alternative capital sources to further enhance our capital position and fund balance sheet growth.”
With the profit generated from operations along with the decrease in our total assets, the Bank’s Total Risk-Based Capital Ratio at year-end increased to 12.23% compared with 11.61% in the immediate prior quarter-end and 9.07% a year ago. At December 31, 2010, Tier 1 Risk-Based Capital Ratio was 10.91% compared to 10.28% at September 30, 2010, and 7.77% a year ago. Fourth quarter Tier 1 Leverage Ratio was 8.55% compared to 8.26% in the third quarter and 6.69% in the fourth quarter of 2009. The Bank’s Tangible Common Equity to Tangible Assets at year-end increased to 8.60% compared with 8.37% in the linked quarter and 7.13% a year ago.
Asset Quality
At December 31, 2010, the allowance for loan losses was $146.1 million, or 6.44% of gross loans, compared to $176.1 million, or 7.35% of gross loans, at September 30, 2010, and $145.0 million, or 5.14% of gross loans a year ago. The ratio of Hanmi’s loan loss allowance to non-performing loans at December 31, 2010, increased to 86.41%, up from 66.19% a year ago. Fourth quarter charge-offs, net of recoveries, were $35.2 million compared to $21.3 million in the third quarter and $57.3 million in the fourth quarter of 2009. For the full year in 2010, net charge-offs were $121.9 million compared to $122.6 million in 2009.
NPLs declined 13% to $169.0 million at December 31, 2010, from $194.7 million at September 30, 2010, and are down 23% from $219.1 million at December 31, 2009. Of the total $169.0 million NPLs, $43.0 million, or 25%, were current on payments. In addition, $69.4 million, or 41%, were marked to current market value with partial charge-offs. Out of the $69.4 million, $26.6 million were categorized as available for sale. We sold 29 NPLs with carrying value of $28.6 million in the fourth quarter, which contributed to the decline of NPLs in the quarter. Year-to-date, we sold 87 loans with carrying value of $156.8 million.
Sale of OREOs, real estate acquired through foreclosures, continued during the fourth quarter, with 5 properties sold for net proceeds of $17.1 million, resulting in a $115,000 net loss. In 2010, OREO sales generated $25.9 million in net proceeds on the sale of 18 properties, resulting in a $196,000 net loss. OREOs totaled $4.1 million at December 31, 2010, down from $20.6 million at September 30, 2010 and also down from $26.3 million a year ago. Hanmi actively manages its loan portfolio and regularly sells assets prior to foreclosure, which partially accounts for the reduction of OREO. The following table shows non-performing loans by loan category:
Total Non-Performing Loans
(‘000)
12/31/2010
% of Total
NPL
9/30/2010
% of Total
NPL
12/31/2009
% of Total
NPL
Real Estate Loans:
Commercial Property
21,129
12.5%
31,103
16.0%
60,159
27.5%
Construction
19,097
11.3%
9,338
4.8%
15,166
6.9%
Land Loans
26,808
15.2%
29,701
15.2%
19
0.0%
Residential Property
2,674
1.6%
2,264
1.2%
3,662
1.7%
Commercial & Industrial Loans:
Owner Occupied Property
68,441
40.5%
90,777
46.6%
96,966
44.3%
Other C&I
30,581
18.1%
31,216
16.0%
42,405
19.4%
Consumer Loans
298
0.2%
330
0.2%
690
0.3%
TOTAL NPL
169,028
100.0%
194,729
100.0%
219,067
100.0%
The proactive approach to resolving problematic credits in 2010 helped reduce delinquent loans on accrual status, which are not included in the NPL total. Delinquent loans on accrual status decreased to $21.5 million, or 0.95% of gross loans at December 31, 2010, from $41.2 million, or 1.46% of gross loans at December 31, 2009. On a sequential quarter basis, the amount of delinquent loans on accrual status decreased from $23.9 million at September 30, 2010 due to a decrease in delinquent construction loans on accrual status. This decrease was partially offset by a minor increase in Commercial & Industrial delinquent loans on an accrual status. The following table shows delinquent loans on accrual status by loan category:
Delinquent loans on accrual status
(‘000)
12/31/2010
% of Total
9/30/2010
% of Total
12/31/2009
% of Total
Real Estate Loans:
Commercial Property
382
1.6%
3,500
8.5%
Construction
4,894
22.8%
8,714
36.5%
Land Loans
150
0.4%
Residential Property
951
4.4%
801
3.4%
1,190
2.9%
Commercial & Industrial Loans:
Owner Occupied Property
10,408
48.5%
9,261
38.7%
23,833
57.8%
Other C&I
5,004
23.3%
4,543
19.0%
11,951
29.0%
Consumer Loans
200
0.9%
195
0.8%
594
1.4%
TOTAL
21,457
100.0%
23,896
100.0%
41,218
100.0%
Balance Sheet
We believe that our deleveraging strategy in the last two years has been successful in reducing portfolio risk and preserving capital. With our enhanced capital levels, we have begun to implement plans to grow our customer base, albeit at moderate levels. With loan demand still soft, we anticipate that any growth will come from attracting new customers and capitalizing on continuing disruption in the regional banking market.
Total assets decreased slightly at the end of the fourth quarter to $2.91 billion, from $2.97 billion at September 30, 2010, and down 8% from $3.16 billion at December 31, 2009. Gross loans, net of deferred loan fees, were $2.27 billion at December 31, 2010, down 5% from $2.39 billion at September 30, 2010, and down 20% from $2.82 billion at December 31, 2009.
Average gross loans decreased 20% to $2.35 billion for the fourth quarter of 2010 from $2.92 billion for the like quarter a year ago and declined 4% during the fourth quarter from $2.46 billion for the third quarter of 2010. Hanmi’s average investment securities portfolio increased 92% to $351.0 million for the fourth quarter of 2010 from $182.6 million for the fourth quarter of 2009 and increased 57% for the fourth quarter of 2010 from $223.7 million from the quarter ended September 30. 2010. The decreases in average gross loans over the past year were the direct result of the balance sheet deleveraging strategy. The Bank increased investment securities to enforce liquidity preservation strategy.
Consistent with the deleveraging strategy, average deposits also decreased 14% to $2.51 billion for the fourth quarter of 2010 from $2.91 billion for the like quarter in 2009 and declined 2% from $2.56 billion for the third quarter of 2010.
The deposit mix at year-end continues to reflect efforts to build core deposits and improve the Bank’s cost of funds. There are no brokered deposits in the deposit mix at year-end. Total deposits decreased 10% year-over-year and declined 2% from the prior quarter. The 10% year-over-year decrease in total deposits was primarily due to a $203 million decrease in brokered deposits. Total deposits were $2.47 billion at December 31, 2010, compared to $2.53 billion at September 30, 2010, and $2.75 billion at December 31, 2009.
Results of Operations
Net interest income, before the provision for credit losses, totaled $26.0 million for the fourth quarter of 2010 which was down 1% from $26.3 million in the linked quarter and down 9% from $28.4 million in the fourth quarter a year ago. Increased liquidity from the capital raise earlier in the year was deployed to cash and cash equivalent balances and investment securities which are generally lower yielding assets. The cost of funds also declined in the quarter reflecting reductions in high-cost time deposits and an increase in low-cost deposits. For the full year in 2010, net interest income before provision for credit losses increased 5% to $105.9 million compared to $101.2 million in 2009.
Loan yields increased and deposit costs decreased which benefited our net interest margin. These benefits were offset by higher balances of investment securities, which generate lower yields but allowing a strong liquidity position. The average yield on the loan portfolio increased 4 basis points to 5.48% from 5.44% from the prior quarter and decreased 6 basis points from the fourth quarter in 2009. For the full year 2010, the average yield on the loan portfolio decreased 9 basis points to 5.40% from 5.49% in 2009. In 2010, the reversal of previously recorded interest income due to the additional non-accrual loans was $3.2 million ($0.3 million in the fourth quarter), resulting in a negative impact on NIM by 11 basis points. The cost of average interest-bearing deposits in the fourth quarter was 1.55%, down 10 basis points from the prior quarter and 71 basis points from the fourth quarter of 2009. For the full year 2010, the cost of average interest bearing deposits was 1.70%, down 127 basis points from a year ago. As a result, Hanmi’s net interest margin was down just one basis point at 3.48% in the fourth quarter of 2010 from 3.49% in the third quarter and up 2 basis points compared to 3.46% in the fourth quarter of 2009. NIM improved 71 basis points to 3.55% for 2010 from 2.84% for 2009.
Despite the quarterly increase in net charge-offs, the provision for credit losses in the fourth quarter of 2010 decreased to $5.0 million, compared to $22.0 million in the prior quarter and $77.0 million in the fourth quarter a year ago, due to the decrease in classified assets, non-performing loans, and overall loan balance. For the full year, the provision for credit losses totaled $122.5 million, down from $196.4 million in 2009. The provision for loan losses has decreased steadily now for four consecutive quarters.
Total non-interest income in the fourth quarter of 2010 was $6.1 million, up 7% from $5.7 million in the third quarter of 2010 and down 23% from $7.8 million in the fourth quarter of 2009. The year-over-year decrease in non-interest income is primarily attributable to decreases in service charges on deposit accounts and a decrease in net gain on sale of loans and securities. Service charges on deposit accounts decreased to $3.3 million for the fourth quarter of 2010 from $3.4 million in the linked quarter and $4.0 million for the same quarter of 2009. The decrease in service charges on deposit accounts was associated with the reduction of the deposit portfolio reflecting the deleveraging strategy. The net gain on the sale of loans decreased 69% from the prior quarter and 80% from the fourth quarter a year ago. In the fourth quarter of 2009, the Bank sold accumulated inventory of SBA loans upon the recovery of the SBA secondary market. For the year, non-interest income decreased 21%, or $6.7 million, to $25.4 million, compared to $32.1 million in 2009, primarily due to a $1.7 million decrease in net gain on sales of investment securities in addition to the aforementioned factors.
Total non-interest expense decreased 10% in the quarter and 4% year-over-year to $21.7 million for the fourth quarter, down from $24.1 million in the third quarter of 2010 and $22.7 million for the fourth quarter a year ago. The overall improvement of non-interest expense in general was across the board. For the year, non-interest expense increased 7.1%, or $6.5 million, to $96.8 million, compared to $90.4 million in 2009, primarily due to expenses related to managing and provisioning for OREO properties and the absence of reversal of a $2.5 million previously accrued liability on a post-retirement death benefit that was recognized in 2009.
Conference Call Information
Management will host a conference today at 1:30 p.m. PST (4.30 p.m. EST) to discuss these financial results. This call will also be broadcast live via the internet. Investment professionals and all others are invited to access the live call by dialing (866) 383-8108 or (617) 597-5343 for international callers at 1:30 p.m. (PST), using access code HANMI. To listen to the call online, either live or archived, visit the Investor Relations page of Hanmi Financial Corporation website at www.hanmi.com. Shortly after the call concludes, the replay will also be available at (888) 286-8010 or (617) 801-6888 for international callers, using access code #12399068 where it will be archived until February 14, 2011.
About Hanmi Financial Corporation
Headquartered in Los Angeles, Hanmi Bank, a wholly-owned subsidiary of Hanmi Financial Corporation, provides services to the multi-ethnic communities of California, with 27 full-service offices in Los Angeles, Orange, San Bernardino, San Francisco, Santa Clara and San Diego counties, and a loan production office in Washington State. Hanmi Bank specializes in commercial, SBA and trade finance lending, and is a recognized community leader. Hanmi Bank’s mission is to provide a full range of quality products and premier services to its customers and to maximize shareholder value. Additional information is available at www.hanmi.com.
Forward-Looking Statements
This press release contains forward-looking statements, which are included in accordance with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of such terms and other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. All statements other than statements of historical fact are “forward –looking statements” for purposes of federal and state securities laws, including, but not limited to, statements about anticipated future operating and financial performance, financial position and liquidity, business strategies, regulatory and competitive outlook, investment and expenditure plans, capital and financing needs and availability, plans and objectives of management for future operations, developments regarding our securities purchase agreement with Woori Finance Holdings, and other similar forecasts and statements of expectation and statements of assumption underlying any of the foregoing. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ from those expressed or implied by the forward-looking statement. These factors include the following: inability to consummate the proposed transaction with Woori Finance Holdings on the terms contemplated in the Securities Purchase Agreement entered into with Woori on May 25, 2010, as amended (the “transaction”); failure to receive regulatory approval for the Transaction; inability to continue as a going concern; inability to raise additional capital on acceptable terms or at all; failure to maintain adequate levels of capital and liquidity to support our operations; the effect of regulatory orders we have entered into and potential future supervisory action against us or Hanmi Bank; general economic and business conditions internationally, nationally and in those areas in which we operate; volatility and deterioration in the credit and equity markets; changes in consumer spending, borrowing and savings habits; availability of capital from private and government sources; demographic changes; competition for loans and deposits and failure to attract or retain loans and deposits; fluctuations in interest rates and a decline in the level of our interest rate spread; risks of natural disasters related to our real estate portfolio; risks associated with Small Business Administration loans; failure to attract or retain key employees; changes in governmental regulation, including, but not limited to, any increase in FDIC insurance premiums; ability to receive regulatory approval for Hanmi Bank to declare dividends to the Company; adequacy of our allowance for loan losses, credit quality and the effect of credit quality on our provision for credit losses and allowance for loan losses; changes in the financial performance and/or condition of our borrowers and the ability of our borrowers to perform under the terms of their loans and other terms of credit agreements; our ability to successfully integrate acquisitions we may make; our ability to control expenses; and changes in securities markets. In addition, we set forth certain risks in our reports filed with the U.S. Securities and Exchange Commission (“SEC”), including attached as an Exhibit to a Current Report on Form 8-K filed with the SEC on June 18, 2010, and our most recent Quarterly Report on Form 10-Q, as well as current and periodic reports filed with the U.S. Securities and Exchange Commission hereafter, which could cause actual results to differ from those projected. We undertake no obligation to update such forward-looking statements except as required by law.
Cautionary Statements
Future issuance of any securities relating to the Woori transaction has not been and will not be registered under the Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction or state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction or state.
HANMI FINANCIAL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(Dollars in Thousands)
December 31,
September 30,
%
December 31,
%
2010
2010
Change
2009
Change
ASSETS
Cash and Due from Banks
$ 60,983
$ 63,455
(3.9)%
$ 55,263
10.4 %
Interest-Bearing Deposits in Other Banks
158,737
218,843
(27.5)%
98,847
60.6 %
Federal Funds Sold
30,000
—
—
—
—
Cash and Cash Equivalents
249,720
282,298
(11.5)%
154,110
62.0 %
Investment Securities
413,963
325,428
27.2 %
133,289
210.6 %
Loans:
Gross Loans, Net of Deferred Loan Fees
2,267,126
2,394,291
(5.3)%
2,819,060
(19.6)%
Allowance for Loan Losses
(146,059)
(176,063)
(17.0)%
(144,996)
0.7 %
Loans Receivable, Net
2,121,067
2,218,228
(4.4)%
2,674,064
(20.7)%
Due from Customers on Acceptances
711
1,375
(48.3)%
994
(28.5)%
Premises and Equipment, Net
17,599
17,639
(0.2)%
18,657
(5.7)%
Accrued Interest Receivable
8,048
8,442
(4.7)%
9,492
(15.2)%
Other Real Estate Owned, Net
4,089
20,577
(80.1)%
26,306
(84.5)%
Deferred Income Taxes, Net
—
—
—
3,608
—
Investment in FHLB and FRB Stock, at Cost
34,731
35,201
(1.3)%
30,697
13.1 %
Bank-Owned Life Insurance
27,350
27,111
0.9 %
34,286
(20.2)%
Income Taxes Receivable
9,188
9,188
—
56,554
(83.8)%
Other Assets
20,682
23,018
(10.1)%
20,649
0.2 %
TOTAL ASSETS
$ 2,907,148
$ 2,968,505
(2.1)%
$ 3,162,706
(8.1)%
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities:
Deposits:
Noninterest-Bearing
$ 546,815
$ 559,764
(2.3)%
$ 556,306
(1.7)%
Interest-Bearing
1,919,906
1,967,622
(2.4)%
2,193,021
(12.5)%
Total Deposits
2,466,721
2,527,386
(2.4)%
2,749,327
(10.3)%
Accrued Interest Payable
15,966
13,727
16.3 %
12,606
26.7 %
Bank Acceptances Outstanding
711
1,375
(48.3)%
994
(28.5)%
FHLB Advances and Other Borrowings
155,220
156,292
(0.7)%
155,725
(0.3)%
Junior Subordinated Debentures
82,406
82,406
—
82,406
—
Accrued Expenses and Other Liabilities
12,868
14,687
(12.4)%
11,904
8.1 %
Total Liabilities
2,733,892
2,795,873
(2.2)%
3,012,962
(9.3)%
Stockholders’ Equity
173,256
172,632
0.4 %
149,744
15.7 %
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$ 2,907,148
$ 2,968,505
(2.1)%
$ 3,162,706
(8.1)%
HANMI FINANCIAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(Dollars in Thousands, Except Per Share Data)
Three Months Ended
December 31,
September 30,
%
December 31,
%
2010
2010
Change
2009
Change
INTEREST AND DIVIDEND INCOME:
Interest and Fees on Loans
$ 32,466
$ 33,681
(3.6)%
$ 40,810
(20.4)%
Taxable Interest on Investment Securities
1,839
1,592
15.5 %
1,414
30.1 %
Tax-Exempt Interest on Investment Securities
9
62
(85.5)%
432
(97.9)%
Interest on Interest-Bearing Deposits in Other Banks
149
165
(9.7)%
70
112.9 %
Dividends on FHLB and FRB Stock
135
135
—
136
(0.7)%
Interest on Federal Funds Sold
15
40
(62.5)%
95
(84.2)%
Total Interest and Dividend Income
34,613
35,675
(3.0)%
42,957
(19.4)%
INTEREST EXPENSE:
Interest on Deposits
7,592
8,299
(8.5)%
13,410
(43.4)%
Interest on Junior Subordinated Debentures
711
739
(3.8)%
690
3.0 %
Interest on FHLB Advances and Other Borrowings
339
364
(6.9)%
412
(17.7)%
Total Interest Expense
8,642
9,402
(8.1)%
14,512
(40.4)%
NET INTEREST INCOME BEFORE PROVISION FOR CREDIT LOSSES
25,971
26,273
(1.1)%
28,445
(8.7)%
Provision for Credit Losses
5,000
22,000
(77.3)%
77,000
(93.5)%
NET INTEREST INCOME (LOSS) AFTER PROVISION FOR CREDIT LOSSES
20,971
4,273
390.8 %
(48,555)
(143.2)%
NON-INTEREST INCOME:
Service Charges on Deposit Accounts
3,279
3,442
(4.7)%
4,022
(18.5)%
Insurance Commissions
1,122
1,089
3.0 %
1,062
5.6 %
Remittance Fees
499
484
3.1 %
530
(5.8)%
Trade Finance Fees
379
381
(0.5)%
439
(13.7)%
Other Service Charges and Fees
323
409
(21.0)%
371
(12.9)%
Bank-Owned Life Insurance Income
239
237
0.8 %
237
0.8 %
Net Gain on Sales of Loans
71
229
(69.0)%
354
(79.9)%
Net Gain on Sales of Investment Securities
5
4
25.0 %
665
(99.2)%
Impairment Loss on Investment Securities
—
(790)
(100.0)%
—
—
Other Operating Income
136
186
(26.9)%
159
(14.5)%
Total Non-Interest Income
6,053
5,671
6.7 %
7,839
(22.8)%
NON-INTEREST EXPENSE:
Salaries and Employee Benefits
9,381
9,552
(1.8)%
8,442
11.1 %
Occupancy and Equipment
2,672
2,702
(1.1)%
2,733
(2.2)%
Deposit Insurance Premiums and Regulatory Assessments
2,204
2,253
(2.2)%
2,998
(26.5)%
Data Processing
1,499
1,446
3.7 %
1,606
(6.7)%
Other Real Estate Owned Expense
681
2,580
(73.6)%
873
(22.0)%
Professional Fees
680
753
(9.7)%
1,354
(49.8)%
Directors and Officers Liability Insurance
716
716
—
293
144.4 %
Other Operating Expenses
3,902
4,077
(4.3)%
4,411
(11.5)%
Total Non-Interest Expense
21,735
24,079
(9.7)%
22,710
(4.3)%
INCOME (LOSS) BEFORE PROVISION (BENEFIT) FOR INCOME TAXES
5,289
(14,135)
(137.4)%
(63,426)
(108.3)%
Provision (Benefit) for Income Taxes
(23)
442
(105.2)%
(27,545)
(99.9)%
NET INCOME (LOSS)
$ 5,312
$ (14,577)
(136.4)%
$ (35,881)
(114.8)%
EARNINGS (LOSS) PER SHARE:
Basic
$ 0.04
$ (0.12)
(133.3)%
$ (0.70)
(105.7)%
Diluted
$ 0.04
$ (0.12)
(133.3)%
$ (0.70)
(105.7)%
WEIGHTED-AVERAGE SHARES OUTSTANDING:
Basic
151,051,903
122,789,120
50,998,103
Diluted
151,197,503
122,789,120
50,998,103
SHARES OUTSTANDING AT PERIOD-END
151,198,390
151,198,390
51,182,390
HANMI FINANCIAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(Dollars in Thousands, Except Per Share Data)
Year Ended
December 31,
December 31,
%
2010
2009
Change
INTEREST AND DIVIDEND INCOME:
Interest and Fees on Loans
$ 137,328
$ 173,318
(20.8)%
Taxable Interest on Investment Securities
5,874
5,675
3.5 %
Tax-Exempt Interest on Investment Securities
225
2,303
(90.2)%
Interest on Interest-Bearing Deposits in Other Banks
468
151
209.9 %
Dividends on FHLB and FRB Stock
532
656
(18.9)%
Interest on Federal Funds Sold
85
2,044
(95.8)%
Total Interest and Dividend Income
144,512
184,147
(21.5)%
INTEREST EXPENSE:
Interest on Deposits
34,408
76,246
(54.9)%
Interest on Junior Subordinated Debentures
2,811
3,271
(14.1)%
Interest on FHLB Advances and Other Borrowings
1,419
3,401
(58.3)%
Total Interest Expense
38,638
82,918
(53.4)%
NET INTEREST INCOME BEFORE PROVISION FOR CREDIT LOSSES
105,874
101,229
4.6 %
Provision for Credit Losses
122,496
196,387
(37.6)%
NET INTEREST INCOME (LOSS) AFTER PROVISION FOR CREDIT LOSSES
(16,622)
(95,158)
(82.5)%
NON-INTEREST INCOME:
Service Charges on Deposit Accounts
14,049
17,054
(17.6)%
Insurance Commissions
4,695
4,492
4.5 %
Remittance Fees
1,968
2,109
(6.7)%
Trade Finance Fees
1,523
1,956
(22.1)%
Other Service Charges and Fees
1,516
1,810
(16.2)%
Bank-Owned Life Insurance Income
942
932
1.1 %
Net Gain on Sales of Loans
514
1,220
(57.9)%
Net Gain on Sales of Investment Securities
122
1,833
(93.3)%
Impairment Loss on Investment Securities
(790)
—
—
Other Operating Income
867
704
23.2 %
Total Non-Interest Income
25,406
32,110
(20.9)%
NON-INTEREST EXPENSE:
Salaries and Employee Benefits
36,730
33,101
11.0 %
Occupancy and Equipment
10,773
11,239
(4.1)%
Deposit Insurance Premiums and Regulatory Assessments
10,756
10,418
3.2 %
Data Processing
5,931
6,297
(5.8)%
Other Real Estate Owned Expense
10,679
5,890
81.3 %
Professional Fees
3,521
4,099
(14.1)%
Directors and Officers Liability Insurance
2,865
1,175
143.8 %
Other Operating Expenses
15,550
18,135
(14.3)%
Total Non-Interest Expense
96,805
90,354
7.1 %
LOSS BEFORE BENEFIT FOR INCOME TAXES
(88,021)
(153,402)
(42.6)%
Benefit for Income Taxes
(12)
(31,125)
(100.0)%
NET LOSS
$ (88,009)
$ (122,277)
(28.0)%
LOSS PER SHARE:
Basic
$ (0.93)
$ (2.57)
(63.8)%
Diluted
$ (0.93)
$ (2.57)
(63.8)%
WEIGHTED-AVERAGE SHARES OUTSTANDING:
Basic
94,322,222
47,570,361
Diluted
94,322,222
47,570,361
SHARES OUTSTANDING AT PERIOD-END
151,198,390
51,182,390
HANMI FINANCIAL CORPORATION AND SUBSIDIARIES
SELECTED FINANCIAL DATA(UNAUDITED)
(Dollars in Thousands)
Three Months Ended
Year Ended
December 31,
September 30,
December 31,
December 31,
December 31,
2010
2010
2009
2010
2009
AVERAGE BALANCES:
Average Gross Loans, Net of Deferred Loan Fees
$ 2,349,660
$ 2,456,883
$ 2,924,722
$ 2,544,472
$ 3,157,133
Average Investment Securities
350,954
223,709
182,635
215,280
188,325
Average Interest-Earning Assets
2,961,297
2,989,762
3,291,042
2,981,878
3,611,009
Average Total Assets
2,949,647
2,983,632
3,356,383
2,998,507
3,717,179
Average Deposits
2,512,893
2,559,116
2,914,794
2,587,686
3,109,322
Average Borrowings
237,702
239,992
244,704
243,690
341,514
Average Interest-Bearing Liabilities
2,186,920
2,238,036
2,598,520
2,268,954
2,909,014
Average Stockholders’ Equity
166,753
155,056
164,767
137,968
225,708
Average Tangible Equity
164,381
152,417
161,169
135,171
221,537
PERFORMANCE RATIOS (Annualized):
Return on Average Assets
0.71%
(1.94)%
(4.24)%
(2.94)%
(3.29)%
Return on Average Stockholders’ Equity
12.64%
(37.30)%
(86.40)%
(63.79)%
(54.17)%
Return on Average Tangible Equity
12.82%
(37.94)%
(88.33)%
(65.11)%
(55.19)%
Efficiency Ratio
67.87%
75.38%
62.59%
73.74%
67.76%
Net Interest Spread (1)
3.07%
3.07%
2.99%
3.15%
2.28%
Net Interest Margin (1)
3.48%
3.49%
3.46%
3.55%
2.84%
ALLOWANCE FOR LOAN LOSSES:
Balance at Beginning of Period
$ 176,063
$ 176,667
$ 124,768
$ 144,996
$ 70,986
Provision Charged to Operating Expense
5,245
20,700
77,540
122,955
196,607
Charge-Offs, Net of Recoveries
(35,249)
(21,304)
(57,312)
(121,892)
(122,597)
Balance at End of Period
$ 146,059
$ 176,063
$ 144,996
$ 146,059
$ 144,996
Allowance for Loan Losses to Total Gross Loans
6.44%
7.35%
5.14%
6.44%
5.14%
Allowance for Loan Losses to Total Non-Performing Loans
86.41%
90.41%
66.19%
86.41%
66.19%
ALLOWANCE FOR OFF-BALANCE SHEET ITEMS:
Balance at Beginning of Period
$ 3,662
$ 2,362
$ 4,416
$ 3,876
$ 4,096
Provision Charged to Operating Expense
(245)
1,300
(540)
(459)
(220)
Balance at End of Period
$ 3,417
$ 3,662
$ 3,876
$ 3,417
$ 3,876
(1) Amounts calculated on a fully taxable equivalent basis using the current statutory federal tax rate.
HANMI FINANCIAL CORPORATION AND SUBSIDIARIES
SELECTED FINANCIAL DATA (UNAUDITED) (Continued)
(Dollars in Thousands)
December 31,
September 30,
December 31,
2010
2010
2009
NON-PERFORMING ASSETS:
Non-Accrual Loans
$ 169,028
$ 194,729
$ 219,000
Loans 90 Days or More Past Due and Still Accruing
—
—
67
Total Non-Performing Loans
169,028
194,729
219,067
Other Real Estate Owned, Net
4,089
20,577
26,306
Total Non-Performing Assets
$ 173,117
$ 215,306
$ 245,373
Total Non-Performing Loans/Total Gross Loans
7.45%
8.13%
7.77%
Total Non-Performing Assets/Total Assets
5.95%
7.25%
7.76%
Total Non-Performing Assets/Allowance for Loan Losses
(2) Commercial and industrial loans include owner-occupied property loans of $894.8 million, $967.9 million and $1.12 billion as of December 31, 2010, September 30, 2010, and December 31, 2009, respectively.
HANMI FINANCIAL CORPORATION AND SUBSIDIARIES
AVERAGE BALANCES, AVERAGE YIELDS EARNED AND AVERAGE RATES PAID(UNAUDITED)
(Dollars in Thousands)
Three Months Ended
December 31, 2010
September 30, 2010
December 31, 2009
Average Balance
Interest
Income/ Expense
Average
Yield/ Rate
Average Balance
Interest
Income/ Expense
Average Yield/
Rate
Average Balance
Interest
Income/ Expense
Average Yield/
Rate
INTEREST-EARNING ASSETS
Loans:
Real Estate Loans:
Commercial Property
$ 746,868
$ 10,144
5.39%
$ 773,589
$ 10,638
5.46%
$ 861,831
$ 11,872
5.47%
Construction
66,221
416
2.49%
71,545
862
4.78%
130,400
1,342
4.08%
Residential Property
63,716
747
4.65%
67,291
805
4.75%
80,257
997
4.93%
Total Real Estate Loans
876,805
11,307
5.12%
912,425
12,305
5.35%
1,072,488
14,211
5.26%
Commercial and Industrial Loans (1)
1,421,369
20,435
5.70%
1,490,811
20,611
5.49%
1,787,795
25,472
5.65%
Consumer Loans
52,251
660
5.01%
54,469
690
5.03%
66,074
965
5.79%
Total Gross Loans
2,350,425
32,402
5.47%
2,457,705
33,606
5.42%
2,926,357
40,648
5.51%
Prepayment Penalty Income
—
64
—
—
75
—
—
162
—
Unearned Income on Loans, Net of Costs
(765)
—
—
(823)
—
—
(1,635)
—
—
Gross Loans, Net
2,349,660
32,466
5.48%
2,456,882
33,681
5.44%
2,924,722
40,810
5.54%
Investment Securities:
Municipal Bonds (2)
21,182
203
3.83%
6,301
95
6.03%
41,653
665
6.39%
U.S. Government Agency Securities
84,904
389
1.83%
92,690
620
2.68%
36,500
437
4.79%
Mortgage-Backed Securities
107,764
467
1.73%
63,439
537
3.39%
77,354
738
3.82%
Collateralized Mortgage Obligations
108,491
550
2.03%
45,747
300
2.62%
14,312
143
4.00%
Corporate Bonds
16,151
135
3.34%
3,130
30
3.83%
286
—
0.00%
Other Securities
12,462
110
3.53%
12,402
103
3.32%
12,530
97
3.10%
Total Investment Securities (2)
350,954
1,854
2.11%
223,709
1,685
3.01%
182,635
2,080
4.56%
Other Interest-Earning Assets:
Equity Securities
35,883
135
1.50%
36,568
135
1.48%
40,605
136
1.34%
Federal Funds Sold and Securities Purchased
Under Resale Agreements
8,239
11
0.53%
6,932
8
0.46%
51,713
65
0.50%
Term Federal Funds Sold
3,043
4
0.53%
22,880
32
0.56%
8,500
30
1.41%
Interest-Bearing Deposits in Other Banks
213,518
149
0.28%
242,790
165
0.27%
82,867
70
0.34%
Total Other Interest-Earning Assets
260,683
299
0.46%
309,170
340
0.44%
183,685
301
0.66%
TOTAL INTEREST-EARNING ASSETS (2)
$ 2,961,297
$ 34,619
4.64%
$ 2,989,761
$ 35,706
4.74%
$ 3,291,042
$ 43,191
5.21%
INTEREST-BEARING LIABILITIES
Interest-Bearing Deposits:
Savings
$ 116,220
$ 804
2.74%
$ 122,122
$ 889
2.89%
$ 104,068
$ 711
2.71%
Money Market Checking and NOW Accounts
414,773
1,003
0.96%
429,601
1,094
1.01%
733,063
3,508
1.90%
Time Deposits of $100,000 or More
1,127,027
4,736
1.67%
1,133,970
5,059
1.77%
835,726
4,930
2.34%
Other Time Deposits
291,198
1,049
1.43%
312,351
1,257
1.60%
680,959
4,261
2.48%
Total Interest-Bearing Deposits
1,949,218
7,592
1.55%
1,998,044
8,299
1.65%
2,353,816
13,410
2.26%
Borrowings:
FHLB Advances
153,693
339
0.88%
153,777
342
0.88%
160,754
412
1.02%
Other Borrowings
1,603
—
0.00%
3,809
22
2.29%
1,544
—
0.00%
Junior Subordinated Debentures
82,406
711
3.42%
82,406
739
3.56%
82,406
690
3.32%
Total Borrowings
237,702
1,050
1.75%
239,992
1,103
1.82%
244,704
1,102
1.79%
TOTAL INTEREST-BEARING LIABILITIES
$ 2,186,920
$ 8,642
1.57%
$ 2,238,036
$ 9,402
1.67%
$ 2,598,520
$ 14,512
2.22%
NET INTEREST INCOME (2)
$ 25,977
$ 26,304
$ 28,679
NET INTEREST SPREAD (2)
3.07%
3.07%
2.99%
NET INTEREST MARGIN (2)
3.48%
3.49%
3.46%
(1) Commercial and industrial loans include owner-occupied commercial real estate loans
(2) Amounts calculated on a fully taxable equivalent basis using the current statutory federal tax rate.
HANMI FINANCIAL CORPORATION AND SUBSIDIARIES
AVERAGE BALANCES, AVERAGE YIELDS EARNED AND AVERAGE RATES PAID(UNAUDITED)
(Dollars in Thousands)
Year Ended
December 31, 2010
December 31, 2009
Average
Balance
Interest
Income/
Expense
Average
Yield/
Rate
Average
Balance
Interest
Income/
Expense
Average
Yield/
Rate
INTEREST-EARNING ASSETS
Loans:
Real Estate Loans:
Commercial Property
$ 791,622
$ 42,507
5.37%
$ 894,408
$ 49,901
5.58%
Construction
82,827
3,618
4.37%
156,619
5,947
3.80%
Residential Property
68,723
3,267
4.75%
85,228
4,329
5.08%
Total Real Estate Loans
943,172
49,392
5.24%
1,136,255
60,177
5.30%
Commercial and Industrial Loans (1)
1,546,115
84,765
5.48%
1,947,669
108,346
5.56%
Consumer Loans
56,121
2,937
5.23%
74,700
4,310
5.77%
Total Gross Loans
2,545,408
137,094
5.39%
3,158,624
172,833
5.47%
Prepayment Penalty Income
—
234
—
—
485
—
Unearned Income on Loans, Net of Costs
(936)
—
—
(1,491)
—
—
Gross Loans, Net
2,544,472
137,328
5.40%
3,157,133
173,318
5.49%
Investment Securities:
Municipal Bonds (2)
10,655
535
5.02%
54,448
3,543
6.51%
U.S. Government Agency Securities
69,112
1,952
2.82%
24,417
1,108
4.54%
Mortgage-Backed Securities
72,985
2,071
2.84%
77,627
3,320
4.28%
Collateralized Mortgage Obligations
45,245
1,092
2.41%
21,365
879
4.11%
Corporate Bonds
4,860
165
3.40%
271
—
0.00%
Other Securities
12,423
405
3.26%
10,197
369
3.62%
Total Investment Securities (2)
215,280
6,220
2.89%
188,325
9,219
4.90%
Other Interest-Earning Assets:
Equity Securities
37,437
532
1.42%
41,399
656
1.58%
Federal Funds Sold and Securities Purchased
Under Resale Agreements
10,346
52
0.50%
84,363
326
0.39%
Term Federal Funds Sold
8,342
33
0.40%
95,822
1,718
1.79%
Interest-Bearing Deposits in Other Banks
166,001
468
0.28%
43,967
151
0.34%
Total Other Interest-Earning Assets
222,126
1,085
0.49%
265,551
2,851
1.07%
TOTAL INTEREST-EARNING ASSETS (2)
$ 2,981,878
$ 144,633
4.85%
$ 3,611,009
$ 185,388
5.13%
INTEREST-BEARING LIABILITIES
Interest-Bearing Deposits:
Savings
$ 119,754
$ 3,439
2.87%
$ 91,089
$ 2,328
2.56%
Money Market Checking and NOW Accounts
464,864
4,936
1.06%
507,619
9,786
1.93%
Time Deposits of $100,000 or More
1,069,600
19,529
1.83%
1,051,994
34,807
3.31%
Other Time Deposits
371,046
6,504
1.75%
916,798
29,325
3.20%
Total Interest-Bearing Deposits
2,025,264
34,408
1.70%
2,567,500
76,246
2.97%
Borrowings:
FHLB Advances
158,531
1,366
0.86%
257,529
3,399
1.32%
Other Borrowings
2,753
53
1.93%
1,579
2
0.13%
Junior Subordinated Debentures
82,406
2,811
3.41%
82,406
3,271
3.97%
Total Borrowings
243,690
4,230
1.74%
341,514
6,672
1.95%
TOTAL INTEREST-BEARING LIABILITIES
$ 2,268,954
$ 38,638
1.70%
$ 2,909,014
$ 82,918
2.85%
NET INTEREST INCOME (2)
$ 105,995
$ 102,470
NET INTEREST SPREAD (2)
3.15%
2.28%
NET INTEREST MARGIN (2)
3.55%
2.84%
(1) Commercial and industrial loans include owner-occupied commercial real estate loans
(2) Amounts calculated on a fully taxable equivalent basis using the current statutory federal tax rate.
CONTACT: BRIAN E. CHO
Chief Financial Officer
(213) 368-3200
DAVID YANG
Investor Relations Officer
(213) 637-4798
Thursday, January 27th, 2011UncategorizedComments Off on Hanmi Financial Corp. (HAFC) Fourth Quarter 2010 Nets First Quarterly Profit of $5.3 Million in Two Years
BASSETT, Va., Jan. 27, 2011 (GLOBE NEWSWIRE) — Bassett Furniture Industries, Inc. (Nasdaq:BSET) announced today its results of operations for its fiscal quarter ended November 27, 2010.
Consolidated sales for the quarter ended November 27, 2010 were $66.0 million as compared to $59.5 million for the quarter ended November 28, 2009, an increase of 10.9%. This sales increase was primarily driven by a 10.1% increase in total wholesale shipments and increased sales at retail due primarily to additional Company-owned stores. Gross margins for the fourth quarter of 2010 and 2009 were 48.3% and 46.5%, respectively. The margin increase was primarily a result of the retail segment’s increased share of the overall sales mix, partially offset by lower margins in both the wholesale and retail segments. Selling, general and administrative expenses, excluding bad debt and notes receivable valuation charges, increased $4.8 million for the fourth quarter of 2010 as compared to the fourth quarter of 2009, primarily due to the net addition of 11 Company-owned retail stores since the fourth quarter of 2009. The Company also recorded $1.4 million of bad debt and notes receivable valuation charges during the fourth quarter of 2010 as compared to $2.2 million for the fourth quarter of 2009, a $0.8 million decrease. The Company reported net income of $1.9 million, or $0.17 per share, for the quarter ended November 27, 2010, as compared to net income of $2.6 million, or $0.22 per share, for the quarter ended November 28, 2009.
In order to better understand profitability trends related to on-going operations, the Company’s management considers the effects of certain items on results for the quarter. Accordingly, the results for the quarter ended November 27, 2010 included $0.5 million of proceeds from the Continued Dumping & Subsidy Offset Act (CDSOA), and $0.8 million of periodic costs associated with carrying idle retail facilities. The results for the quarter ended November 28, 2009 included a $1.7 million tax benefit associated with a one-time carryback of net operating losses due to a change in tax law, $1.6 million of proceeds from the CDSOA, pretax charges of $1.1 million associated with the closure of the Company’s fiberboard manufacturing facility in Bassett, Va., $0.5 million associated with the impairment of goodwill, $0.4 million associated with updates to certain assumptions concerning existing lease termination accruals, and $0.5 million of periodic costs associated with carrying idle retail facilities. Excluding these items, the net income for the quarter ended November 27, 2010 would have been $2.3 million as compared to net income of $1.7 million for the quarter ended November 28, 2009. See the attached Reconciliation of Net Income (Loss) as Reported to Net Income (Loss) as Adjusted.
“We are pleased to report an 11% sales increase for the fourth quarter of 2010,” said Robert H. Spilman Jr., President and CEO. “While we do not believe that the overall pace of sales has improved significantly on an industry-wide basis, we are making progress on several fronts to grow our top line. This includes slight improvements in sales in our Company-owned retail fleet, the addition of new accounts outside our store network, and improved service levels on our imported products by virtue of our strategy to carry higher levels of inventory on our key items. The profit that we generated during the quarter resulted from a higher level of sales enhanced by an expense structure that has been aggressively trimmed for several quarters. We are very focused on doing everything that we can to generate future growth while continuing to monitor our operating expenses.”
Wholesale Segment
Net sales for the wholesale segment were $49.3 million for the fourth quarter of 2010 as compared to $44.8 million for the fourth quarter of 2009, an increase of 10.1%. This increase is due to a 5.6% improvement in wholesale orders as compared to the fourth quarter of 2009. Furthermore, shipments were increased to bring down existing backlogs that had built up in the second and third quarters of 2010 due to delays in receiving imported product from certain of the Company’s overseas vendors. In an effort to mitigate the stock outages caused by these delays and improve service levels to customers, the Company has increased inventory levels during the second half of 2010. Approximately 55% of wholesale shipments during the fourth quarter of 2010 were imported products compared to approximately 50% for the fourth quarter of 2009. Gross margins for the wholesale segment were 31.0% for the fourth quarter of 2010 as compared to 32.5% for the fourth quarter of 2009. This decrease is primarily due to higher freight costs on imported product during the fourth quarter of 2010, while the fourth quarter of 2009 included a favorable adjustment to the last in, first out (LIFO) inventory valuation reserves due to inventory reductions in that year. Wholesale SG&A, excluding bad debt and notes receivable valuation charges, increased $1.3 million, or 12.1%, for the fourth quarter of 2010 as compared to 2009. As a percentage of net sales, SG&A increased 0.5 percentage points to 25.0% for the fourth quarter of 2010 as compared to 24.5% for the fourth quarter of 2009. The Company recorded $1.4 million of bad debt and notes receivable valuation charges for the fourth quarter of 2010, as compared with $2.2 million for the fourth quarter of 2009.
The wholesale backlog, representing orders received but not yet shipped to dealers and company stores, was $12.5 million at November 27, 2010 as compared with $10.3 million at November 28, 2009. The $2.2 million increase is primarily due to the improvement in order levels as compared to the fourth quarter of 2009.
“As noted, we were able to reduce our backlog on imported wood items during the quarter, which had a positive effect on our wholesale revenue,” continued Mr. Spilman. “We were also able to generate a 5.6% increase in wholesale written orders during the period. The introduction of our “Go To” program of promotionally priced wood products at the High Point market was well received and will be promoted aggressively in 2011. Those products will be stocked at our three U.S. distribution centers and in our Asia warehouse. The domestic upholstery product that we introduced last spring and are manufacturing at our recently re-opened facility in Newton, NC is performing very well at retail and already comprises approximately 15% of our total upholstery volume. We will expand this assortment at the next High Point show as we seek to leverage our superior U.S. value and service propositions to take market share.”
Retail Segment
At November 27, 2010, the total store network included 54 licensee-owned stores and 47 Company-owned and operated stores. During the three months ended November 27, 2010, the Company acquired certain assets of, and now operates one additional licensee store, while another store acquired during the first quarter of 2010 was closed at the end of the fourth quarter. The following table summarizes the changes in store count during the year ended November 27, 2010:
November 28,
New
Stores
Stores
November 27,
2009
Stores
Acquired
Closed
2010
Company-owned stores
36
2
11
(2)
47
Licensee-owned stores
68
–
(11)
(3)
54
Total
104
2
–
(5)
101
The Company-owned stores had sales of $34.8 million in the fourth quarter of 2010 as compared to $27.5 million in the fourth quarter of 2009, an increase of 26.6%. The increase was comprised of a $7.1 million increase from the net addition of 11 stores since the end of the fourth quarter of 2009, and a $0.2 million, or 0.7% increase in comparable store sales (“comparable” stores include those locations that have been open and operated by the Company for all of each comparable reporting period).
While the Company does not recognize sales until goods are delivered to the customer, the Company’s management tracks written sales (the dollar value of sales orders taken, rather than delivered) as a key store performance indicator. Written sales for comparable stores decreased by 1.4% for the fourth quarter of 2010 as compared to the fourth quarter of 2009.
Gross margins for the quarter decreased 0.7 percentage points to 48.1% as compared to the fourth quarter of 2009 primarily due to lower margins in the recently acquired stores. SG&A increased $3.4 million from the fourth quarter of 2009, primarily due to increased store count. On a comparable store basis, gross margins decreased 0.1 percentage points to 48.8% and SG&A decreased 1.3 percentage points to 50.1% for the fourth quarter of 2010 as compared to the comparable 2009 period. Operating losses for the comparable stores were reduced by 48.7% to $0.3 million. In all other stores (consisting of the 14 stores which have been acquired, opened or closed during the twelve months ended November 27, 2010), the operating loss was $0.5 million or 6.5% of sales. This higher level of operating losses reflects the fact that several of the acquired stores were struggling or failing at the time of acquisition. It has generally taken six to 12 months of operations by corporate retail management to either implement the changes necessary to improve performance in the acquired stores or to make a final determination regarding the on-going viability. Refer to the accompanying schedule of Supplemental Retail Information for results of operations for the Company’s retail segment by comparable and all other stores. The dollar value of retail backlog, representing orders received but not yet shipped to customers, was $13.7 million, or an average of $291 thousand per open store, at November 27, 2010 as compared with $8.7 million, or an average of $241 thousand per open store, at November 28, 2009.
“2010 was an extremely busy year in our corporate retail network,” added Mr. Spilman. “The fact that we acquired 11 licensee stores, closed two existing locations, and opened two new facilities while operating our existing stores presented a tremendous challenge for our team. We were pleased with the 49% loss reduction in our comparable stores during the quarter. Performance at this level for the entire fleet is our goal and the fact that our 35 comparable stores achieved it during the quarter is encouraging and significant. 2011 will also be a challenge as we are currently closing four existing corporate stores and will certainly acquire additional stores over the course of the year. We are also seeking to expand our network with new stores in certain markets where we currently operate. Despite the upheaval that store acquisitions and closings have produced, our comp store operating performance improved again in 2010, giving us the confidence that our corporate store network will continue to contribute to the Company’s improving operating performance.”
Balance Sheet and Cash Flow
The Company generated $6.1 million of cash from operating activities during the fourth quarter of 2010, primarily due to improved collections from wholesale customers as order backlogs were reduced, tighter working capital management, and the receipt of a $1.7 million Federal income tax refund associated with a one-time carryback of net operating losses due to a change in tax law; the benefit from which was recognized in earnings during the fourth quarter of 2009. In addition to the $11.1 million of cash on-hand, the Company has investments of $15.1 million, primarily consisting of $14.3 million in cash, money market accounts, bond funds, and individual treasuries, and $0.8 million in a hedge fund. Although the $14.3 million is primarily cash and other liquid assets, the Company presents these as long-term assets as they are pledged as collateral for the revolving debt agreement.
The Company has four mortgages totaling approximately $9.4 million that will mature during the 12 month period following November 27, 2010. The Company expects to satisfy these obligations through a variety of means, which may include refinancing, drawing from its revolving credit facility, or paying from cash on hand or future operating cash flow. However, there can be no assurance that any of these strategies will be successful.
After having voluntarily repaid the outstanding balance of $15.0 million on its revolving credit facility during the second quarter of 2010, the Company ended the fourth quarter with no amounts outstanding. The facility, which matured on November 30, 2010, has been extended until February 28, 2011. The Company is continuing discussions with its bank regarding the amendment and extension of the facility beyond its current maturity. While there can be no assurance that these discussions will result in a favorable outcome, the Company expects to have an amended and extended facility in place prior to February 28, 2011.
Potential Sale of the International Home Furnishings Center
The Company also announced today that it is engaged in negotiations for the sale of its 46.9% interest in International Home Furnishings Center, Inc. (“IHFC”). No definitive agreement for the sale has been reached. Any such sale would be made only as part of the simultaneous sale of 100% of the ownership interests in IHFC to the prospective purchaser. The Company is one of four shareholders of IHFC.
“The proposed sale of IHFC offers us the opportunity to unlock value in a key non-core asset that we believe is not currently fully recognized in the Company’s stock price as well as to significantly strengthen our already strong balance sheet,” said Mr. Spilman. “Although there can be no assurance that an agreement among all of the required parties will be reached, we hope to complete the sale by the end of February.”
About Bassett Furniture Industries, Inc.
Bassett Furniture Industries, Inc. (Nasdaq:BSET), is a leading manufacturer and marketer of high quality, mid-priced home furnishings. With 101 licensee- and company- owned stores, Bassett has leveraged its strong brand name in furniture into a network of corporate and licensed stores that focus on providing consumers with a friendly environment for buying furniture and accessories. The most significant growth opportunity for Bassett continues to be the Company’s dedicated retail store program. Bassett’s retail strategy includes affordable custom-built furniture that is ready for delivery in the home within 30 days. The stores also feature the latest on-trend furniture styles, more than 750 upholstery fabrics, free in-home design visits, and coordinated decorating accessories. For more information, visit the Company’s website at bassettfurniture.com. (BSET-E)
Certain of the statements in this release, particularly those preceded by, followed by or including the words “believes,” “expects,” “anticipates,” “intends,” “should,” “estimates,” or similar expressions, or those relating to or anticipating financial results for periods beyond the end of the fourth quarter of fiscal 2010, constitute “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended. For those statements, Bassett claims the protection of the safe harbor for forward looking statements contained in the Private Securities Litigation Reform Act of 1995. In many cases, Bassett cannot predict what factors would cause actual results to differ materially from those indicated in the forward looking statements. Expectations included in the forward-looking statements are based on preliminary information as well as certain assumptions which management believes to be reasonable at this time. The following important factors affect Bassett and could cause actual results to differ materially from those indicated in the forward looking statements: the effects of national and global economic or other conditions and future events on the retail demand for home furnishings and the ability of Bassett’s customers and consumers to obtain credit; and the economic, competitive, governmental and other factors identified in Bassett’s filings with the Securities and Exchange Commission. Any forward-looking statement that Bassett makes speaks only as of the date of such statement, and Bassett undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Comparisons of results for current and any prior periods are not intended to express any future trends or indication of future performance, unless expressed as such, and should only be viewed as historical data.
BASSETT FURNITURE INDUSTRIES, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations – Unaudited
(In thousands, except for per share data)
Quarter Ended
Quarter Ended
Year Ended
Year Ended
November 27, 2010
November 28, 2009
November 27, 2010
November 28, 2009
Percent of
Percent of
Percent of
Percent of
Amount
Net Sales
Amount
Net Sales
Amount
Net Sales
Amount
Net Sales
Net sales
$ 65,991
100.0%
$ 59,523
100.0%
$ 235,254
100.0%
$ 232,722
100.0%
Cost of sales
34,097
51.7%
31,845
53.5%
122,566
52.1%
129,882
55.8%
Gross profit
31,894
48.3%
27,678
46.5%
112,688
47.9%
102,840
44.2%
Selling, general and administrative expense
excluding bad debt and notes receivable valuation charges
29,660
44.9%
24,850
41.7%
110,808
47.1%
103,789
44.6%
Bad debt and notes receivable valuation charges
1,431
2.2%
2,241
3.8%
6,567
2.8%
15,205
6.5%
Income from Continued Dumping & Subsidy Offset Act
(488)
-0.7%
(1,627)
-2.7%
(488)
-0.2%
(1,627)
-0.7%
Restructuring and asset impairment charges
–
–
1,599
2.7%
–
–
2,987
1.3%
Lease exit costs
–
–
372
0.6%
–
–
2,434
1.0%
Income (loss) from operations
1,291
2.0%
243
0.4%
(4,199)
-1.8%
(19,948)
-8.6%
Other income (loss), net
556
0.8%
825
1.4%
1,991
0.8%
(4,505)
-1.9%
Income (loss) before income taxes
1,847
2.8%
1,068
1.8%
(2,208)
-0.9%
(24,453)
-10.5%
Income tax benefit
94
0.1%
1,498
2.5%
206
0.1%
1,754
0.8%
Net income (loss)
$ 1,941
2.9%
$ 2,566
4.3%
$ (2,002)
-0.9%
$ (22,699)
-9.8%
Basic income (loss) per share
$ 0.17
$ 0.22
$ (0.17)
$ (1.99)
Diluted income (loss) per share
$ 0.17
$ 0.22
$ (0.17)
$ (1.99)
BASSETT FURNITURE INDUSTRIES, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
Assets
November 27, 2010
November 28, 2009
Current assets
Cash and cash equivalents
$ 11,071
$ 23,221
Accounts receivable, net
31,621
34,605
Inventories
41,810
33,388
Other current assets
6,969
13,312
Total current assets
91,471
104,526
Property and equipment
Cost
142,362
152,153
Less accumulated depreciation
96,112
101,517
Property and equipment, net
46,250
50,636
Investments
15,111
14,931
Retail real estate
27,513
28,793
Notes receivable, net
7,508
8,309
Other
9,464
9,034
59,596
61,067
Total assets
$ 197,317
$ 216,229
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable
$ 24,893
$ 14,711
Accrued compensation and benefits
6,652
6,490
Customer deposits
9,171
5,946
Other accrued liabilities
11,594
11,730
Current portion of real estate notes payable
9,521
4,393
Total current liabilities
61,831
43,270
Long-term liabilities
Post employment benefit obligations
11,004
10,841
Bank debt
–
15,000
Real estate notes payable
4,295
16,953
Distributions in excess of affiliate earnings
7,356
10,954
Other long-term liabilities
6,526
8,877
29,181
62,625
Commitments and Contingencies
Stockholders’ equity
Common stock
57,795
57,274
Retained earnings
48,459
50,461
Additional paid-in-capital
478
481
Accumulated other comprehensive income
(427)
2,118
Total stockholders’ equity
106,305
110,334
Total liabilities and stockholders’ equity
$ 197,317
$ 216,229
BASSETT FURNITURE INDUSTRIES, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows – Unaudited
(In thousands)
Year Ended
Year Ended
November 27, 2010
November 28, 2009
Operating activities:
Net loss
$ (2,002)
$ (22,699)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
5,966
6,604
Equity in undistributed income of investments and unconsolidated affiliated companies
(4,737)
(2,319)
Provision for restructuring and asset impairment charges
–
2,987
Lease exit costs
–
2,434
Provision for lease and loan guarantees
1,407
2,834
Provision for losses on accounts and notes receivable
6,567
15,205
Other than temporary impairment of investments
–
1,255
Realized income from investments
(2,272)
(764)
Payment to terminate lease
–
(400)
Other, net
504
(2,364)
Changes in operating assets and liabilities
Accounts receivable
(4,467)
(6,744)
Inventories
(5,443)
11,704
Other current assets
5,262
3,451
Accounts payable and accrued liabilities
7,003
(7,064)
Net cash provided by operating activities
7,788
4,120
Investing activities:
Purchases of property and equipment
(2,013)
(1,096)
Proceeds from sales of property and equipment
4,247
129
Acquisition of retail licensee stores, net of cash acquired
(378)
(481)
Proceeds from sales of investments
9,101
26,234
Purchases of investments
(8,851)
(6,939)
Dividends from affiliates
937
3,847
Net cash received on licensee notes
494
645
Net cash provided by investing activities
3,537
22,339
Financing activities:
Net repayments under revolving credit facility
(15,000)
(4,000)
Repayments of real estate notes payable
(7,530)
(812)
Issuance of common stock
142
95
Repurchases of common stock
–
(75)
Cash dividends
–
(1,142)
Payments on other notes
(1,087)
(1,081)
Net cash used in financing activities
(23,475)
(7,015)
Change in cash and cash equivalents
(12,150)
19,444
Cash and cash equivalents – beginning of period
23,221
3,777
Cash and cash equivalents – end of period
$ 11,071
$ 23,221
BASSETT FURNITURE INDUSTRIES, INC. AND SUBSIDIARIES
Segment Information – Unaudited
(In thousands)
Quarter ended
Quarter ended
Year Ended
Year Ended
November 27, 2010
November 28, 2009
November 27, 2010
November 28, 2009
Net Sales
Wholesale
$ 49,322
(a)
$ 44,803
(a)
$ 176,255
(a)
$ 179,534
(a)
Retail
34,842
27,501
122,241
105,378
Inter-company elimination
(18,173)
(12,781)
(63,242)
(52,190)
Consolidated
$ 65,991
$ 59,523
$ 235,254
$ 232,722
Operating Income (Loss)
Wholesale
$ 1,561
(b)
$ 1,340
(b)
$ 2,431
(b)
$ (9,100)
(b)
Retail
(863)
(799)
(7,387)
(8,131)
Inter-company elimination
105
46
269
1,077
Income from CDSOA
488
1,627
488
1,627
Restructuring and asset impairment charges
–
(1,599)
–
(2,987)
Lease exit costs
–
(372)
–
(2,434)
Consolidated
$ 1,291
$ 243
$ (4,199)
$ (19,948)
(a) Excludes wholesale shipments for dealers where collectibility is not reasonably assured at time of shipment as follows:
November 27, 2010
November 28, 2009
Quarter ended
$ 85
$ 174
Year ended
947
7,149
(b) Includes bad debt and notes receivable valuation charges as follows:
November 27, 2010
November 28, 2009
Quarter ended
$ 1,431
$ 2,241
Year Ended
6,567
15,205
BASSETT FURNITURE INDUSTRIES, INC. AND SUBSIDIARIES
Reconciliation of Net Income (Loss) as Reported to Net Income (Loss) as Adjusted (Unaudited)
(In thousands, except for per share data)
Quarter ended
Per
Quarter ended
Per
Year Ended
Per
Year Ended
Per
November 27, 2010
Share
November 28, 2009
Share
November 27, 2010
Share
November 28, 2009
Share
Net income (loss) as reported
$ 1,941
$ 0.17
$ 2,566
$ 0.22
$ (2,002)
$ (0.17)
$ (22,699)
$ (1.99)
One-time tax benefit (1)
–
–
(1,672)
(0.15)
–
–
(1,672)
(0.15)
Income from CDSOA
(488)
(0.04)
(1,627)
(0.14)
(488)
(0.04)
(1,627)
(0.14)
Restructuring and asset impairment charges
–
–
1,599
0.14
–
–
2,987
0.26
Lease exit costs
–
–
372
0.03
–
–
2,434
0.21
Other than temporary impairment of securities
–
–
–
–
–
–
1,255
0.11
Closed stores and idle retail facility charges
804
0.07
450
0.04
2,256
0.20
2,062
0.18
Net income (loss) as adjusted
$ 2,257
$ 0.20
$ 1,688
$ 0.14
$ (234)
$ (0.01)
$ (17,260)
$ (1.51)
(1) $1.7 million tax benefit in 2009 associated with the one-time carryback of net operating losses resulting from a change in tax law.
The Company has included the “as adjusted” information because it uses, and believes that others may use, such information in comparing the Company’s operating results from period to period. The “as adjusted” information is not presented in conformity with generally accepted accounting principals in the United States. However, the items excluded in determining the “as adjusted” information are significant components in understanding and assessing the Company’s overall financial performance for the periods covered.
BASSETT FURNITURE INDUSTRIES, INC. AND SUBSIDIARIES
Supplemental Retail Information – Unaudited
(In thousands)
35 Comparable Stores
27 Comparable Stores
Quarter Ended
Quarter Ended
Year Ended
Year Ended
November 27, 2010
November 28, 2009
November 27, 2010
November 28, 2009
Percent of
Percent of
Percent of
Percent of
Amount
Net Sales
Amount
Net Sales
Amount
Net Sales
Amount
Net Sales
Net sales
$ 26,928
100.0%
$ 26,734
100.0%
$ 82,063
100.0%
$ 86,131
100.0%
Cost of sales
13,782
51.2%
13,661
51.1%
41,982
51.2%
45,293
52.6%
Gross profit
13,146
48.8%
13,073
48.9%
40,081
48.8%
40,838
47.4%
Selling, general and administrative expense*
13,492
50.1%
13,747
51.4%
43,288
52.8%
46,279
53.7%
Loss from operations
$ (346)
-1.3%
$ (674)
-2.5%
$ (3,207)
-3.9%
$ (5,441)
-6.3%
All Other Stores
All Other Stores
Quarter Ended
Quarter Ended
Year Ended
Year Ended
November 27, 2010
November 28, 2009
November 27, 2010
November 28, 2009
Percent of
Percent of
Percent of
Percent of
Amount
Net Sales
Amount
Net Sales
Amount
Net Sales
Amount
Net Sales
Net sales
$ 7,914
100.0%
$ 767
100.0%
$ 40,178
100.0%
$ 19,247
100.0%
Cost of sales
4,318
54.6%
431
56.2%
21,631
53.8%
10,535
54.7%
Gross profit
3,596
45.4%
336
43.8%
18,547
46.2%
8,712
45.3%
Selling, general and administrative expense
4,113
52.0%
461
60.0%
22,727
56.6%
11,402
59.2%
Loss from operations
$ (517)
-6.5%
$ (125)
-16.3%
$ (4,180)
-10.4%
$ (2,690)
-14.0%
*Comparable store SG&A includes retail corporate overhead and administrative costs.
CONTACT: J. Michael Daniel, Vice-President
and Chief Accounting Officer
(276) 629-6614 - Investors
Jay S. Moore, Director of
Communications
(276) 629-6450 - Media
Thursday, January 27th, 2011UncategorizedComments Off on Bassett (BSET) Announces 11% Sales Increase for the Fourth Quarter
DAQING, China, Jan. 24, 2011 /PRNewswire-Asia-FirstCall/ — China Nutrifruit Group Limited (NYSE Amex: CNGL) (“China Nutrifruit” or “the Company”), a leading producer of premium specialty fruit based products in China (“PRC”), today announced that the Company entered into a supply contract (the “Contract”) with Doehler Food and Beverage Ingredients (Rizhao) Co., Ltd. (“Doehler Rizhao”) to supply 1,500 tons of its fruit concentrate products.
Doehler Rizhao, a subsidiary of DoehlerGroup, is a global consumer brand which offers a variety of fruit concentrate juices, including apple, pear, strawberry and kiwi juice concentrates. . Pursuant to the Contract, China Nutrifruit will supply 1,500 tons of fruit concentrate products to Doehler Rizhao in January 2011 at the prevailing market price.
“Our new supply contract with Doehler Rizhao marks an important milestone for China Nutrifruit as we diversify our customer base with the addition of a global consumer brand,” commented Mr. Changjun Yu, Chairman of China Nutrifruit. “Our products passed stringent testing criteria and we are currently performing the contract. We believe this demonstrates the high-quality and market acceptance of our premium specialty fruit products. We are encouraged by our co-operation with Doehler Rizhao and will continue to step up our marketing efforts to further expand our customer base. We anticipate increased sales contribution from international customers in fiscal year 2011 and are confident that our nutritious specialty products will be well received in both the domestic and international markets.”
About China Nutrifruit Group Limited
Through its subsidiary Daqing Longheda Food Company Limited, China Nutrifruit, is engaged in developing, processing, marketing and distributing a variety of food products processed primarily from premium specialty fruits grown in Northeast China, including golden berry, crab apple, blueberry, seabuckthorn, blackcurrant and raspberry. The Company’s processing facility possesses ISO9001 and HACCP series qualifications. Currently, the Company has established an extensive sales and distribution network throughout 17 provinces in China. For more information, please visit http://www.chinanutrifruit.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act“”). Such statements include, among others, those concerning our supply contract with Doehler Rizhao, our ability to expand our international customer base,our expectation regarding market reception of our products, our expected financial performance in FY2011 and strategic and operational plans, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words “believe,““expect,““anticipate,““project,““targets,““optimistic,““intend,““aim,““will“ or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in China; any statements of belief or intention; any of the factors mentioned in the “Risk Factors“ section of our Annual Report on Form 10-K for the year ended March 31, 2010, and other risks and uncertainties mentioned in our other reports filed with the Securities and Exchange Commission. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.
Company Contact:
Investor Relations Contact:
Mr. Colman Cheng, Chief Financial Officer
Mr. Crocker Coulson, President
China Nutrifruit Group Limited
CCG Investor Relations
Tel:+ 852 9039 8111
Tel: +1-646-213-1915 (NY office)
Email: zsj@chinanutrifruit.com
Email: crocker.coulson@ccgir.com
Website: www.chinanutrifruit.com
Website: www.ccgirasia.com
Elaine Ketchmere, Partner
Tel: +1-310-954-1345 (LA office)
Email: elaine.ketchmere@ccgir.com
Monday, January 24th, 2011UncategorizedComments Off on China Nutrifruit (CNGL) Signs Supply Contract with Doehler Rizhao
SAN DIEGO, Jan. 24, 2011 /PRNewswire/ — Genoptix, Inc. (Nasdaq: GXDX) announced today that it has entered into a definitive merger agreement to be acquired by Novartis. Under the terms of the merger agreement, Novartis will commence an all cash tender offer for all outstanding shares of common stock of Genoptix at USD$25.00 per share. The transaction implies, on a fully-diluted basis, a total equity value of approximately USD$470 million and an enterprise value of USD$330 million.
The $25.00 per share cash offer price represents a premium of 39% over Genoptix’ unaffected closing share price of $17.98 on December 13, 2010 and a 27% premium over the closing price of USD$19.76 on January 21, 2011.
Genoptix’ Chief Executive Officer, Tina S. Nova, Ph.D., stated, “We believe this transaction provides substantial value and liquidity to our stockholders. We are excited about becoming part of the Novartis Molecular Diagnostics (MDx) unit and continuing to enhance the value that we bring to our core community oncologist customers. We share Novartis’ strong commitment to transforming patient care, improving health outcomes for patients and enhancing the suite of diagnostic tools for our physician customers.”
Genoptix’ board of directors unanimously determined that the merger agreement and the transactions contemplated thereby are fair to and in the best interests of Genoptix and its stockholders, and recommends that Genoptix’ stockholders tender their shares and adopt the merger agreement.
Each of Genoptix’ directors and executive officers has agreed to tender their shares in the offer.
The transaction is conditioned upon the tender of at least a majority of the shares of Genoptix in the tender offer, receipt of regulatory approvals and other customary closing conditions. The transaction is expected to close within the first half of 2011.
The terms and conditions of the tender offer will be described in the tender offer documents, which will be filed with the U.S. Securities and Exchange Commission (“SEC”).
Barclays Capital is serving as financial advisor to Genoptix and Cooley LLP is serving as Genoptix’ legal advisor.
About Genoptix, Inc.
Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.
This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Genoptix. The tender offer for shares of Genoptix described in this press release has not yet been commenced. The offer to buy shares of Genoptix common stock will be made only pursuant to the offer to purchase and related materials that Novartis will file on Schedule TO with the SEC. At the same time, Genoptix will file its recommendation of the tender offer on Schedule 14D-9 with the SEC. Genoptix stockholders and other investors should read these materials carefully because they contain important information, including the terms and conditions of the offer. These materials and any other documents filed by Novartis or Genoptix with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov and by contacting Genoptix Investor Relations at 800-881-3100. In addition, investors and security holders will be able to obtain free copies of the documents filed with the SEC on Genoptix’ website at www.Genoptix.com. Investors and security holders are urged to read the Schedule TO, as amended from time to time, and the Schedule 14D-9, as amended from time to time, and the other relevant materials before making any investment decision with respect to the tender offer.
Statements in this press release that relate to future results and events are forward-looking statements based on Genoptix’ current expectations regarding the tender offer and transactions contemplated by the merger agreement. Actual results and events in future periods may differ materially from those expressed or implied by these forward-looking statements because of a number of risks, uncertainties and other factors. There can be no assurances that a transaction will be consummated. Other risks, uncertainties and assumptions include the possibility that expected benefits may not materialize as expected; that the transaction may not be timely completed, if at all; that, prior to the completion of the transaction, if at all, Genoptix may not satisfy one or more closing conditions; that the merger agreement may be terminated; and the impact of the current economic environment, fluctuations in operating results, market acceptance of Genoptix’ services, and other risks that are described in Genoptix’ Annual Report on Form 10-K for the year ended December 31, 2009, in its most recent Quarterly Report of Form 10-Q and in its subsequently filed SEC reports. Genoptix undertakes no obligation to update these forward-looking statements except to the extent otherwise required by law.
SOURCE Genoptix, Inc.
Monday, January 24th, 2011UncategorizedComments Off on Genoptix (GXDX) Announces Agreement to be Acquired by Novartis
ROANOKE, Va., Jan. 24, 2011 /PRNewswire/ — Optical Cable Corporation (Nasdaq GM: OCCF) (“OCC®” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended October 31, 2010.
OCC’s consolidated net sales for fiscal year 2010 were the highest in the Company’s history.
Fourth Quarter 2010 Financial Results
Consolidated net sales for the fourth quarter of fiscal year 2010 increased 31.1% to $18.5 million compared to net sales of $14.1 million for the comparable period in fiscal year 2009. Net sales in both the Company’s commercial market and its specialty markets increased during the fourth quarter of fiscal year 2010 compared to the same period last year. The acquisition of Applied Optical Systems, Inc. (“AOS”) by OCC on October 31, 2009 also contributed to the net sales growth achieved by the Company in the fourth quarter of fiscal year 2010.
Gross profit increased 47.9% to $7.2 million in the fourth quarter of fiscal year 2010, compared to $4.8 million for the fourth quarter of fiscal year 2009. Gross profit margin, or gross profit as a percentage of net sales, increased to 38.8% in the fourth quarter compared to 34.4% in the same period last year.
OCC recorded net income attributable to the Company of $1.5 million, or $0.23 per basic and diluted share, for the fourth quarter of fiscal year 2010, compared to a net loss of $90,000, or $0.01 per basic and diluted share, for the fourth quarter of fiscal year 2009.
During the fourth quarter of fiscal year 2010, OCC reversed a $666,000, or $0.10 per share, goodwill impairment charge associated with a purchase accounting adjustment in connection with the AOS acquisition. Excluding the positive impact that this goodwill impairment charge reversal had on income from operations, the Company’s proforma net income attributable to OCC was $808,000, or $0.13 per share, during the fourth quarter of fiscal year 2010.(1)
Fiscal Year 2010 Financial Results
Consolidated net sales increased 15.2% to $67.5 million in fiscal year 2010, compared to $58.6 million in fiscal year 2009. Net sales growth during the fiscal year was achieved over a broad customer base and product mix, with notable increases in both commercial and specialty markets, despite the difficult economic environment. The AOS acquisition also contributed to the net sales growth achieved by the Company in fiscal year 2010.
Geographically, OCC achieved consolidated net sales growth both in international markets and within the United States. Net sales to customers located outside of the United States increased 14.3% in fiscal year 2010 compared to the prior year, and net sales to customers located in the United States increased 15.6%.
Gross profit increased 19.8% to $23.8 million for fiscal year 2010, compared to $19.8 million for fiscal year 2009. Gross profit margin, or gross profit as a percentage of net sales, increased to 35.2% for fiscal year 2010 from 33.9% for fiscal year 2009.
For fiscal year 2010, OCC recorded a net loss attributable to the Company of $5.7 million, or $0.95 per basic and diluted share, compared to a net loss of $1.9 million, or $0.34 per basic and diluted share, for fiscal year 2009. Significantly contributing to the net loss for fiscal year 2010 was a non-recurring, non-cash net impairment charge of $5.6 million recorded to write-off the carrying value of the goodwill associated with the acquisition of AOS.
Excluding the non-recurring, non-cash net goodwill impairment charge of $5.6 million, the Company would have reported a net loss attributable to OCC of $153,000, or $0.03 per share, for fiscal year 2010.(2)
At the end of fiscal year 2010, OCC’s net book value attributable to OCC was $27.9 million, or $4.44 per share. In addition, OCC had a retained earnings balance of $21.9 million, or $3.48 per share as of the end of the fiscal year. OCC’s share price closed at $3.70 per share on Friday, January 21, 2011.
Management’s Comments
Neil Wilkin, President and Chief Executive Officer of OCC, said, “During the fiscal fourth quarter, we built on OCC’s strong momentum to finish the year with the highest net sales in our company’s history. Importantly, we generated record revenue by meeting the needs of our diverse, global customer base, which is increasingly taking advantage of OCC’s comprehensive suite of products and integrated solutions. With our strategic acquisitions now positively contributing to our bottom line results, we are focused on maintaining our operational discipline and executing on our plan to grow sales and earnings in order to create meaningful value for shareholders.”
Mr. Wilkin added, “In addition to achieving record sales, we are pleased to have further strengthened our balance sheet and initiated a quarterly dividend to provide a regular return of capital to our shareholders. Despite challenging economic and market conditions, we demonstrated OCC’s strength in 2010 and we are confident in OCC’s strategy, market position and prospects for continued growth and value creation in the future.”
Company Information
Optical Cable Corporation (“OCC”) is a leading manufacturer of a broad range of fiber optic and copper data communications cabling and connectivity solutions primarily for the enterprise market, offering an integrated suite of high quality, warranted products which operate as a system solution or seamlessly integrate with other providers’ offerings. OCC’s product offerings include designs for uses ranging from commercial, enterprise network, datacenter, residential and campus installations to customized products for specialty applications and harsh environments, including military, industrial, mining and broadcast applications. OCC products include fiber optic and copper cabling, fiber optic and copper connectors, specialty fiber optic and copper connectors, fiber optic and copper patch cords, pre-terminated fiber optic and copper cable assemblies, racks, cabinets, datacom enclosures, patch panels, face plates, multi-media boxes and other cable and connectivity management accessories, and are designed to meet the most demanding needs of end-users, delivering a high degree of reliability and outstanding performance characteristics.
OCC® is internationally recognized for pioneering the design and production of fiber optic cables for the most demanding military field applications, as well as of fiber optic cables suitable for both indoor and outdoor use, and creating a broad product offering built on the evolution of these fundamental technologies. OCC also is internationally recognized for its role in establishing copper connectivity data communications standards, through its innovative and patented technologies.
Founded in 1983, OCC is headquartered in Roanoke, Virginia with offices, manufacturing and warehouse facilities located in each of Roanoke, Virginia, near Asheville, North Carolina and near Dallas, Texas. OCC primarily manufactures its fiber optic cables at its Roanoke facility which is ISO 9001:2008 registered and MIL-STD-790F certified, its enterprise connectivity products at its Asheville facility which is ISO 9001:2008 registered, and its military and harsh environment connectivity products and systems at its Dallas facility which is ISO 9001:2008 registered and MIL-STD-790F certified.
Optical Cable Corporation, OCC®, Superior Modular Products, SMP Data Communications, Applied Optical Systems, and associated logos are trademarks of Optical Cable Corporation.
Further information about OCC is available on the Internet at www.occfiber.com.
FORWARD-LOOKING INFORMATION
This news release by Optical Cable Corporation and its subsidiaries (collectively, the “Company” or “OCC”) may contain certain forward-looking information within the meaning of the federal securities laws. The forward-looking information may include, among other information, (i) statements concerning our outlook for the future, (ii) statements of belief, anticipation or expectation, (iii) future plans, strategies or anticipated events, and (iv) similar information and statements concerning matters that are not historical facts. Such forward-looking information is subject to variables, uncertainties, contingencies and risks that may cause actual events to differ materially from our expectations, and furthermore, such variables, uncertainties, contingencies and risks may also adversely affect Optical Cable Corporation and its subsidiaries, the Company’s future results of operations and future financial condition, and/or the future equity value of the Company. Factors that could cause or contribute to such differences from our expectations or could adversely affect the Company include, but are not limited to: the level of sales to key customers, including distributors; timing of certain projects and purchases by key customers; the economic conditions affecting network service providers; corporate and/or government spending on information technology; actions by competitors; fluctuations in the price of raw materials (including optical fiber, copper, gold and other precious metals, and plastics and other materials affected by petroleum product pricing); fluctuations in transportation costs; our dependence on customized equipment for the manufacture of our products and a limited number of production facilities; our ability to protect our proprietary manufacturing technology; our ability to replace royalty income as existing patented and licensed products expire by developing and licensing new products; market conditions influencing prices or pricing; our dependence on a limited number of suppliers; the loss of, or conflict with, one or more key suppliers or customers; an adverse outcome in litigation, claims and other actions, and potential litigation, claims and other actions against us; an adverse outcome in regulatory reviews and audits and potential regulatory reviews and audits; adverse changes in state tax laws and/or positions taken by state taxing authorities affecting us; technological changes and introductions of new competing products; changes in end-user preferences for competing technologies, relative to our product offering; economic conditions that affect the telecommunications sector, certain technology sectors or the economy as a whole; changes in demand of our products from certain competitors for which we provide private label connectivity products; terrorist attacks or acts of war, and any current or potential future military conflicts; changes in the level of military spending by the United States government; ability to retain key personnel; inability to recruit needed personnel; poor labor relations; the inability to successfully complete the integration of the operations of our new subsidiaries; the impact of changes in accounting policies and related costs of compliance, including changes by the Securities and Exchange Commission (SEC), the Public Company Accounting Oversight Board (PCAOB), the Financial Accounting Standards Board (FASB), and/or the International Accounting Standards Board (IASB); our ability to continue to successfully comply with, and the cost of compliance with, the provisions of Section 404 of the Sarbanes-Oxley Act of 2002 or any revisions to that act which apply to us; the impact of changes and potential changes in federal laws and regulations adversely affecting our business and/or which result in increases in our direct and indirect costs, including our direct and indirect costs of compliance with such laws and regulations; the impact of the Patient Protection and Affordable Care Act of 2010, the Health Care and Education Reconciliation Act of 2010, and any revisions to those acts that apply to us and the related legislation and regulation associated with those acts, which directly or indirectly results in increases to our costs; the impact of changes in state or federal tax laws and regulations increasing our costs; impact of future consolidation among competitors and/or among customers adversely affecting our position with our customers and/or our market position; actions by customers adversely affecting us in reaction to the expansion of our product offering in any manner, including, but not limited to, by offering products that compete with our customers, and/or by entering into alliances with, making investments in or with, and/or acquiring parties that compete with and/or have conflicts with customers of ours; voluntary or involuntary delisting of the Company’s capital stock from any exchange on which it is traded; the deregistration by the Company from SEC reporting requirements, as a result of the small number of holders of the Company’s capital stock; adverse reactions by customers, vendors or other service providers to unsolicited proposals regarding the ownership or management of the Company; the additional costs of considering and possibly defending our position on such unsolicited proposals; impact of weather or natural disasters in the areas of the world in which we operate and market our products; an increase in the number of the Company’s capital stock issued and outstanding; economic downturns and/or changes in market demand, exchange rates, productivity, or market and economic conditions in the areas of the world in which we operate and market our products; and our success in managing the risks involved in the foregoing. The foregoing is not intended to be complete and the Company is subject to other variables, uncertainties, contingencies and risks than those set forth above.
(1) This reversal of a goodwill impairment charge partially reduces the $6.2 million non-cash, non-recurring goodwill impairment charge recorded by the Company during the second quarter of fiscal year 2010. The purchase accounting adjustment made during the fourth quarter was primarily the result of the Company’s adjustment to the valuation of certain deferred tax assets acquired in the purchase of AOS, and is not a result of a re-evaluation of the goodwill impairment recorded during the second quarter of fiscal year 2010. There is no tax benefit associated with the reversal of the goodwill impairment charge in the fourth quarter, as it is considered a non-deductible permanent item for tax purposes. Accordingly, there is no change to the tax expense as reported for fourth quarter of fiscal year 2010 in determining the proforma net loss and net loss per share.
(2) This proforma net loss attributable to OCC and proforma net loss per share attributable to OCC are calculated by excluding the non-cash, non-recurring net impairment of goodwill charge of $5.6 million that was recorded during fiscal year 2010 from the Company’s net loss attributable to OCC as reported for the fiscal year ended October 31, 2010. The net goodwill impairment charge of $5.6 million during fiscal year 2010 consists of (i) a $6.2 million goodwill impairment charge recognized during the second quarter of fiscal year 2010 and (ii) a $666,000 reversal of the goodwill charge associated with a purchase accounting adjustment recognized during the fourth quarter of fiscal year 2010. There is no tax benefit associated with the goodwill impairment charge, as it is considered a non-deductible permanent item for tax purposes. Accordingly, there is no change to the tax expense as reported for fiscal year 2010 in determining the proforma net loss and net loss per share.
(Financial Tables Follow)
OPTICAL CABLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(thousands, except per share data)
(unaudited)
Three Months Ended
October 31,
Fiscal Year Ended
October 31,
2010
2009
2010
2009
Net sales
$ 18,464
$ 14,080
$ 67,506
$ 58,589
Cost of goods sold
11,298
9,233
43,746
38,748
Gross profit
7,166
4,847
23,760
19,841
SG&A expenses
6,028
5,336
24,268
22,345
Royalty income, net
(309)
(198)
(1,233)
(878)
Amortization of intangible assets
146
199
587
825
Impairment of goodwill
(666)
–
5,580
–
Impairment of intangible assets (other than goodwill)
–
153
–
344
Income (loss) from operations
1,967
(643)
(5,442)
(2,795)
Interest income (expense), net
(157)
653
(542)
149
Other, net
(3)
(9)
65
16
Other income (expense), net
(160)
644
(477)
165
Income (loss) before income taxes
1,807
1
(5,919)
(2,630)
Income tax expense (benefit)
455
91
91
(706)
Net income (loss)
$ 1,352
$ (90)
$ (6,010)
$ (1,924)
Net loss attributable to noncontrolling
interest (2)
(122)
–
(277)
–
Net income (loss) attributable to OCC
$ 1,474
$ (90)
$ (5,733)
$ (1,924)
Net income (loss) per share attributable to
OCC: Basic and diluted
$ 0.23
$ (0.01)
$ (0.95)
$ (0.34)
PROFORMA net income (loss) attributable to OCC, EXCLUDING impairment of goodwill (1)
$ 808
$ (153)
PROFORMA net income (loss) per share attributable to OCC, EXCLUDING impairment of goodwill: Basic and diluted (1)
$ 0.13
$ (0.03)
OPTICAL CABLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (continued)
(thousands, except per share data)
(unaudited)
Three Months Ended
October 31,
Fiscal Year Ended
October 31,
2010
2009
2010
2009
Weighted average shares outstanding:
Basic and diluted
6,388
6,543
6,015
5,656
(1) Proforma net income (loss) attributable to OCC and proforma net income (loss) per share attributable to OCC are calculated by excluding the non-cash, non-recurring net impairment of goodwill charge of $5.6 million associated with the acquisition of Applied Optical Systems, Inc. (“AOS”) that was recorded during fiscal year 2010 from the Company’s net loss attributable to OCC as reported for the fiscal year ended October 31, 2010. The goodwill impairment charge of $5.6 million consists of (i) a $6.2 million goodwill impairment charge recognized during the second quarter of fiscal year 2010 and (ii) a $666,000 reversal of the goodwill charge associated with a purchase accounting adjustment recognized during the fourth quarter of fiscal year 2010. The purchase accounting adjustment made during the fourth quarter was primarily the result of the Company’s adjustment to the valuation of certain deferred tax assets acquired in the purchase of AOS, and is not a result of a re-evaluation of the goodwill impairment recorded during the second quarter of fiscal year 2010. There is no tax benefit associated with the goodwill impairment charge, as it is considered a non-deductible permanent item for tax purposes. Accordingly, there is no change to the tax expense as reported for fiscal year 2010 in determining the proforma net loss and net loss per share.
(2) Accounting Standards Codification 810-10, Consolidation (“ASC 810-10“), was adopted by OCC effective for fiscal year 2010 as it relates to noncontrolling interests. There are no noncontrolling interest amounts presented for fiscal year 2009 since the minority interest’s share of losses attributable to Centric Solutions LLC was charged against the Company’s majority interest in accordance with the previous accounting literature.
OPTICAL CABLE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEET DATA
(thousands)
(unaudited)
October 31,
2010
October 31,
2009
Cash and cash equivalents
$ 2,522
$ 1,948
Trade accounts receivable, net
10,660
9,533
Inventories
14,423
12,306
Other current assets
3,062
3,915
Total current assets
30,667
27,702
Non-current assets
14,624
22,625
Total assets
$ 45,291
$ 50,327
Current liabilities
$ 7,762
$ 7,632
Non-current liabilities
9,949
9,438
Total liabilities
17,711
17,070
Total shareholders’ equity attributable to OCC
27,857
33,257
Noncontrolling interest (a)
(277)
–
Total shareholders’ equity
27,580
33,257
Total liabilities and shareholders’ equity
$ 45,291
$ 50,327
(a) ASC 810-10, Consolidation, was adopted by OCC effective for fiscal year 2010 as it relates to noncontrolling interests. There are no noncontrolling interest amounts presented for fiscal year 2009 since the minority interest’s share of losses attributable to Centric Solutions LLC was charged against the Company’s majority interest in accordance with the previous accounting literature.
AT THE COMPANY:
Neil Wilkin
Tracy Smith
Chairman, President & CEO
Senior Vice President & CFO
(540) 265-0690
(540) 265-0690
investorrelations@occfiber.com
investorrelations@occfiber.com
AT JOELE FRANK, WILKINSON BRIMMER KATCHER:
Andrew Siegel
Aaron Palash
(212) 355-4449 ext. 127
(212) 355-4449 ext. 103
occf-jfwbk@joelefrank.com
occf-jfwbk@joelefrank.com
Monday, January 24th, 2011UncategorizedComments Off on Optical Cable Corp. (OCCF) Reports Fourth Quarter and Fiscal Year 2010 Financial Results
Jan. 24, 2011 (Business Wire) — Clinical Data, Inc. (NASDAQ: CLDA), today announced that the U.S. Food and Drug Administration (FDA) has approved vilazodone HCl tablets, to be marketed under the brand name Viibryd™, for the treatment of adults with major depressive disorder (MDD).1 Viibryd is a new molecular entity and the first and only selective serotonin reuptake inhibitor and 5HT1A receptor partial agonist.1 Clinical Data plans to make Viibryd available in U.S. pharmacies in the second quarter of this year.
U.S. Food and Drug Administration Approves Viibryd(TM) (vilazodone HCl tablets) for Major Depressive Disorder (see accompanying press release for details)(Photo: Business Wire)
“When treating MDD, our goal is to offer treatment options that meet the individual needs of each patient,” said Stephen M. Stahl, M.D., Ph.D., Professor of Psychiatry, University of California, San Diego. “Viibryd is an important new treatment option with proven efficacy and a demonstrated safety profile.”
The mechanism of the antidepressant effect of Viibryd is not fully understood but is thought to be related to its enhancement of serotonergic activity in the central nervous system (CNS) through selective inhibition of serotonin reuptake. Viibryd is also a partial agonist at serotonergic 5HT1A receptors; however, the net result of this action on serotonergic transmission and its role in Viibryd’s antidepressant effect are unknown.1
The efficacy of Viibryd as a treatment for MDD was established in two 8-week, multicenter, randomized, double-blind, placebo-controlled studies in adults who met the criteria for MDD. In these studies, patients were titrated over two weeks to a dose of 40 mg of Viibryd once daily. Viibryd was superior to placebo in the improvement of depressive symptoms as measured by the mean change from baseline to week 8 in the Montgomery-Asberg Depression Rating Scale (MADRS) total score.
Viibryd was demonstrated to be safe in clinical studies. In the placebo-controlled, Phase III studies, the most commonly observed adverse reactions in Viibryd-treated patients were diarrhea, nausea, vomiting and insomnia. No single adverse event led to discontinuation of treatment in greater than 1% of patients. Overall, 7.1% of the patients who received Viibryd discontinued treatment due to an adverse reaction, compared to 3.2% of placebo-treated patients. Viibryd has not been associated with any clinically important changes in laboratory test parameters including liver function tests, ECG including QT interval, or vital signs. In addition, Viibryd had no effect on body weight as measured by mean change from baseline in the 8-week studies. Among the common adverse reactions (≥2%) related to sexual function with Viibryd compared to placebo were decreased libido (4% vs. <1%), abnormal orgasm (3% vs. 0%), delayed ejaculation (2% vs. 0%, males only), and erectile dysfunction (2% vs. 1%, males only).1
“While there are currently available treatments for MDD, no one therapy works for every patient and side effect profiles vary, which may impact both compliance and treatment success,” said Carol R. Reed M.D., Executive Vice President and Chief Medical Officer of Clinical Data. “Viibryd will be a new choice for healthcare providers and their patients who are suffering from depression.”
“Viibryd is the only antidepressant that is a selective serotonin reuptake inhibitor and 5HT1A receptor partial agonist,” said Drew Fromkin, President and CEO of Clinical Data. “It is also the first drug that the Company has developed, and to have received marketing approval from the FDA on its first review is a significant milestone for Clinical Data.”
About Depression
Major depressive disorder (MDD), also called major depression, is a mental disorder characterized by an imbalance of chemicals in the brain, also called neurotransmitters, and is one of the most common mental disorders in the U.S. A person diagnosed with MDD exhibits a combination of symptoms that interfere with one’s ability to work, sleep, study, eat, and enjoy once–pleasurable activities. Though an episode of depression may occur only once in a person’s life, it more commonly recurs throughout a person’s lifetime.2
The World Health Organization estimates that MDD affects approximately 18 million people in the U.S.3 More than 212 million prescriptions were written for antidepressants in 2009.4
About Viibryd (vilazodone HCl tablets)
Viibryd was approved for marketing by the FDA on January 21, 2011 for the treatment of MDD in adults. Clinical Data holds exclusive worldwide rights to Viibryd from Merck KGaA, Darmstadt, Germany. The safety of Viibryd was evaluated in 2,177 patients diagnosed with MDD.
Important Information About Viibryd
Indication
VIIBRYD (vilazodone) is indicated for the treatment of major depressive disorder (MDD) in adults.1
Important Safety Information
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders.Anyone considering the use of VIIBRYD or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need.Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior.Families and caregivers should be advised of the need for close observation and communication with the prescriber.VIIBRYD is not approved for use in pediatric patients.1
Contraindications
VIIBRYD must not be used concomitantly in patients taking MAOIs or in patients who have taken MAOIs within the preceding 14 days due to the risk of serious, sometimes fatal, drug interactions with serotonergic drugs. Allow at least 14 days after stopping VIIBRYD before starting an MAOI.1
Warnings and Precautions
All patients treated with antidepressants should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the first few months of treatment and when changing the dose. Consider changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse or includes symptoms of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, or suicidality that are severe, abrupt in onset, or were not part of the patient’s presenting symptoms.1Families and caregivers of patients being treated with antidepressants should be alerted about the need to monitor patients.1
The development of potentially life-threatening serotonin syndrome or Neuroleptic Malignant Syndrome (NMS)-like reactions has been reported with antidepressants alone, but particularly with concomitant use of serotonergic drugs (including triptans) with drugs which impair metabolism of serotonin (including MAOIs), or with antipsychotics or other dopamine antagonists. Symptoms of serotonin syndrome were noted in 0.1% of patients treated with VIIBRYD. Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g., hyperreflexia, incoordination) and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea). Patients should be monitored for the emergence of serotonin syndrome or NMS-like signs and symptoms while treated with VIIBRYD.1
Symptoms of mania/hypomania were noted in 0.1% of patients treated with VIIBRYD in clinical studies. As with all antidepressants, VIIBRYD should be used cautiously in patients with a history or family history of mania or hypomania.1
Prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder. VIIBRYD is not approved for use in treating bipolar depression.1
Discontinuation symptoms have been reported with discontinuation of serotonergic drugs such as VIIBRYD. Gradual dose reduction is recommended, instead of abrupt discontinuation, whenever possible. Monitor patients for these symptoms when discontinuing VIIBRYD. If intolerable symptoms occur following a dose decrease or upon discontinuation of treatment, consider resuming the previously prescribed dose and decreasing the dose at a more gradual rate.1
Like other antidepressants, VIIBRYD should be prescribed with caution in patients with a seizure disorder.1
The use of drugs that interfere with serotonin reuptake, including VIIBRYD, may increase the risk of bleeding events. Patients should be cautioned about the risk of bleeding associated with the concomitant use of VIIBRYD and NSAIDs, aspirin, or other drugs that affect coagulation or bleeding.1
Advise patients that if they are treated with diuretics, or are otherwise volume depleted, or are elderly they may be at greater risk of developing hyponatremia while taking VIIBRYD.1 Although no cases of hyponatremia resulting from VIIBRYD treatment were reported in the clinical studies, hyponatremia has occurred as a result of treatment with SSRIs and SNRIs. Discontinuation of VIIBRYD in patients with symptomatic hyponatremia and appropriate medical intervention should be instituted.1
Adverse Reactions
The most commonly observed adverse reactions in MDD patients treated with VIIBRYD in placebo-controlled studies (incidence ≥ 5% and at least twice the rate of placebo) were: diarrhea (28% vs. 9%), nausea (23% vs. 5%), insomnia (6% vs. 2%), and vomiting (5% vs. 1%).1
Please see full prescribing information for VIIBRYD at www.viibryd.com. To report suspected adverse reactions, please call Clinical Data, Inc. at 1-877-878-7200 or the FDA at 1-800-FDA-1088 / www.fda.gov/medwatch.
VIIBRYD™ is a trademark of Clinical Data, Inc. and its affiliates.
Conference Call Information
Date: Monday, January 24, 2011
Time: 8:30 a.m. ET
Internet: The live webcast can be accessed at www.clda.com, in the Investor Relations section.
Clinical Data’s mission is to develop first-in-class and best-in-category therapeutics. The Company’s lead product, Viibryd, was approved for marketing by the FDA for the treatment of major depressive disorder in adults. The Company is also advancing its late-stage drug candidate, Stedivaze, a pharmacologic stress agent in Phase III development for use during myocardial perfusion imaging. Clinical Data has promising drug candidates entering the clinic in major therapeutic areas including asthma, ophthalmology and diabetes. To learn more, please visit the Company’s website at www.clda.com.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This press release contains certain forward-looking information and statements that are intended to be covered by the safe harbor for forward looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as “expect(s)”, “feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements about our ability to successfully introduce Viibryd; our ability to expand our long-term business opportunities; and all other statements regarding future performance. All such information and statements are subject to certain risks and uncertainties, the effects of which are difficult to predict and generally beyond the control of the Company, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements contained in this press release. These risks and uncertainties include, but are not limited to, whether Viibryd will be successfully marketed; the strength of our intellectual property rights, including, but not limited to, our patents for the various polymorphic versions of Viibryd; competition from pharmaceutical and biotechnology companies; general economic conditions; and those risks identified and discussed by Clinical Data in its filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements that speak only as of the date hereof. Clinical Data does not undertake any obligation to publish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in Clinical Data’s SEC periodic and interim reports, including but not limited to its Annual Report on Form 10-K for the fiscal year ended March 31, 2010, Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2010, and Current Reports on Form 8-K filed from time to time by the Company.
NEW YORK, Jan. 21, 2011 /PRNewswire/ — CleanTech Innovations, Inc. (Nasdaq: CTEK), a U.S. company and a market leader in China’s clean technology solutions in the wind energy industry, announced today that CleanTech has signed two initial wind tower supply contracts totaling US$11 million (RMB 72,732,000, including VAT tax) with a subsidiary of China HuaNeng Group, the largest energy company in China. CleanTech will supply these wind towers to HuaNeng in 2011. HuaNeng has been a long-standing customer of CleanTech. China HuaNeng Group posted US$35 billion in revenue for 2010 and had total assets of US$99 billion.
The completion of the $20 million in bridge financing with institutional investors on December 13, 2010, made it possible for CleanTech to submit contract bids to HuaNeng before the December 18, 2010 bidding deadline.
CleanTech has submitted other contract bids to HuaNeng and other large energy companies in China. CleanTech anticipates winning additional wind tower supply contracts throughout 2011.
Bei Lu, Chairman & CEO of CleanTech commented: “These two recent contracts represent approximately 50% of our entire 2010 revenues. The new contracts are critical to meeting our 2011 revenue targets in a favorable market environment. CleanTech’s management team is also the founders of our company. As CleanTech has already disclosed publicly, our entire management and insider holdings are locked up and prohibited from any share sales for at least 3 years through December 2013. CleanTech management’s vested interest is completely aligned with those of our public shareholders. We look forward to delivering another year of record earnings growth in 2011.”
Large state-owned energy companies such as HuaNeng are the final customers and integrators of the wind energy industry in China. Topping the five major power producers in China, HuaNeng accounts for 11.9% of domestic power capacity, and 17% of China’s clean energy capacity. In 2010, HuaNeng accounted for 12.8% of China’s total power generation.
About CleanTech Innovations, Inc.
CleanTech Innovations, Inc. (Nasdaq: CTEK) is a U.S. public company with its primary operations in China. CleanTech designs and manufactures high performance clean technology products that promote renewable energy generation, energy savings and pollution reduction. CleanTech’s products include wind turbine towers, bellows expansion joints and pressure vessels, which are broadly used in the wind power, steel, coking, petrochemical, high voltage electricity transmission and thermoelectric industries. CleanTech’s longstanding customers include China Guodian, HuaNeng Energy, Sinosteel and other industrial companies.
Safe Harbor Statement
All statements in this press release that are not historical are forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ from the company’s expectations. You are cautioned not to place undue reliance on any forward-looking statements in this press release as they reflect CleanTech’s current expectations with respect to future events and are subject to risks and uncertainties that may cause actual results to differ materially from those contemplated. Potential risks and uncertainties include, but are not limited to, the risks described in CleanTech’s filings with the Securities and Exchange Commission.
Corporate Contact
Mr. Jason Li
Corporate Communications
CleanTech Innovations, Inc.
Tel: 011-86- 157-1403-7180
Email: investors@ctiproduct.com
Website: www.ctiproduct.com
SOURCE CleanTech Innovations, Inc.
Friday, January 21st, 2011UncategorizedComments Off on CleanTech Innovations, Inc. (CTEK) Receives $11 Million In Initial Wind Tower Supply Contracts